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Summary
This thesis describes a series of studies investigating the relationship between diet, 
and in particular carbohydrate intake, and risk factors for type 2 diabetes and 
coronary heart disease (CHD).
The first study investigated the effect of advice to increase carbohydrate intake as 
part of dietaiy advice to follow the dietary guidelines on metabolic risk factors for 
CHD in postmenopausal women (Chapter 3).
The results showed that subjects appeared to have followed the dietary advice given 
as they reported significantly reducing their total daily energy (P = 0.011), fat {P = 
0.008) and non-milk extrinsic sugar (NMES) intake ( f  = 0.015), and significantly 
increasing their total carbohydrate {P = 0.026), starch {P = 0.013^ and non-starch 
polysaccharide (NSP) intake (P = 0.050). Subjects also significantly increased their 
dietary glycaemic index (GÎ) (P = 0.011). There was a significant reduction in body 
mass index (BMI) (P = 0.014), and an adverse effect on fasting plasma lipids 
including an increase in fasting TAG (P = 0.014), and a decrease in HDL cholesterol 
concentrations (P -  0.021). Subjects reported increasing their consumption of fiuit 
and vegetables, and there was a significant increase in the ‘antioxidant power’ of 
plasma (P = 0.007). This appears to have mostly been associated with an increase in 
fruit intake.
Conelation analyses showed that simple sugars appeared to have a more adverse 
effect on plasma lipids than starch. From this a decision was made to study the 
relationships between GI and plasma lipids and other metabolic risk factors in data 
that had already been collected.
The main findings of this case control study on offspring of patients of type 2 
diabetes (olfspring) and control subjects (Chapter 4) showed that there were no 
differences in habitual dietary intake, GI or GL between the groups. Offspring were 
found to demonstrate many of the features of the metabolic syndrome as they had 
greater levels of adiposity and female offspring had significantly higher waist to hip
ratio IP = 0.036), waist circumference (P -  0.063) and BMI (P = 0.083) compared 
with female control subjects. Offspring were significantly more insulin resistant 
compared with control subjects with significantly higher fasting insulin (P = 0.049) 
and higher HOMAir (P = 0.052) and significantly lower HDL cholesterol 
concentrations (P = 0.011).
However, dietaiy GI and GL were not found to be directly associated with any of the 
metabolic parameters measured in the study, but GI was positively coiTelated with 
waist circumference (P = 0.039) and waist to hip ratio (P = 0.043), mid measures o f 
adiposity were significantly correlated with many of the metabolic parameters 
measured in the study. Thus, while the glycaemic quality of the diet did not appear to 
directly influence metabolic risk factors, the results do support the idea that they 
influence metabolic risk factors through their effect on adiposity, and in particular 
central adiposity.
There are very few intervention studies tliat have been carried out in healthy 
individuals, of either short or longer-term. Thus, to find out if  the benefits of 
reducing fat intake (i.e. cholesterol lowering) could be maintained, and the adverse 
effects associated with increasing carbohydrate intakes could be avoided if dietary 
fat was replaced with carbohydrates o f low GI, a high and low GI a short-term 
experimental intervention study on healthy individuals was carried out (Chapter 5).
The results of this randomised crossover study showed that the low GI diet has some 
beneficial effects in that it reduced total (P = 0.029) and LDL cholesterol. Both high 
and low GI intervention diets had adverse effects on TAG and HDL cholesterol 
concentrations but this was probably due to the fact that the diets were high in 
carbohydrate (70% energy intake). TAG concentrations were found to be higher after 
the low GI diet (P = 0.004), which was not an expected finding but could possibly be 
explained by the fact that the low GI diet was higher in sugars compared with the 
high GI diet (P = 0.001). These results are interesting and suggest that the overall 
carbohydrate and sugar content o f the diet have a more important influence on 
plasma lipids and other metabolic parameters than the glycaemic quality of the diet.
til
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In these studies, there were some very important beneficial effects found (reduction 
in body weight, increase in ‘antioxidant power’, reduction in total and LDL 
cholesterol) following dietary advice. However, this same advice led to adverse 
effects on TAG and HDL cholesterol which are associated with in increased risk of 
CHD. In the first study, worse effects were found when women increased their 
simple sugar’ intake at the expense of starch intake. Also low GI diet in the third 
study seemed to have a more adverse effect on TAG and HDL cholesterol compared 
with the high GI diet. However, the low GI diet was higher in sugar compared with 
the high GI diet. The fact that these carefully planned low GI diet was high in sugar 
highlights an interesting problem with the concept of GI. Some foods which are high 
in sugar* especially fi-uctose have a low GI but still have an adverse effects on lipids. 
This fact is not generally known and makes it difficult for the general public to 
follow the dietaiy guidelines safely. For this reason it may be safer to advise the 
public to consume more slowly digestible carbohydrates (such as wholegrain cereals, 
pulses) rather than low GI foods which could still contain a high proportion of sugar 
which could mask the positive effects of the low GI diet on lipids. Overall, the 
results from this thesis highlight the need for more research to develop safer and 
more appropriate dietary guidelines which can be easily and clearly communicated to 
the general public.
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Chapter 1
Introduction
1.1 Introduction
This thesis describes a series of studies investigating the relationship between diet 
and risk factors for type 2 diabetes and coronary heart disease (CHD).
Chi’onic imbalance of normal metabolism is a cause of a number of complex 
diseases such as type 2 diabetes mellitus and atherosclerosis (Whitefield et a l 2004). 
Results of the WHO project, Monitoring Trends and Determinants of Cardiovascular 
Disease (MONICA) in 21 European countries, indicate that CHD incidence is higher 
in Northern, Central and Eastern regions than in Southern and Western Europe 
(WHO Regional Office for Europe, 2002). CHD causes more than 100,000 deaths 
per year in the UK and Scotland is number one in the world for this disorder (The 
Scottish Office, 2000). In the UK it has been estimated that 2.65 million men and 
women have or have had CHD (either angina or heart attack). The UK is 
experiencing a slow decline in coronary mortality rate (Yarnell et al 2003). In 
Scotland, the prevalence of CVD was around 23.5% in 1998 and there was no 
change since 1995. Results of the 1998 Scottish health suiwey showed that the 
Scottish population, particularly women, were more likely to have ischemic heart 
disease (IHD) or stroke than people in England (The Scottish Office, 2000).
Recent data show that mortality from CHD in Scotland is higher than the UK 
average and is the highest in the western world (Tunstall et a l 1999). From the 21 
countries in the MONICA study which monitored trends and deteiminants of 
cardiovascular disease, Glasgow had the highest mortality from CHD (Tunstall et al 
1999; Richards et a l 2002). Large-scale epidemiological studies have revealed that 
hypercholesterolaemia and hypertriglyceridemia are major risk factors for CHD. A 
meta-analysis of 17 population based studies showed a 76% increase in
cardiovascular disease risk in women and a 31% increase in men associated with a 
one mmol/L increase in plasma triacylglycerol (TAG) levels (Austin, 1999). Both 
endogenous and exogenous TAG contribute to the circulating level of TAG and 
dietary carbohydrate is one of the most important precui'sors for plasma TAG in the 
human diet.
CuiTent dietary guidelines recommend a high carbohydrate diet (>55% energy from 
carbohydrate), but several studies have indicated adverse effects of such a diet on 
plasma lipids with an increase in TAG and a decrease in HDL cholesterol (Shah et 
al 1994; Kasim-karakas et a l 1997; Jeppesen et a l 1997; Kasim-karakas et al, 2000; 
Hudgins et a l 2000; Mittendorfer and Sidossis, 2001 and Bunyard et al., 2002). It 
may be that the type of carbohydrate is important, for example its digestibility, the 
glycaemic index (GI) of the food and the physiological state of the subject. These 
factors are investigated in the studies presented in this thesis.
Dietary carbohydrate inake has increased since 1963 by 126g per day in USA. The 
type of cai'bohydrate has also changed. This increase in consumed carbohydrate 
includes an increase in fmctose com symp intake (10% of total energy intake) 
(Gross et a l 2004). Consumption of fructose has increased because soft drinks and 
some foods have been sweetened with high fructose corn syrup by manufacturers 
(Bray et al 2004). There have been several studies that suggest ftuctose may be an 
independent risk factor for high TAG (Gross et a l 2004). This evidence will be 
discussed later.
A high carbohydrate diet is also usually low in fat. Results of the National suiwey of 
energy and macronutrient intakes in the UK have shown reductions in per capita 
energy and fat intakes since 1975, while carbohydrate intakes has been steady over
the period (Department of Agriculture, 2004). Glucose and fatty acids are the major 
oxidative fuels in human metabolism and account for approximately 80% of 
oxidative metabolism. Their classification and metabolism will be considered 
separately and their interactions discussed. Before the relationships between diet 
and disease are discussed in this chapter, nonnal metabolism will be considered 
briefly and the effects of diet on metabolism discussed in more detail.
There are a number of different study designs used in the studies that will be discussed in 
this thesis and that have been used in the research described in this thesis. Different designs 
are used for different purposes and there are a number of strengths and weaknesses 
associated with each (Gibney et al. 2004). Epidemiological studies evaluate the association 
between exposures such as diet or other characteristics with disease risk or risk factors and 
try to explain differences seen. Observation, epidemiological studies include case control, 
cross-sectional and cohort studies. Case-control studies examine whether persons with a 
disease have the same diet as individuals without and, assume that the measure of dietary 
exposure (ie. plasma lipids) has not been influenced by the disease process. The strengths of 
case control studies is that are relatively inexpensive to carry out as they require smaller 
number of subjects compared with prospective studies and for this reason are very good for 
studying rare diseases. In cross-sectional studies, diseases or risk factors and exposure such 
as diet are measured at the same time and this is a weak design for assessing causal 
relationships. Cohort studies can be either retrospective or prospective and assess whether 
persons with, for example, a high dietaiy fat intake develop the disease or die from the 
disease more often than those who do not have a high fat intake. Cohort studies have a 
number of strengths in that the exposure comes before the development of the disease and 
they do not rely on subjects’ memory of what they had eaten in the past. One major problem 
with observational studies in general is the presence of confounding factors. Confounding 
happens when one the component of diet is associated with another dietary factor that is
related to the disease or risk factor that you are interested in. Intervention studies are 
superior to observation studies in that a researcher is able to test for an independent effect of 
one nutrient and to hold the others constant A randomised controlled trial is considered to 
be the best method for a number of reasons including: control or untreated group, the 
subjects or patients are randomised into treatment groups which reduces the likelihood or 
chance findings, and they are blinded which controls for the placebo effect. Sometimes 
RCTs can have a cross-over design which means that both groups follow both treatments or 
intervention in turn, usually with a wash-out period in between. However, RCTs are 
expensive to carry out and the results depend heavily on the compliance of subjects. Quasi- 
experimental studies are often carried out where a RCT is not always possible, such as in 
studies where dietary advice is given and randomisation is not always possible. These 
strengths of these type of studies is that they do have a before and after measurement and can 
be conducted in free-living subjects which means the intervention can be more relevant to 
real life situation. However, this design also has limitations in that it also depends on 
compliance which is difficult to control in free living subjects and can the results can be 
influenced by non intervention effects for example, sometimes when subjects are given 
dietary advice they also change their physical activity habits (Gibney et al. 2004).
1.2 Carbohydrate
The single most important source of food energy in the world is dietary carbohydrate 
(FAO/WHO 1997). Depending on the geographic area and individual economic 
conditions, carbohydrates comprise 40 to 80 percent of total food energy intake. In 
the UK, 50% of daily energy comes from fat (Englyst et al. 1992). The Food and 
Agriculture organization (FAQ) and World Health Organization (WHO) Expert 
Consultation (FAO/WHO 1997; 2003), which provide evidence to improve 
nutritional knowledge for developing and developed countries, include the widely 
accepted definition and classification for dietary carbohydrate described below.
Starch is the primary product of photosynthesis by which plants use energy from
sunlight to synthesise carbohydrate from carbon dioxide and water. Sugars have been
divided into intrinsic and non-intricnsic sugars depending on their situation in food
(see later). The major sources of carbohydrates in the diet are:
® Cereals,
« Root crops,
® Sugar crops,
® Pulses,
• Vegetables,
® Fruits,
® Milk products (Department of Health, 1991).
1.2.1 Classification
There are various types of classification for carbohydrates including structural 
(degree of polymerisation according to biochemical structure) and physiological 
classifications according to the fate and digestibility of the carbohydrate. This latter 
type of classification includes the glycaemic index and amount of rapidly available 
carbohydrate, and is considered more relevant for the evaluation of the physiological 
effects of dietary carbohydrate. The fate and effects of dietary carbohydrates depend 
on the nature of the carbohydrate, the matrix of the food and the biochemical 
structure of the consumed meal (Laville, 2004). Carbohydrates are more 
conventionally classified according to their structure and the molecular size (i.e. the 
number of sugar units) into:
Monosaccharides containing one sugar unit (such as glucose, galactose, and 
fructose)
Disaccharides containing 2 sugar units (e.g. sucrose, lactose, trehalose)
• Oligosaccharides containing 3-9 sugar units (e.g. maltodextrins, raffinose, 
stachyose, fructo-oligosaccharides)
• Polysaccharides containing >9 sugar units (e.g. amylose, amylopectin, 
modified starches, and non-starch polysaccharides such as cellulose, 
hemicellulose, pectin, hydrocolloids) (Gibney et a l  2002).
Table 1.1 Various types of dietary carbohydrate and their digestion products
Class Example DP Site of 
digestion
Produced
metabolites
Monosaccharides Glucose 1 Small intestine Glucose
Fructose 1 Small intestine Fructose
Dissaccliarides Lactose 2 Small intestine Glucose+Fructose
Sucrose 2 Small intestine Glucose+Galactose
Oligosaccharides Raffinose
Inulin
Pyrodextrins
3
3-9
3-9
Large intestine SCFA, acetate, 
propionate and 
butyrate
Polysaccharides Starches >9 Small intestine§ Glucose-via 
maltose, 
maltotriose and 
dextrins
NSP >9 Large bowel SCFA
* Source: Gibney et at. 2002, DP: Degree of polymerisation, NSP: Non starch polysaccharides,
SCFA: Short chain fatty acids, § Some starch escapes small intestine digestion and in all these 
conditions the carbohydrate enters the large bowel and is fermented to SCFA by colonic bacteria.
1.2.2 Carbohydrate digestion
Table 1.2 summarises the process of digestion and absorption of dietary 
carbohydrates and fats in different parts of the gastrointestinal (GI) tract in humans.
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1.2.3 Carbohydrate metabolism
Carbohydrates are metabolised by several pathways with different functions. These 
pathways usually start with glucose, although other sugars can enter through 
appropriate intermediates. The released energy is trapped in the form of ATP for use 
by energy-consuming activities of the cell. Glucose uptake by the tissues is 
controlled by facilitated diffusion tissue specific transporters (GLUTs) which are 
physiologically expressed and this leads to differential uptake of glucose in different 
organs (Grover-McKay e/'a/. 1999).
Glucose can be:
* Stored as glycogen (glycogenesis)
• Synthesised from non-carbohydrate sources (gluconeogenesis)
® Catabolised to provide energy (38 adenosine triphosphate (ATP)
molecules/ glucose molecule)
® Converted to non-carbohydrate sources (e.g. non-essential amino
acids)
® Converted to other carbohydrates or their derivatives (e.g. pentoses,
uronic acids) or non-carbohydrate metabolites
® Converted to fatty acids.
The process for glucose catabolism occurs in the following phases:
® Glycolysis or Embden-Meyerhof pathway: the breakdown of glucose
to pyruvic acid in the cytosol (Figure 1.1),
# Oxidation of pyruvate after transport into the mitochondria and acetyl 
Co A formation,
@ Krebs or tricarboxilic acid (TCA) cycle: Oxidation of acetyl CoA
from catabolism of carbohydrates, lipids and proteins into carbon 
dioxide, FADH2, NADH and GTP (Figure 1.2)
® Oxidative phosphorylation electron transport chain produces ATP and
water (Frayn, 2003a).
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Figure 1.1 Glycolysis (Embden-Meyerhof pathway)
DHAP: Dihydroxyacetone phosphate
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Figure 1.2 Krebs cycle and the pathways that lead to it.
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Figure 1.2 illustrates the main reactions leading to oxidation of various substrates in 
the TCA cycle. The electron transport system produces ATP, the main energy 
storage compound in living organisms from high-energy intermediates such as 
NADH, FADH2 and GTP produced during glycolysis and the TCA cycle. Its 
cleavage to ADP and inorganic phosphate fuels biochemical processes in cells. In 
this way, essential physiological processes such as muscle contraction, nerve action, 
and protein synthesis are possible. Thus oxidation of organic compounds in food to 
CO2 , accompanied with the formation of the reduced form of nicotinamide adenine 
dinucleotide and flavin adenine dinucleotide and (NAD and FADH2 coenzymes) 
provides the substrates for ATP synthetase linked to the enzyme complexes in the 
oxidative phosphorylation chain finally producing water. Glycolysis takes place in 
the cytosol, the TCA cycle takes place in the mitochondria and the electrons and 
hydrogen ions for ATP production are produced within the mitochondrian matrix 
(Rees and Howard, 1999). Important shunt pathways regulate the passage of 
intermediates between the cytoplasm and mitochondria regulating the process.
For each turn of the TCA cycle 12 ATP are produced for each citric acid, 15 ATP are 
produced from each pyruvic acid entry into the cycle. In this way, 38 ATP molecules 
are the result of the total oxidation of one glucose molecule. Any carbon entering the 
TCA cycle as Acetyl CoA leaves as CO2 as indicated in figure 1.3. This means that 
fatty acids and some amino acids which enter as Acetyl CoA can not be used for 
gluconeogenesis which uses oxaloacetate as a precursor.
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1.2.4 Physiological effects of carbohydrates
Carbohydrates are not only major sources of energy but also have various 
physiological effects. There are some aspects of carbohydrate stmcture that affect 
their physiological function, such as the rate of digestion, absorption and colonic 
fermentation (Table 1.3).
® The natur e of the carbohydrate and absorbed monosaccarides is important in 
determining the effects on plasma lipids and provides a fundamental feature 
of this thesis. Glucose from digestible starch is absorbed entirely. However, 
only approximately half of the carbohydrate in fruit and dairy products 
provides glucose, the rest is composed of fructose or galactose which do not 
raise blood glucose or insulin levels (Lee and Wolever, 1998; Wolever, 
2003).
• The amount of carbohydrate absorbed influences plasma glucose and insulin
responses after oral consumption. Unabsorbed carbohydrates will enter the 
colon.
9 The rate of carbohydrate absorption is an important factor in determining
plasma glucose and in particular plasma insulin levels. Rate of absoiption is 
affected by many factors such as food form, starch structure, particle size, 
food processing, viscosity, cooking temperature and moisture of the prepared 
meal as well as any factor which may delay gastric emptying such as fat or 
soluble fibre in the meal (Bjorck et al. 1994).
9 The fermentation of carbohydrate by colonic bacteria results in the
production of short-chain fatty acids (SCFA) such as acetate, propionate and 
butyrate (Jenkins et a l 1998). These may independently influence glucose 
and lipid metabolism. For instance, acetate has no direct effect on glucose
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metabolism (Scheppach et a l 1988) however it results in reduction in plasma 
NEFA levels. Acetate is also incorporated into newly synthesised lipids. 
Wolever et a l in 1991 showed that rectal infusion of acetate (180 mmol), 
propionate (60 mmol) and propionate and acetate (180 mmol) increased 
blood lipids. Acetate increased serum cholesterol, glucagon, and acetate 
concentrations and reduced NEFA within 30 minutes. In contrast, propionate 
caused an increase in serum propionate, glucose, and glucagon with no effect 
on cholesterol level. The addition of propionate to acetate resulted in no 
significant increase in serum cholesterol. Therefore, colonic propionate is a 
gluconeogenic substrate in humans and inhibits the utilization of acetate for 
cholesterol synthesis (Wolever et a l 1991). SCFA may also have protective 
effects against chronic colonic diseases. A reduction of colon cancer risk 
was shown to be related to resistant starch intake (Kendall et a l 2004). 
Resistant starch enters the colon and increases the production of butyric acid. 
Butyric acid provides a fuel for the epithelial cells of the large intestine and 
promotes colonic health (Duncan et a l 2004). It has been shown that 
butyrate is a potential anti-cancer molecule as it stimulates apoptosis and 
inliibits histoire deacetylase (Buda et a l 2003; Davie, 2003).
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Table 1.3 Physiological effect of carbohydrate structure and digestibility
Physiological effect Rapidly digestible 
carbohydrates
Non-digestible
Carbohydrates
Energy 4 Kcal/g 2 Kcal/g if fermented
Gut motor activity No effect May delay gastric emptying and 
SBTT but speeds up colonic 
transit depends on viscosity
Satiety No real effect Could increase satiety if they 
slow gastric emptying
Blood glucose and Increases rapidly Slow increase or less insulin
Insulin produced
Lipid metabolism and Increase TAG If decrease acetate and increase
plasma lipids concentrations propionate may decrease TAG
Increase NEFA levels and increase HDL- 
cholesterol levels
Colonic microflora None Increase fermentation 
Increase bacteria 
May have selected effects 
(prebiotic)
Bile acid 
Deliydroxylation
None Increase
Protein glycation Increases No effect
SBTT: Small bowel transit time
1.2.5 Control of carbohydrate metabolism
Carbohydrate digestion and absorption is one of the highly efficient processes in the 
body. Only 5% of the energy intake is lost in faeces (Frayn, 2003a; Mendosa, 2005). 
The rate of glucose uptake is determined by the rate of hydrolysis of the 
carbohydrates, which are susceptible to pancreatic and intestinal enzymes. Factors
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such as particle size, food structure, carbohydrate structure (e.g. ratio of amylose to 
amylopectin in starch), lipid content of food, presence of enzyme inhibitors, the rate 
of gastric emptying and transit time in the small intestine may influence this process, 
through the action of hormones such as cholecystokinin and gastrin and stimulation 
of duodenal and ileal receptors. For example, lipids in the ileum slow the transit of 
intestinal contents through the earlier parts of the small intestine (Jenkins et al. 
2002c). Once absorbed the plasma levels of glucose are controlled by insulin and 
glucagon. Many effects of diet on plasma lipids are caused by changes in plasma 
levels or sensitivity to insulin and glucagon.
1.2.6 Insulin and Glucagon
1.2,6.1 Insulin
The P-cells of the pancreas produce a peptide hormone, called insulin, secreted in 
response to increased plasma glucose. Insulin has two types of action: stimulatory 
and inhibitory (Figure 1.3). Insulin stimulates glucose uptake by all tissues except 
the liver and the synthesis of new lipid and glycogen from glucose. It increases the 
uptake of glucose stimulating the movement of GLUT 4 transporters from the 
cytoplasm into the ceil membrane. The liver does not have GLUT 4 and therefore is 
not affected. Instead insulin reduces the release of glucose by the liver. It also 
inhibits lipolysis, proteolysis, ketogenesis, glycolysis and gluconeogesis. When 
blood glucose is low and insulin levels decrease there is increased glycogenolysis 
and gluconeogensis in the liver, which in turn produces an increase in plasma 
glucose level. Low insulin also causes an increase in proteolysis in the muscle, 
which releases amino acids and after transamination, stimulates gluconeogenesis. 
Lipolysis in adipose tissues also increases and releases glycerol and free fatty acids
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to act as fuels and for the glycerol to enter gluconeogenesis. Insulin therefore has an 
important role in maintaining blood glucose and releasing other substrate in a highly 
controlled manner for human metabolism (Sonksen and Sonksen, 2000; Pessin and 
Saltiel, 2000).
Figure 13 The actions of Insulin 
INSULIN
Liver Muscle
Decreased glucose output 
due to decreased 
gluconeogenesis and 
increased glycogen synthesis
I t
Glucose uptake & 
storage in the 
form of glycogen
Adipose tissue
^  Glucose uptake 
and storage
Increase lipid synthesis t t Save amino acids t Synthesis of TAG from FF A
Protein synthesis ^  skeletal muscle 
synthesis
Inhibits release of FF A 
from TAG
Decreased ketogenesis ^  Amino acid uptake
Inliibits
gluconeogenesis
Glucose uptake 
^  Proteolysis stops
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1.2.6.2 Insulin Resistance
Insulin resistance is the resistance of the tissues to the physiological effects of 
insulin. It is thought to result from chronic high insulin levels, due perhaps to high 
intakes of fast release carbohydrate, low fibre diets and high adiposity. The high 
levels of insulin, in turn, down regulate the response of cells to normal levels of 
insulin. This can then result in the development of late onset or type II diabetes. The 
body has to produce more insulin to get the same action in response to normal 
postprandial glucose levels.
Apart from plasma glucose concentration, it has been shown that dietary 
macronutrient composition (e.g. carbohydrate, fat and protein) stimulates adipose 
tissue lipoprotein lipase (Yost et a l 1998) and insulin secretion (Daly, 2003). There 
is evidence that a high fat diet resulted in insulin resistance (Lovejoy et a l 1992) 
and higher risk of type II diabetes and CVD (Marshall et a l 1991). However, some 
studies failed to show any difference in insulin sensitivity between high fat (HF) and 
high carbohydrate (HC) diets (Swinburn et a l\99 \', Borkman et a l 1991).
Insulin resistanee, which is the term given to the situation in which the actions of 
insulin are blunted in the presence of normal or increased insulin secretion (Gibney 
et al. 2005), is a cental feature in the development of type 2 diabetes and is now 
recognised to play a role in many of the risk factors for CHD such as abnormal lipid 
levels or dyslipidemia. It is also now recognised that insulin resistance may be the 
common linlc between obesity, impaired glucose tolerance or type 2 diabetes, 
dyslipidemia (high LDL cholesterol, low HDL cholesterol, high TAG
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concentrations), hypertension and impaired fibrinolysis which together have been 
called metabolic syndrome or syndrome X (Reaven et al. 1996).
1.2.6.3 Glucagon
The action of insulin is balanced by the secretion of glucagon from the a-cells of the 
islets of Langerhans of the pancreas. Its action is almost the opposite of insulin. 
That is, it elevates blood glucose concentration by stimulating gluconeogenesis and 
inhibiting glycolysis in the liver. Glucagon does not affect glycogenolysis in muscle 
but stimulates glycogenolysis in the liver. Glucagon secretion is also regulated by 
amino acids. Glucagon opposes the action of insulin on lipogenesis by inhibiting the 
activity of acetyl-CoA carboxylase, which leads to an inhibition of lipogenesis.
Table 1.4 Factors affecting glucagon secretion (Jiang and Zhang, 2003)
Stimulators Inhibitors
Glucogenic amino acids: Glucose
Glycine, Alanin, Serin, Theronin & Free fatty acids
Cystein Ketones
CCK & Gastrin Insulin
Cortisol Secretin
Infections & other stresses a-Adrenergic stimulors
Acetylcholine
P-Adrenergic stimulators
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Figure 1.4 The actions of Glucagon.
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Giyconeogenesis is 
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No receptor, no effect for 
skeletal muscle, amino acid 
uptake and glycogen in 
skeletal muscle.
Adipose tissue
Stimulation of FF A 
release from TAG,
1.2.6.4 C-Peptide
Pancreatic p-cells secrete C-peptide which is the connecting part between the two 
subunits of insulin, in equimolar amounts to insulin (Rubenstein et a l 1969). It has 
an important physiological role in the biosynthesis of insulin and facilitates the 
formation of the disulphide bonds between the insulin subunits (Wahren, 2004). 
When proinsulin is converted to insulin in the pancreas, C-peptide is released. This 
peptide has been shown to increase glucose uptake into skeletal muscle cells without 
action through the insulin receptor (Zierth et a l 1996). The pancreatic secretion of 
insulin is well reflected by plasma C-peptide levels and high levels of C-peptide are 
associated with insulin resistance and development of chronic disease (Jenkins et al 
1988).
Results of C-peptide determination among 1999 healthy women from the Nurses’ 
Health Study I and II showed that there was a significant and positive trend for a
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relationship between C-peptide level and dietary glycaemic load. Similarly, subjects 
in the highest quintile of energy-adjusted, fructose intake had 13.9% higher C- 
peptide level than subjects in lowest quintile. C-peptide was negatively correlated 
with a higher intake of cereal (15.6% lower, P for trend=0.03) after control for other 
covariates.
An increased insulin level is associated with higher C-peptide levels and high intakes 
of fructose and high glycaemic index foods (Chen et al. 1999). Rapidly digestible 
carbohydrate leads to the development of resistance to the effects of insulin in 
normal diets. With higher C-peptide concentrations there will be higher metabolic 
disturbance,; whereas consumption of carbohydrates high in fibre, such as whole- 
grain foods, is associated with lower C-peptide and consequently insulin 
concentrations (Wu et al. 2004).
1,3 Dietary fats
Dietary fats are important organic components in the diet. Fats are composed of a 
carbon skeleton with hydrogen and oxygen substitutions and are the inose dense 
dietary source of energy (9kcal/g). Dietary fats also supply nutrients such as 
essential fatty racids (e.g. linoleic and linolenic acids) and fat-soluble vitamins 
(vitamins A, D, E and K). Although fats improve palatability of cooked food in the 
diet (Gibney, 1999), they significantly increase the risk of chronic and degenerative 
diseases and consequently, influence human morbidity and mortality (FAO/WHO, 
2003).
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Lipids are classified into three categories based on their role in the body including 
provision of energy, structural (e.g. phosphoglycerides), storage (e.g. 
triacyl glycerides) and metabolic lipids (e.g. steroid hormones). Fats are esters of 
fatty acids with glycerol. Therefore, the main components of dietaryfats are fatty 
acids, carboxylic acids with the structure of RCOOH. R is acyl carbon (varying in 
length from 4 to greater than 30, e.g. butyrate, stearate, palmitate). These fatty acids 
could be either saturated (e.g. palmitic and stearic acids), or monounsaturated (e.g. 
oleic acid) or polyunsaturated (e.g. a-linolenic acid) including one or more double 
bonds, respectively. Polyunsaturated fatty acids are further subclassified to n-3 (e.g. 
a-linolenic, docosahexanoic and eicosapentanoic acids) and n-6 fatty acids based on 
the position of first double bound in the fatty acid chain (close to CH3). n-3 fatty 
acids, mainly found in fish and marine products, have been shown to be associated 
with lower risk of myocardial infarction and CHD (Agostoni and Bruzzese, 1992). 
Sterols are another important group of lipids in human nutrition as a vital component 
in the membranes, precursors of bile salts for fat digestion and finally as precursors 
for steroid hormones (Frayn, 2003a).
The process of digestion and absoiption of fats is shown in Table 1.2. Long chain 
fatty acids after absorption and estérification in the intestinal cells are converted to 
TAG and are packaged in the Golgi apparatus into chylomicrons. The chylomicrons 
are then secreted into lymphatic capillaries that surround the intestinal cells and via 
the larger lymph vessels to the thoracic duct, a one-way valve into the systemic 
circulation. Chylomicrons reach their highest level in circulating blood after a meal 
and as they pass around the circulation their TAG contents are hydrolysed by 
lipoprotein lipase mostly secreted by adipocytes and hepatocytes (Figure 1.4)
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(Schaefer, 2002; Metzler, 2003). Most long-chain fatty acids are oxidised through 
the p-oxidation pathway.
Dietary fats from animal and plant sources consist of mainly TAGs and a small 
proportion of free fatty acids (FFA), particularly short-chain fatty acids (Department 
of Health, 1991).
Figure 1.5 Transport of lipids by plasma lipoproteins
Adipose tissue TAG Capillary bloodPeripheral tissue
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H DL
FFA TAG
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CE LPL
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FFA: Free fatty acid 
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1.3.1 Lipoproteins
Lipids, which are hydrophobic compounds, are the major stores of energy producing 
substances for hmnan metabolism. These non-water soluble compounds are 
transported by lipoproteins in the circulating blood (Table 1.4). Lipoproteins are 
particles with a relatively hydrophilic surface and a highly hydrophobic core. 
Cholesterol esters, triglycerides (TAG), apoproteins, and phospholipids are 
components contained within each type of lipoprotein. Depending on the type of 
lipoprotein; the amount of each component varies. Major lipoproteins are classified 
into chylomicrons (CM), very low-density lipoproteins (VLDL), low-density 
lipoproteins (LDL), and high-density lipoproteins (HDL) (Table 1.5; Olson, 1998; 
Fielding and Frayn, 1999).
Table 1.5 Lipoprotein classes
Major lipids in Lipoprotein Main Apolipoproteins
different lipoproteins composition (%)
Dietary TAG Chylomicrons TAG (90%) B48, AI, All, C and 
E
Endogenous TAG VLDL TAG (65%) B 100,CandE
Cholesterol and LDL Cholesterol BlOO
cholesterol ester (45%)
Cholesterol ester and HDL Protein (50%) AI, All, C and E
phospholipids
(Olson, 1998; Frayn,, 2003a ; Redgrave, 2004 ; Manchekar et a l 2004)
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Apoproteins are the protein constituents of lipoproteins. Apoproteins are categorised 
on the basis of their function into four classes A, B, C, and E. Apoprotein A is sub 
classified further to apo AI, All and AIII. Apo A-III was previously called Apo D 
(Connelly and Kuksis, 1981; Olson, 1998). The plasma lipid transport system 
includes various lipoproteins, their receptors at the cellular sites and different 
enzymes in the tissues and circulation involving in lipid metabolism (Goldberg and 
Schonfeld, 1985).
After lipid absorption, TAG is resynthesised and coated with phospholipids, apo A 
and apo B-48 in the enterocytes. The resulting large particles are chylomicrons 
(CMs,) which are the largest particles among lipoproteins. CMs are composed 
mainly of TAG (90%), proteins, cholesterol, cholesteryl esters and phospholipids 
(Olson, 1998). CMs are transported from the gut into the lymphatic system and 
finally via the thoracic duct into the bloodstream. When CMs enter into the tissues 
(e.g. adipose tissue), their TAG are cleaved and fatty acids are released by LPL 
action. The produced fatty acids are used by the tissues for energy or stored as TAG 
in adipose tissues (Redgrave, 2004). After LPL action, the CMs slu'ink into CM 
remnants. These remnants are recognised and taken up by apo E and apo B receptors 
in the liver. In this way, CMs are considered as the main dietary lipid carrier (Olson, 
1998; Figures 1.6 and 1.7).
VLDLs transport endogenous produced TAG in the liver. Similar to CMs, TAG is 
the main constituent of VLDLs (65%). LPL hydrolyses the TAG inside VLDLs and 
release free fatty acids. The degradation of VLDLs results in VLDL remnants called
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intermediate-density lipoprotein (IDL) which becomes LDL by further degradation 
(Hill and McQueen, 1997; Frayn, 2003b; Figures 1.6 and 1.7).
LDLs are the main earner of cholesterol in the circulation. The LDL particles contain 
cholesterol and cholesteiyl esters (65%) and protein (20%). The main apoprotein of 
LDLs is apo B-100. LDLs may be removed from the circulation by either LDL 
receptors or scavenger routes. These routes seem to be important when the LDL levels 
are high and cholesterol is incorporated into atheromatous plaques (Hill and 
McQueen, 1997; Frayn, 2003a).
HDLs are the smallest lipoproteins. The high proportion of protein in HDL causes its 
high density. The main apoproteins of HDL are apo AI and apo AIL HDL particles 
are derived from gut and also the liver. HDLs originated from the liver are HDL3, 
which are discoid shaped lipoproteins. By transferring free cholesterol and 
phospholipids released by LPL from TAG-rich lipoproteins (chylomicrons and 
VLDL) to HDL3 via LCAT action, HDL2 (a spherical shaped HDL) is produced 
(Figure 1.5). HDL2 contains 50% protein and 20% cholesterol and cholesteryl esters. 
HDL2 takes free cholesterol to the liver and is converted to pre~p HDL or apo AI 
which are ready for further circulation (Olson, 1998; Frayn, 2003a; Redgrave, 2004; 
Manchekar et al. 2004). When plasma TAG increases, HDL transfers cholesteryl 
esters into TAG-rich lipoprotein via cholesteryl ester transferase protein (CETP). 
Thus HDL transfers cholesterol to the liver and reduces of plaque formation and 
CHD.
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The different classes of lipoproteins interact with each other and exchange contents. 
Two interconnected exogenous and endogenous cycles in lipoprotein metabolism 
exist and the liver plays pivotal role in their metabolism (Hill and McQueen, 1997). 
Two enzymes, lipoprotein lipase (LPL) and lecithin:cholesterol acyl transferase 
(LCAT) are key elements in lipoprotein metabolism, LPL in the tissues and mainly 
adipose tissue releases free fatty acids and glycerol from chylomicrons and VLDL 
into the tissues while LCAT forms cholesterol esters from free cholesterol and fatty 
acids (Hill and Me Queen, 1997). There are four main steps in the reverse cholesterol 
transport (RCT) system exist (ie movement of cholesterol to the liver). Binding of the 
free cholesterol from peripheral tissues by HDL particles causes an efflux of free 
cholesterol. The second step is the conversion of free cholesterol in HDL particles to 
cholesterol esters by LCAT. The transfer of cholesteryl ester from HDL to apo B 
containing particles (VLDL and LDL) in exchange for TAG is the third step which is 
facilitated by cholesterol transfer protein (CETP). Subsequently, the produced 
cholesterol is taken up by the liver through the specific receptors for LDL or returned 
to the periphery (Hill and McQueen, 1997).
Transfer of lipids between the plasma lipoproteins is catalysed by CETP and this 
protein clears cholesterol from peripheral tissues (Bruce et a l 1998). CETP has a 
two-fold action in cholesterol metabolism. One is transferring cholesterol from HDL 
to VLDL and LDL. A reduction in activity of CETP level leads to an increase in HDL 
level (Hill and McQueen, 1997). However, other studies have shown that CETP 
action results in the production of pre-p-1 HDL in the degradation of HDL2 and 
therefore may lead to an increase in HDL levels similar to the protective effects of
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moderate alcohol consumption (Hannuksela et a l 1992). Therefore, HDLs act as a 
cholesteryl ester shuttle (Figure 1.5 and Figure 1.7).
Figure 1.6 shows the relationships between chylomicrons from the gut and VLDL 
from the liver. Dietary lipids and in vivo biosynthesised lipids enter the metabolic 
system through the liver and peripheral tissues (Goldberg and Schonfeld, 1985; Olson, 
1998)
Figure 1.6 HDL and lipid metabolism (Olson, 1998; Frayn, 2003a; Redgrave, 
2004; Manchekar et a l 2004)
LCAT
Apo AI (pre PHDL) + FC + PL
LPL
TAG rich lipoprotein
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29
Figure 1.7 Comparison of the fate of dietary lipid and newly synthesised lipid as it 
enters the circulation
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1,4 Interrelationship between metabolism of dietary carbohydrate 
and fat
There are many interactions between the metabolism of carbohydrates and fats 
(Randle, 1998; Fried and Rao, 2003; Frayn, 2003b). Carbohydrates provide the 
carbon skeleton for fatty acid synthesis. Oxidation of carbohydrate produces acetyl 
residues that are exported from the mitochondria as citrate and then converted to 
fatty acyl-CoA. Acyl-CoA is then incorporated into TAG which is mainly exported 
from the liver as VLDL (Fried and Rao, 2003; Frayn, 2003b). TAG is synthesised 
every day by the liver («40-100g/day) from dietary carbohydrates and free fatty 
acids. If the amount of consumed carbohydrates exceeds requirements, carbohydrates 
are converted to TAG within hepatocytes and adipocytes (Austin, 1997; Fried and 
Rao, 2003) and hepatic VLDL secretion is increased. In this way high-carbohydrate 
diets may act in a similar way to high-fat diets resulting in higher levels of plasma 
TAG (Truswell, 1994).
Excess carbohydrate leads to an increase in movement of glucose and fructose 
through glycolysis. This increases acetyl Co A that then provides more substrates for 
De novo fatty acid synthesis (Frayn and Kingman, 1995).
Carbohydrate feeding through the action of insulin also up-regulates the activity of 
the enzymes, which synthesize fatty acids. The activity of hepatic synthases and the 
NADPH-generating enzymes significantly increases in rats fed on glucose and 
fructose, which in turn led to a significant increase in the rate of TAG secretion 
(Kazumi et al. 1997).
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It has been shown that a low-fat diet in healthy subjects caused a reduction in plasma 
LDL-cholesterol concentration (Dreon et al. 1997). In another study, consumption of 
a low-fat diet resulted in a change in LDL pattern in 44% of subjects (Krauss and 
Dreon, 1995). The low-fat diet also significantly increased plasma TAG 
concentrations and reduced HDL-cholesterol concentrations (Parks et al. 1999).Thus 
consumption of high carbohydrate diet could induce fatty acid biosynthesis through 
De novo lipogenesis by carbohydrate over feeding of either glucose or fructose.
1.4.1 Insulin and hepatic TAG secretion
TAG is stored in adipose tissue (adipocytes), and is produced by intracellular 
lipoprotein lipase (LPL). After that hoianone sensitive lipase (HSL) action leads to 
the production of NEFA (Frayn, 1998). Insulin and NEFA levels are related, as when 
insulin level increases after meal, plasma NEFA is suppressed (Singer et al. 1985). 
Insulin reduces the hydrolysis of lipids in adipose tissues and causes an inhibition in 
VLDL-TAG secretion. In this way, resistance to the effects of insulin could result in 
a chronic increase in circulating NEFA levels by increasing the rate of lipolysis in 
the liver. In addition, some resistance to the physiological effects of insulin can 
develop in less physically active people (Zammit et al. 2001). The activity of 
muscles, which are the major site for insulin dependent glucose metabolism, and also 
the type of diet and its constituents contribute to the development of this disorder 
which is a critical point in the development of insulin resistance.
High fructose intake (Taghibiglou et al. 2000) or consumption of high fat diets 
(Boden et al. 1995) in human subjects or in experimental animals blocks the enzyme 
that catalyzes long-chain fatty acids P-oxidation within mitochondria (Carnitine
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palmitoyl transferase I), which produces resistance to the effects of insulin. If the 
oxidation of fatty acids exceeds their metabolism, they divert toward glyceride 
synthesis.
Increased FFA and glucose levels that regulate VLDL output from the liver and 
elevate TAG concentrations inhibit apo-B degradation also caused by an increase in 
VLDL secretion. Meanwhile, lipoprotein lipase levels decrease and result in 
decreased clearance of VLDL and the final result would be more TAG rich particles, 
fewer HDL and smaller LDL particles leading to insulin resistance. Impaired VLDL 
lipolysis which depletes HDL by delaying the transfer of apoproteins from TAG rich 
lipoproteins to the HDL and increased hepatic lipase activity to facilitate HDL 
clearance are some of mechanisms of the decreased levels of HDL in the mentioned 
conditions (Howard, 1999).
Decreased HDL-C coneentration and reduction in LDL particles size, which is equal 
to an increase in concentration of circulating small dense LDL lipoproteins, are the 
metabolie consequences that develop in response to an increase in TAG levels. They 
are the major components of dyslipidemia which occur in insulin resistance 
(Howard, 1999).
1.4.2 Glucose- fatty acid cycle
Randel introduced the concept of a Glucose-Fatty acid cycle in 1963. It integrates 
fatty acid and glucose metabolism (Randle, 1963), as if FFA could produce 
inhibitory effect for glucose metabolism as an oxidative fuel. The presence of FFA 
determines the rate of fat oxidation and directly inhibits glucose metabolism (Guerre-
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Millo, 2003; Frayn, 2003b). A series of studies have confirmed a mechanism in 
which an increase in fatty acid oxidation reduces glucose uptake and oxidation in 
muscle tissues and the major role of this mechanism in reducing insulin sensitivity 
and glucose utilisation that can lead to insulin resistance (Belfiore et a l 1998).
High FFA in the cell promotes fatty acid oxidation while it inhibits glucose oxidation 
(Beshef et a l 2003). This phenomenon also promotes glycogen synthesis 
accompanied by more fat storage (Randle, 1998). A central point in this relationship 
is that fatty acids reduce glucose oxidation and uptake in muscle tissues (Frayn 
,2003b). Fatty acid oxidation can lead to reduced glucose utilisation. High levels of 
fatty acid have been shown to stimulate glucose production similar to what happens 
in type 2 diabetes which is followed by stimulation of glucose production and 
deterioration of glucose intolerance (Frayn, 2003b). An increase in actyl-CoA 
production by more (3-oxidation of FFA is an important issue. Acetyl-CoA as an 
inhibitor of pyruvate dehydrogenase, is required for oxidative utilisation of glucose 
(Randle, 1998; Hegarty et a l 2003).
The glueose-fatty acid cycle and the probable effects of increased availability of 
acetyl-CoA and p-oxidation of FFA are summarised in Figure 1.9. The high ratio of 
fatty acid oxidation and the resultant acetyl-CoA develop high concentration of 
citrate through citrate synthase. In addition, the ratios of NADH/NAD"^ and 
ATP/ADP increase. High aeetyl-CoA/CoA and NADH/NAD"^ ratios inliibit pyruvate 
dehydrogenase and in this way oxidation of pyruvate from glycolysis is suppressed.
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Figure 1.9 Glucose-fatty acid cycle
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Three mechanisms have been hypothesised to explain the inhibitory effects of fatty 
acids on glucose oxidation through this cycle:
9 The inliibition of pyruvate dehydrogenase which mediated by increased ratio of 
acetyl-CoA to CoA,
® The inhibition of phosphofructokinase by an increase in citrate,
9 The inliibition of hexokinase by glucose-6-phosphate (Randle et al. 1994).
Figure 1.10 shows the inhibitory effects of fatty acids on glucose metabolism.
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Figure 1.10 Inhibitory effect of FFA on glucose metabolism
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Formation of citrate from acetyl-CoA can inhibit another glycolytic enzyme, 
phosphofructokinase, which diminishes glucose utilisation (Figure 1.11; Belfiore et 
a l 1998).
g
;
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Figure 1.11 Inliibitory effect of citrate on glucose oxidation
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The main mechanism for the glucose-fatty acid cycle is when fatty acid oxidation in 
muscle reduces glucose uptake and oxidation. The link between lipid accumulation 
and insulin resistance goes beyond the classic glucose-fatty acid cycle. A mechanism
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for insulin resistance and its major role in reducing insulin sensitivity and glucose 
utilisation has recently been proposed. It is postulated that accumulation of long- 
chain fatty acyl-CoA plays a critical role and leads to insulin resistance (Hegarty et 
al 2003).
Thus, the glucose-fatty acid cycle is not a metabolic cycle and does not show the 
interconversion of glucose-fatty acid, but it represents a coordination of a series of 
metabolic regulations in glucose and fat metabolism. When the concentrations of 
insulin and glucose are high, the malonyl CoA produced suppresses fatty acid 
oxidation, however, when the oxidation of fatty acids increase and the produced 
citrate inhibits pyruvate dehydrogenase, glucose uptake and oxidation reduce. 
Simply elevated glucose levels cause stimulation in insulin production and 
suppresses FFA release from fat depots (Frayn, 2003b).
The fatty acids released by the physiologic action of LPL may be isolated in adipose 
tissue. The released fatty acids may be esterified or released as Non-Esterified Fatty 
Acids (NEFA) into circulating blood. NEFA or free fatty acids are metabolic fuels 
and account for a greater variation in energy flux compared to glucose and reflect 
nutritional status and physical activity (Frayn et a l 1997). Acute elevation of NEFA 
causes hyperinsulinemia without an effect on insulin secretion rate in healthy 
subjects. This condition has been observed in obesity; impaired glucose tolerance, 
diabetes and dislipidemia linlced to insulin resistance and hyperinsulinemia (Baient et 
al 2002) and similar metabolic disorders.
38
1.5 Carbohydrate and fat requirements and recommendations
Carbohydrate is an important nutrient for different organs in the body, particularly 
for the neural tissues. Unlike other tissues, neural tissue preferentially uses glucose 
as fuel and adapts to oxidation of ketone bodies only after prolonged fast (Wolever,
2003).
The minimum amount of glucose needed for brain utilisation is 130 g/day. 
Therefore, carbohydrate should be at least 25% of a 2000 kcal diet (Jenkins et al
2004). In very low carbohydrate diets (e.g. Atkins diet with <20 g/day carbohydrate 
content), fat and protein must supply the rest of required energy, this may adversely 
affect health because of ketosis and also because vegetables and fruits may be 
restricted. This type of diet may also not meet other nutrient requirements including 
vitamins and minerals.
Results of per capita energy and nutrient intakes from household food and drink in 
the UK have shown a longterm decrease in energy intake between 1975 and 2002-03 
(from 2489 kcal/day to 2091 kcal/day, respectively). Average fat intakes have also 
decreased steadily over the period (-24%), particularly by decreasing saturated and 
monounsaturated fatty acids. Regarding carbohydrate intakes, there was a reduction 
between 1975 and 1991 (331 g/person/day compared with 250 g/person/day). Per 
capita intake of carbohydrates was around 270 g/day from 1992 to 2000 and then it 
has been reduced by 6.9% (average intake was 265 g/day in 2002-03). In term of 
percentage of energy, there has been no significant change in carbohydrate intakes 
(47.2% in 1975 and 47.5% in 2002-03; Figure 1.12). Non-milk extrinsic sugars 
which are usually refeiTcd as added sugars has decreased from 87 g/person/day to 82
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g/person/day while no significant changes were found for total sugar and starch 
intakes since 1975 (Department of Agriculture, 2004).
Figure 1.12 Contribution of fat and carbohydrate in energy intake (Department of
Agriculture, 2004)
Fat Carbohydrate
Year
Recommended daily amounts (RDAs) for energy and nutrients in the UK were set in 
1979. In 1987, the Committee on Medical Aspects of Food Policy (COMA) 
reviewed the RDA and Dietary Reference Value (DRV) was set (Committee on 
Medical Aspects of Food Policy 1984).
The definition of DRV for nutrients is usually based on estimation of average 
requirements for different groups of the population. The basic assumption in the 
DRV definition is that nutrient requirements are normally distributed. There are also 
some limitations for a number of nutrients and no DRVs are available. For example, 
as dietary carbohydrate and fat consist of variety of groups with different chemical 
and physiological properties, no exact DRV could be defined or estimated for fat.
40
fatty- acids, starches and sugars. However, some dietary guidelines have been 
proposed such as contribution of starch or sugars to the energy intake (Department of 
Health, 1991). Recommendations for carbohydrate and fat intake as DRV are given 
as the desirable contribution of these macronutrients to either daily total energy 
intake (including alcohol) or food energy. The acceptable carbohydrate intake ranges 
from 45% to 65% of daily energy intake (Jenlcins et a l 2004). For example, the 
recommended DRV for carbohydrate and fat are 50% and 35% of food energy in the 
UK, respectively (Table 1.6, Department of Health, 1991). The average intake of fat 
and carbohydrates in the British adults is summarised in Table 1.7.
Table 1.6 DRV for fat and carbohydrates for adults as a percentage of daily 
energy intake
Population average (%)
Total energy Food energy
Total fat 33 35
Saturated fatty acids 10 11
Cz5“polyunsaturated fatty acids 6 6.5
C/5-monounsaturated fatty acids 12 13
Trara-fatty acids 2 2
Total fatty acids 30 3Z5
Total carbohydrates 47 50
Non-milk extrinsic sugars 10 11
Intrinsic and milk sugars and starch 37 39
Non-starch polysaccharides (g/day) 18 N/A
(Department of Health, 1991).
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Table 1.7 Daily intakes of energy, fat and carbohydrates by the British population
Men
(N=1087)
Women
(N=1110)
Total
Energy (kcal) 2450 1680 2061
Total fat (g) 102.3 73.5 87.8
Carbohydrates (g) 272 193 232
Sugars (g) 115 86 100
Starch (g) 156 106 130
Non-starch polysaccharides (g) 11.2 12.5 11.6
(Department of Health 1991)
1.5.1 Simple sugars
Highly refined carbohydrates could be considered as ‘empty calories’ as they provide 
energy but not any essential nutrients (Department of Health, 1991; Jenkins et al.
2004). Although carbohydrate intake has not shown a marked change, simple sugar 
consumption has increased. For instance, in the United States, dietary carbohydrates 
showed a steady decrease from 500g/day (in 1963) to 374g/day (in 1991) and then it 
increased back to 500 g/day after 34 years (in 1997). The increase in dietary 
carbohydrate was parallel to an increase in not only highly refined carbohydrates but 
also increases in total fat and energy and a decrease in dietary fibre intake (Gross et 
al. 2004). Refined sugars are easily digestible carbohydrates A number of studies 
have shown that these type of carbohydrates are associated with higher risk or 
incidence of chronic diseases such as obesity, type 2 diabetes, insulin resistance and 
CHD (Katan et al. 1997; Parks 2001; Fried and Rao 2003; Jenkins et al. 2004).
Simple sugars in the diet are derived from those, which occur naturally in foods (e.g. 
lactose in milk, fructose in fruits) called intrinsic sugars and those, which are added
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to the foods during food processing and production, called non-milk extrinsic sugars 
(NMES). There are two different recommendations:
(1) no limitation has been recommended for intrinsic or milk sugars,
(2) intake of NMES should not exceed 10% of total energy intake (Department 
of Health, 1991).
1.5.2 Fructose and high fructose corn syrup
Dietary carbohydrate intake increased since 1963 by 126 g per day in the USA and 
the average daily intake of fructose is from 19g per day to 37g (Glinsmann and 
Parks, 1995). Consequently, consumption of fructose has increased, because soft 
drinks and some foods have been sweetened by manufacturers with corn syrup. 
Although it does not stimulate insulin secretion from p-cells and in the postprandial 
state and it has a smaller postprandial insulin secretion effect than glucose containing 
foods and beverages (Elliott et a l 2002), fructose causes a dramatic increase in 
circulating TAG level. There was an exaggerated postprandial iipemia after fructose 
feeding revealed by a significant increase at TAG level (Jeppessen et al 1995). 
They showed that adding fructose (50g) to the standard fat load for 11 healthy adult 
subjects meals, resulted in a higher postprandial TAG level. In this way, TAG-rich 
lipoproteins of intestinal origin may play a role in the fructose-induced increase of 
postprandial Iipemia, The other suggested mechanism for this observation would be 
an impaired TAG clearance.
Although the reason for the different effects of fructose on TAG level is not yet clear 
(Jeppessen et a l 1995; Grant et a l 1994; Arefaine et a l 1998), this monosaccharide 
has less glycaemic effect and induces lower insulin secretion than glucose and starch.
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Pancreatic p cells are not stimulated by fructose intake, so foods and beverages, 
which contain fructose, have smaller effects on postprandial insulin level than 
glucose (Elliott et al. 2002), However, the increase in the prevalence of obesity, 
which is attributed to increase in dietary intake of fructose containing food and 
beverages is linked to insulin resistance (American Diabetes Association, 2000).
The increase in carbohydrate intake in developed countries is associated with 
increased intake in fructose containing corn syrup and this has expanded 
dramatically, because soft drinks and some foods have been sweetened by 
manufacturers to produce more tasty foods (Gross et al. 2004; Bray et al. 2004). 
Although dietary fructose reduces circulating insulin level it increases TAG levels 
and consequently worsens the lipid profile (Jenkins et al. 2002e; Wu et al. 2003; 
Teff and Townsend 2004; Elliot et al. 2002).
1.5.3 Starch
Starches are the major type of dietary polysaccharides. Starchy foods not only play 
an important role in energy provision for the body but also contain other nutrients. 
Starches are classified according to the rate of digestibility due to physical state of 
starch granules such as rapidly digestible starch (e.g. found in bread, cooked rice and 
potatoes), slowly digestible starch (e.g. raw cereals, beans and whole grains) and 
resistant starch (e.g. raw potatoes). Resistant starch, which escapes digestion in the 
small intestine, is a substrate for colonic feimentation and results in production of 
short-chain fatty acids. These fatty acids are absorbed and contribute up to 10% of 
body energy supply (Department of Health, 1991; Jenldns et al. 1998). The ratio of 
simple to complex carbohydrate (i.e. sugar/starch ratio) in the diet may influence
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fatty-acid synthesis. That is lower (40:60) compared with the higher (60:40) sugar to 
starch ratio in a low-fat food resulted in trace increase in de novo fatty acids in 
VLDL-TAG (Hudgins et al. 1996).
Starch accounts for around half of the carbohydrate intake by the British population. 
The DRV for starch accompanied by intrinsic and milk sugars is that it should 
provide 39% of daily food energy (Department of Health, 1991).
1.5.4 Dietary fibre and non-starch polysaccharides
One of the major factors influencing digestability and the rate of absorption of 
carbohydrate foods, and hence postprandial glycaemia, is their dietary fibre content.
In 1976 Trowell defined dietary fibre as the edible parts of plants and the remnants 
of plant cells that are resistant to hydrolysis by human enzymes. This includes all 
indigestible polysaccharides that undergo full or partial fermentation in the large 
intestine (Trowell et al. 1976) and include cellulose, hemicelluloses, lignin, 
pentrosans, pectins, gums, waxes, mucilages, modified cellulose and some processed 
polysaccharides. Dietary fibres are not nutrients, but they produce important 
physiological effects on human metabolism. (Table 1.8)
The term dietary fibre in the UK was later replaced by non-starch polysaccharides 
(NSP), which include cellulose and non-cellulosic polysaccharides (British Nutrition 
Foundation Task Force, 1990 and Prosky, 2000a), These are compounds in the plant 
cell walls such as pectin, cellulose, hemicellulose, pentosan and gums (e.g. guar gum 
and arabic gum). Fruits, vegetables, legumes, and cereals are NSP rich foods. NSP 
are categorised into soluble and insoluble NSP. Soluble NSP may form viscous gels
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in the small intestine, which can reduce the absorption of other nutrients such as 
carbohydrate and fat (Edwards and Parrett, 1994). They are fermented by the 
colonic bacteria and produce SCFA (acetate, propionate and butyrate in the 
approximate molar ratio of 60: 25: 15) and gas. Insoluble NSP have little effect in 
the small intestine and are relatively resistant to bacterial fermentation and maintain 
their water holding capacity (WHC), which increases stool output (Cummings and 
Englyst, 1987). Cellulose and lignin are examples of insoluble NSP. The ratio of 
soluble to insoluble (S/I ratio) NSP in food varies. For instance, fruits and vegetables 
have higher S/I ratio whereas wheat has a lower ratio.
The physiological effects of NSP are summarised below in Table 1.8.
Table 1.8 Physiological effects of NSP
Function Soluble NSP Insoluble NSP
Gel formation Increase^ -
Water Holding Capacity " Increase®
Colonic fermentation Increase Slow or resistant’’
Gas production Increase^ '^ '’ -
Transit time Decrease Decrease's
Water absorption in the Increase ^ -
colon
Stool output - Increase’
Absorption in GI FermentatioiT -
Gastric emptying - Increase’ ’’
Blood cholesterol Decrease^ Decrease due to 
increase in bile 
excretion ’
Blood glucose Decrease‘S ^ -
Insulin sensitivity Increased“‘^ ‘*
br&__1 _ Ct _ _ i_r__
Increase's* d
dTT_l____
1998UArjmandi et a i  1992a; ^Turner et u/. 1990).
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The cunent recommendations are to encourage people to consume more NSP rich 
foods because of their beneficial effects. Consumption of NSP have been shown to 
be associated with an increase in insulin sensitivity, anti-carcinogenic effects in large 
bowel, decreased risk for type 2 diabetes (Salmeron et al. 1997a; Salmeron et al. 
1997b; Uchenna et al. 1998; Gross et al. 2004), and CVD (Jenkins et al. 2002) 
(Department of Health, 1991; Bessesen, 2001b; Brand-Miller et a l 2003). The 
average intake of NSP in the UK is between 11 to 13 g/day, of which around half 
and 40% is provided by vegetables, and cereals, respectively. The DRV for NSP is 
an average 18 g/day (ranged hom 12-24 g/day) from a variety of foods including 
fruits, vegetables, cereals (Department of Health, 1991).
1.5.5 Dietary Fat
Obesity and especially abdominal obesity is an important metabolic risk factor for 
insulin resistance, which is increasing worldwide. The prevalence of metabolic 
diseases also has increased with greater dietary fat consumption (Hooper et al.
2001). The quantity and quality of the fat In the diet has changed in the National Diet 
SuiTeys over the last three decades in the UK. However, there are large variations in 
the amount of total fat intake across countries in different parts of the world 
(FAO/WHO, 2003). The assessment of fat intake and subsequent CHD mortality in a 
cohort of randomly selected adults aged 40-75 years old for 16 years sincel 984-1985 
up to 2000-2001 in the UK showed there is a positive and significant relationship 
between fat intake and mortality from CHD while taking account of other CFID 
related risk factors (Boniface and Tefft 2002), however the cross-sectional Scottish 
Heart Health Study (Bolton-Smith et a l 1992) did not find any association in males 
or females.
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There is strong evidence for the link between fat intake and risk of chronic diseases 
such as CVD in experimental animals. Studies in animal models of atherosclerosis in 
hamsters or transgenic models of atherosclerosis in mice, (Mangiapane et al. 1999) 
indicated the contribution of a high saturated fat diet to CVD disorders. Atherogenic 
processes were also seen in healthy human subjects after a high saturated fat diet (Hu 
et al. 2001) and large scale epidemiologic studies confirm these associations (Hooper 
et al. 2001). Reduction in total fat intake and especially intake of saturated fatty 
acids is an important aspect of dietary guidelines, particularly in Western countries. 
The recommended intake for dietary fat in the UK is 33% of total energy (including 
alcohol) and 35% of food energy (excluding alcohol) (Table 1.5). The proportion of 
saturated fat should be around one third of energy from fat (i.e. about 10% of total 
dietary energy). Mono- and poly- unsatmnted fatty acids should provide on average 
about 12% and 6% of dietary energy, respectively. The proportion of saturated fatty 
acids should not exceed 10% of total energy (Department of Health, 1991). Storage 
lipid plants (e.g. vegetable oils) and marine animals (e.g. fish) are good dietary 
sources of fat.
y \  /y
Cis Trans
Figure 1.13 Geometric configuration of unsaturated fatty acids.
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Vegetables, cereal products and fat spreads are main sources of n-3 and n-6 fatty 
acids in the diet of British adults (Gregory et al. 1990). The other important issue is 
the geometric nature of the consumed unsaturated fatty acids (Constant, 2004).
Figure 1.13 shows the geometric structure of two different conformations of
unsaturated fatty acids present in human metabolism. The production of the trans 
form of unsaturated fatty acids (mono, di and poly unsaturated fatty acids) by thermo 
reactive processes results in a higher melting point compared with the isomeric 
compound of the same fatty acid in cis configuration (van Greevenbroek et n/. 1998; 
Wang et al. 2003). This will affect membrane fluidity and response to hormones. 
Several large-scale studies report trans fatty acids as a significant risk factor for CHD 
(Lichtenstein et al. 2003), in contrast, some smaller scale studies did not reveal any 
association with insulin resistance (Lovejoy et al. 2002).
1.6 Effects of high carbohydrate (HC) diets
As a high carbohydrate diet is recommended for the whole population, it is important 
to consider the scientific basis on which these recommendations were made and 
whether the recommendation is still relevant.
The interaction between dietary carbohydrate and lipid metabolism in health and 
disease has been a major research interest since Ruderman et al. (1971) reported an 
increase in plasma TAG levels on a high carbohydrate diet. Disturbances in 
carbohydrate metabolism characterised by high glucose concentrations and other 
features of insulin resistance are more likely to be accompanied by dyslipidemia 
(Abbasi et al. 2000; Parks and Hellerstein, 2000; Bessesen, 2001, Isomaa et al. 2001 ; 
Hellerstein, 2002; Thomas and Wolever, 2003). In 80% of patients with type 2
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diabetes, metabolic syndrome (i.e. obesity, dyslipidemia, hypertension, and 
microalbuminuria) is observed (Bos et al, 2003). The presence of insulin resistance 
and metabolic syndrome in type 2 diabetic patients results in hypertriglyceridemia 
and low HDL-cholesterol concentrations and high levels of small dense LDL 
particles and consequently a higher risk of atherosclerosis (Goldberg, 2000).
The health effects of increasing carbohydrate intake through decreasing dietary fat 
have been investigated through various epidemiological and inteiwention studies. 
Although there is no universally accepted definition for HC and low carbohydrate 
(LC) diet according to either percentage of energy intake derived from carbohydrate 
or absolute amount of carbohydrate in the diet, most studies have defined HC diet as 
a diet with 55% or more energy from different types of carbohydrate (Jeppesen et al 
1997). Some aspects, such as the difference between high or low carbohydrate diets 
in isoenergetic conditions as well as different level of energy intake, amount of 
dietary carbohydrate (gradient effect), various chemical forms of carbohydrates 
(simple or complex), rate of carbohydrate digestibility, quality of carbohydrate 
(glycaemic index of food), duration of study (short- and long- term), in animal 
models and human, in healthy and patients subjects (particularly type 2 diabetic 
patients), interaction by genetic and lifestyle factors (e.g. physical activity level) 
have been of concern. Although some studies revealed variability in the response to 
HC diet, health benefits such as lower risk of CHD and type 2 diabetes, weight loss, 
reduction in total and LDL-cholesterol concentrations have been reported.
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1.6,1 Beneficial effects of HC diets
The LF-HC diets might play a role in weight loss associated with improvements in 
glucose metabolism and insulin sensitivity. Diets higher in unrefined carbohydrates 
and dietary fibre have been shown to slow down glycaemic and insulinaemic 
responses compared with refined carbohydrate diets. For example, increased whole- 
grain intake was associated with decreased risk of CHD after adjustment for age and 
smoking (Liu et al. 1999). Therefore, such diets may protect from the development 
of type 2 diabetes and related health outcomes (Hu et al. 2001b), Dietary patterns 
including higher intakes of fruits, vegetables, legumes, fish, poultry, and whole 
grains, a so-called ‘prudent’ dietary pattern, has been shown to be associated with a 
lower risk for CHD (RR=0.76, 95%CI: 0.60-0.98) compared with the ‘Western 
dietary pattern’ characterised by higher intakes of red and processed meats, sweets 
and desserts, french fries, and refined grains which significantly increased the risk of 
CHD (Fung et al. 2001). The protective effects against CHD have been shown by 
increasing consumption of fruits and vegetables, particularly green leafy vegetables 
and vitamin C-rich types (RR=0.80, 95% Cl: 0.69 to 0.93; Joshipura et al. 2001).
The HC-LF diet including at least five portions of fruit and vegetables per day is 
supposed to reduce risk of CHD (Ullmaim et al. 1991; Rimm et al. 1996; Dreon et 
al. 1999; Liu et al. 1999; Joshipura et al. 2001; Cemea et al. 2003). Reductions in 
body weight, total cholesterol, LDL and HDL cholesterol concentrations were shown 
following the American Heart Association Step 1 diet, as a HC-LF and low 
cholesterol, after 10 weeks among overweight and obese women (Bunyard et al.
2002). However, a two-week isoenergetic HC and HF inteiwention diets (i.e. 75% 
and 10% V5 30% and 55% energy from carbohydrate and fat, respectively) failed to 
show any significant difference in plasma total cholesterol concentration
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(Mittendorfer and Sidossis, 2001). Variability in response to HC diet among healthy 
people could be a major factor (Ruderman et a l 1971; Mancini et a l 1973; Parks et 
al 1999; Parks and Heilerstein, 2000). In addition, different types of dietary 
carbohydrates have different glucose and insulin responses (Wolever et a l 1988; 
Riccardi et a l 2003), and consequently, may result in different metabolic effects 
(Laville, 2004).
1.6.2 Adverse effects of HC diets
Reduction in fat intake (at 33%) and its replacement by carbohydrate in which 
energy intake is maintained at the same level is recommended in the UK. However, 
this recommendation does not seem to reduce the risk of CHD. Despite the potential 
beneficial effects of a HC diet, there is evidence indicating that HC diet leads to 
increases in plasma TAG and a decrease in HDL cholesterol concentrations (Chen et 
al 1993; Jeppesen et a l 1997; Koutsari et a l 2000). Hypertriglyceridemia as a 
predictor of CHD risk has been reported through intense studies after following not 
only a HF diet but also HC diet (Kasim-Karakas et a l 1997; Austin, 1999; Parks et 
al 1999; Hudgins et a l 2000; Kasim-Karakas et a l 2000; Parks and Heilerstein 
2000; Parks, 2001; Heilerstein, 2002). The increase in TAG levels, however, has 
been associated with a reduction in LDL particle size (Kasim-Karakas et a l 1997).
Short-term inteiwention studies have similarly reported hypertriglyceridemia and 
reduction in HDL-cholesterol levels. The effect of two experimental isoenergetic 
diets: (1) HC diet (60% of energy from carbohydrate and 25% from fat) and (2) HF 
diet (40% and 45% energy from carbohydrate and fat, respectively) for three weeks, 
showed higher fasting TAG and VLDL cholesterol concentrations and lower HDL
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cholesterol level after the HC diet compared with the HF diet (Kasim-Karakas et al. 
1997).
In order to maintain glucose homeostasis, an increase in carbohydrate intake imposes 
a demand for insulin secretion. An increase in TAG and a decrease in HDL- 
cholesterol concentrations have been reported following diets high in either 
carbohydrate or polyunsaturated fat (Brunner et al. 2001). As HC diet is one of the 
reasons for hypertriglyceridemia, there has been an interest to find the best type of 
carbohydrate to avoid disturbances in glycemia. Results of various studies have 
shovm that, high amylopectin starch (Kabir et al. 1998) and wheat starch (Lever- 
Metzger et al. 1996) induce hyperglycemia, hyperinsulinemia and 
hypertriglyceridemia as well as increasing adiposity in normal and diabetic rats.
The major metabolic pathway for supply of energy reserves and cellular structure is 
fatty acid synthesis, which is regulated by diet (e.g. HC and low-fat (LF) diets) and 
hormonal controls (e.g. insulin, glucagon and thyroid hormones) (Hillgartner et al, 
1995). For instance, three week consumption of a high GI diet may lead to adverse 
effects on lipogenic enzymes (i.e. fatty acid synthase and LPL) to increase plasma 
lipids and fat accumulation while low GI diets (low in amylopectin and high in 
amylose) inliibits long-term fat accumulation by inhibition of these lipogenic 
enzymes in normal and diabetic rats (Kabir et al. 1998).
De novo lipogenesis has been proposed as one of the probable mechanisms to 
explain dyslipidemia following a HC diet. De novo lipogenesis is defined as the 
process by which carbon units from carbohydrates are used for fat synthesis (Parks,
53
2001). Fatty acids synthesised from dietary triglycerides, sugars from consumed 
carbohydrates, adipose tissue or remnant TAG following the action of LPL on 
chylomicrons are the sources of VLDL-TAG synthesis in the liver (Figure 1.14).
Hudgins et a l (2000) showed that diets high in simple sugars were significantly 
associated with higher de novo lipogenesis in healthy subjects. This condition may 
stimulate VLDL-TAG synthesis but little is known about stimulation of fatty acid 
synthesis in humans. However, results of the in vivo measurements of fatty acid 
synthesis have revealed that despite high body carbohydrate stores and stimulation of 
de novo lipogenesis by HC diet in humans, fatty acid synthesis through this process 
is quantitatively minor (Heilerstein et a l 1996). One of the possible hypotheses is 
that high monosaccharide diets increase blood glucose levels and are more likely 
increase fatty acid synthesis from glucose by providing more carbon units to the 
liver. Therefore, elevated levels of glucose and insulin may stimulate de novo 
lipogenesis. Parks (2002) failed to find any positive association between these 
parameters among subjects followed HC diets but there was a positive relationship 
between insulin concentration and de novo lipogenesis in subjects on HF diet (Figure 
1.15). Non-digestible oligosaccharides (e.g. oligofructose) may directly influence 
increased lipogenesis. Oligofructose is fermented in the colon and provides shoit- 
chain fatty acids (SCFA). It has been suggested that TAG and cholesterol synthesis 
are affected by the proportion of propionic to acetic acid. In one study, 
supplementation with 15g/day oligofructose in healthy subjects reduced fasting TAG 
level by 21% (Parks, 2002).
Proposed factors influencing the control of liver TAG secretion are:
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• the form of carbohydrate (solid or liquid),
• the level of carbohydrate processing in food,
® the physical state of the carbohydrate in the diet 
(Parks & Heilerstein 2000; Parks 2002).
Figure 1.14 De novo lipogenesis (*)
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In general, these studies are mostly very short term and the effects may not be 
sustained over a longer time. There are arguments for appropriate amounts of
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carbohydrate and fat in daily energy intake (Hung et al. 2003). The controversy for 
dietary fat and carbohydrate for the management of diabetes has produced three main 
guidelines for the management of diabetes since 2000.
In the first approach, saturated fatty acids (SF) were avoided and it was emphasised 
to provide energy from carbohydrate and monounsaturated fatty acids (MUFA), 
however there was no regard to carbohydrate quality in the recommendations of the 
American Diabetes Association (ADA). The most recent ADA advice is for for 
diabetics to reduce body weight and increase physical activity, with 60-70% of 
energy from MUFA and complex carbohydrate with no attention to the quality of 
carbohydrate (Parks, 2002).
Nevertheless, there is a special interest in the quality of carbohydrate (e.g. glycaemic 
index). Low glycaemic index (low GI) and high fibre carbohydrates are 
recommended and this type of dietary carbohydrate is considered as an important 
parameter for diabetes management. The Canadian Diabetes Association (CDA) and 
the Diabetes Australia (DA) have also recommended low fat, low saturated fat and 
high carbohydrate diet (FAO/WHO, 1997).
The European Association for the Study of Diabetes (EASD) has combined the two 
approaches (The Diabetes and Nutrition Study Group (DNSG) of European 
Association for the study of Diabetes, 2000). The American Heart Association 
(AHA) in 2000 and National Cholesterol Education Programme (NCEP) in the third 
Adult Treatment Panel (ATP-III) in 2001 (LaRosa and Gotto, 2004) (Isomaa et al. 
2001; Isomaa, 2003) have addressed nutritional management of diabetes and insulin
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resistance and they recommend the modification of carbohydrate quality by an 
increase in dietary fibre and MUFA up to 20% of daily energy intake.
1.7 Glycaemic index (GI)
The concept of Glycaemic Index is an extension of the dietary fibre theory that was 
introduced by Burkitt and Trowell in 1977. Consumption of fibre reduces the rate of 
nutrients influx from intestine (Jenlcins et al. 2002). The rate of digestion contributes 
to the postprandial blood glucose and secreted insulin in response to the dietary 
intake of carbohydrate containing foods (Wolever and Bolognesi 1996).
In order to guide food choices in 1997, a committee of experts commissioned by the 
F AO and the WHO reviewed the research evidence regarding the importance of 
carbohydrates in human nutrition and health. They accepted the use of glycaemic 
index (GI) method to classify foods rich in carbohydrate and that to consume from 
carbohydrates with low GI is good for health. A low GI diet can reduce postprandial 
glucose levels and keep blood glucose levels within a normal range (Brynes et al.
2005) which may increase insulin sensitivity.
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Figure 1.15 Blood glucose response to low and high GI foods up to two
Blood glucose concentration
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Jenkins (1981) proposed that the accepted categories in the classification of dietary 
carbohydrate and the division of simple and complex carbohydrates could not 
explain all the characteristics and observations of the physiological effects of 
different carbohydrate consumption especially in diabetics (Opperman et al. 2004). 
Jenkins introduced the GI theory in 1981 and since then has carried out much 
research into this concept and th application of this new classification in 
understanding of carbohydrates in the diet of diabetic patients and especially in the 
postprandial condition.
58
1.7.1 Definition of GI
The GI of a food can provide useful information on the likely effect of a carbohydrate- 
containing food on postprandial blood glucose. It is based on the area under the 
postprandial blood glucose curve after enough of the food to contain 50g of 
carbohydrate compared with 50g of readily digestible carbohydrate. A syrup of 
glucose or white bread is used as the standard digestible carbohydrate. The GI is 
expressed as a percentage of the glycaemic response to the reference food. Figure 1.15 
shows the difference in glycaemic response between foods with high and low GI. The 
GI of a food does not reflect the quantity of carbohydrate in the food. If a food 
contains very little carbohydrate you need to eat a large volume to cany out the 
measurement, which may affect the result.
1.7.2 Definition of glycaemic load (GL)
The term glycaemic load (GL) quantifies the average glycaemic effect of a portion of 
food and was introduced in 1997 (Frost et al. 1999; Liu et al. 2000; Jenkins et al. 
2000b; Laville, 2004). The GI of a carbohydrate containing food provides information 
on the nature of food while the GL reflects the resultant blood glucose and insulin 
level (Nantel, 2003). The GL is the product of the amount of available carbohydrate 
and the GI of the food and is calculated by multiplying GI of the food by carbohydrate 
content of the food divided by 100 (Foster-Powell et al. 2002).
1.7.3 Calculation of average GI and GL
Average GI and GL are calculated by either direct assessment of GI for foods or use of 
previously determined and published values for each food. For determination of 
average GI and GL values, dietary data should be analysed. To obtain carbohydrate
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content for each food, a list of the consumed food items is provided and then 
carbohydrate content is estimated. The GI for each food is selected appropriately from 
the International Table of Glycémie Index and Glycémie Load Values (Foster-Powell 
et al. 2002). The average GI in the table is based on studies in either healthy or 
diabetic subjects (type 1 or type 2 diabetes) and foods have been sorted descending 
according to their carbohydrate content. It has been shown that GI values determined 
in normal subjects correlate well with those found in diabetic subjects (Wolever et a l 
1987). Even though people with diabetes have higher blood glucose values, they are 
members of the same human species and they show the same differences in rates of 
digestion and absorption of carbohydrate (Brand-Miller and Mendosa, personal 
communication on 17, August 2003). For food items with high carbohydrate content 
and without GI, it is recommended to consider the GI from similar or the closest food 
item by type and amount of carbohydrate. It is also suggested that if 80% of the 
consumed food items with GI value from the top of the list are prepared, it could be 
enough for calculation of GL and average GI (Jenkins 2003, the 9^ '^  European Congress 
on Nutrition, Rome).
1.7 4 Advantages and disadvantages of GI and GL
There are several advantages and disadvantages to the use of GI and GL. A 
physiological classification of dietary carbohydrates in common foods has an 
important advantage over the traditional classification using molecule size. 
Classification of a food based on its glycaemic response provides an indication of the 
carbohydrate quality (Schenk et al. 2003) and also a reasonable insight into the link 
between foods and health outcomes. GI has been shown to be a strong predictor of 
HDL-C and C-reactive protein levels in healthy and patients with chi'onic disease
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such as metabolic syndrome, CHD, obesity and some kinds of cancer. (Brand-Miller 
et al. 2003; Frost et al 1999; Liu et al 2000). However, many factors such as food 
form, cooking method, processing and structure of starch have a strong influence on 
the GI of foods. There can be a great variability of the GI of foods depending on the 
botanic origins of the food, the time and temperature during cooking, and the fat and 
water content (Brand-Miller et al. 2003; Laville 2004). Moreover the GI of a food 
does not reflect the real postprandial glycaemia of the normal portion size of the food 
in conjunction with other meal ingredients. The GL improves on this but still does 
not necessarily reflect the true postprandial consequences of the diet.
The determination of the postprandial response for each food, which is required by 
both GI and GL, is expensive and in general people use the published international 
table of GI and GL values instead of measuring their own foods (Sydney University- 
Glycaemic Index Research Seiwice 2003). This means that many studies may under 
or overestimate the response to the foods in their country’s diet. Table 1.9 and 1.10 
summarise advantages and disadvantages of application of GI and GL. Table 1.11 
presents some examples of food with different GI and GL.
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Table 1.11 Glycaemic Index by Glycaemic Load (Mendosa 2004)
LOW GI MED GI HI GI
All-bran cereal (8*,42**) Beets (5,64) Popcorn (8,72)
Apples (6,38) Cantaloupe (4,65) Watermelon (4,72)
Carrots (3,47) Pineapple (7,59) Whole wheat flour bread (9,71)
Ghana dal (3,8) Sucrose (table sugar) (7,68)
Chick peas (8,28)
Grapes (8,46)
LOW
GL
Kidney beans (7,28)
Nopal (0,7)
Oranges (5,42)
Peaches (5,42)
Peanuts (1,14)
Pears (4,38)
Pinto beans (0,39)
Red lentils (5,26)
Strawberries (1,40)
Sweet corn (9,54)
Apple juice (11,40) Life cereal (16,66) Cheerios (15,74)
Bananas (12,52) New potatoes (12,57) Shredded wheat (15,75)
Buckwheat (16,54) Wild rice (18,57) White wheat flour bread (11,70)
MED
GL
Fettucine (18,40)
Navy beans (12,38)
Orange juice (12,50)
Parboiled rice (17,47)
Pearled barley (11,25)
Sourdough wheat bread 
(15,54)
HI GL
Linguine (23,52) Couscous (23,65) Baked Russet potatoes (26,85)
Macaroni (23,47) Sweet potatoes (27,61) Cornflakes (21,81)
Spaghetti (20,42) White rice (23,64)
Adapted from Foster Powell et al., 2002; Mendosa, 2004 
GI: Low=l~55 Med=56-69 High=70-100
GL: Low=l-10 Med=ll-19 High=20 or more
* Food GL 
** Food GI
GL (g) =((GI (%) /100)) * Carbohydrate (g))
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There is not a general agreement about the importance of GI on human health, 
nutrition and disease prevention (Ludwig and Eckel, 2002; Kelly et al 2004). Table 
1.12 summarises the name and references of organizations that did accept or did not 
encourage application of GI parameter as a base for dietary managment. It is 
therefore important to consider the epidemiological evidence for the importance of 
GI and GL in the incidence of chronic disease.
Table 1.12 Approval and disapproval of GI by different organizations in the 
world (Opperman et al. 2004).
Organization 
approved use of GI
References Organization 
disapproved use of GI
References
Joint FAG/WHO 1997 American Diabetes 2001
Expert Consultation Association
on Carbohydrates
European Association 2000 American Heart Krauss et al.
for the study of Association 2000
Diabetes (EASD)
Canadian Diabetes 2000 American Dietetic 1999
Association Association
Diabetes UK 2003
Dietitians Association 1997
of Australia
1.8 Association between dietary GI and GL and chronic disease
There are several epidemiological studies which have investigated the association 
between GI, GL and chronic diseases including cardiovascular diseases, cancer and 
type 2 diabetes (Ludwig, 2003c; Tables 1.13, 1.14) GL has been suggested as an
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independent risk factor for myocardial infarction (Ford and Liu, 2001; Liu et a l 
2001), cancer (Augustin et al. 2001; Augustin et al. 2003) and type 2 diabetes 
(Salmeron et al. 1997a; Salmeron et al. 1997b).
Liu et al. examined the association between dietary GL and risk of coronary heart 
disease (CHD) in 75,000 women aged 38-63 years in 1984 and after 10 years follow- 
up using a validated food frequency questionnaire. Over 10 years follow-up, 208
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fatal and 553 non-fatal myocardial infarction occurred. After adjustment for other 
CHD risk factors (e.g. age, smoking, total energy intake), a high dietary GL was 
associated with a higher risk of CHD (Liu et al. 2001).
The first cross-sectional study in UK investigated the relationship between dietary GI 
and cardiac risk factor such as HDL cholesterol, was carried out by Frost et al. in 
1999. The retrospective study was undertaken on 7-day weighed records of 1,420 
British adults. Results showed that there was a negative correlation between dietary 
GI and serum HDL cholesterol concentrations (Frost et al. 1999). Ford and Liu (Ford 
and Liu, 2001) in the US population also confirmed this finding. They reported that 
plasma HDL level was inversely associated with dietary GI after adjustment for risk 
factors for CHD, that is the HDL level for the lowest GI quintile was 1.36 mmol.L'^ 
while its concentration was 1.26 mmol.L'^ in the highest quintile of GI.
1.8.1 GI and GL and Type 2 diabetes mellitus
Diet is one of the pivotal factors which influences the development of type 2 diabetes 
(Hu et al. 2001a; van Dam et al. 2002b). HC-LF diets might aid in weight loss 
associated with improvements in glucose metabolism and insulin sensitivity.
„.,s
Complex and unrefined carbohydrates cause slower glycaemic and insulinaemic 
responses compared with highly processed refined grains and in this way play a 
protective effect on the development of type 2 diabetes (Meyer et al. 2000; Hu et al. 
2001b).
Dietary GI has been used as a carbohydrate quality indicator for studies investigating 
the link between dietary carbohydrate and the risk of type 2 diabetes. The link 
between dietary GI and GL in relation to lipid profile has mostly been studied with 
diabetic patients. Dietary carbohydrates may influence the risk of developing type 2 
diabetes. For example, there is strong evidence indicating the association between 
lower dietary fibre intake and an increased risk of developing type 2 diabetes 
(Salmeron et al. 1997a; Salmeron et al. 1997b; Meyer et al. 2000) whereas a few 
studies have reported no association between total carbohydrate intake and diabetes 
risk (Salmeron et al. 1997a; Salmeron et al. 1997b; Meyer et al. 2000).
A number of epidemiological studies have investigated the association between the 
GI or GL of diet and diabetes risk using multivariate adjusted relative risk (RR). For 
example, the Nurses’ Health Study has revealed that increase in GI of diet was 
positively associated with risk of type 2 diabetes after 6 years follow-up. The 
adjusted RR for women was 1.37 (95% Cl: 1.09, 1.71) for an increase in GI of 15 
units and 1.47 (95% Cl: 1.16, 1.86) for the highest quintile of dietary GL. Women 
with both a high GL and a low cereal fibre intake were at an even higher risk of type 
2 diabetes (2.43; 95% Cl: 1.12, 5.27) (Salmeron et al. 1997a). Among men, the RR 
was 1.37 (95% Cl; 1.02, 1.83) for extreme quintiles of dietary GL and 2.17 (95% Cl: 
1.04, 4.54) for the combination of a high GL and a low intake of cereal fibre
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(Salmeron et al. 1997b). However, the Iowa Women’s Health Study cohort failed to 
find any associations between GI and GL and diabetes risk in the six-year follow-up 
(Meyer et al. 2000).
1.8.2 GI and GL and Coronary heart disease
Dietary GI and GL are suggested as important dietary indicators in relation to lipid 
metabolism and insulin-related disturbances and consequently CHD risk (Wolever et 
al. 1991; Frost et al. 1999; Liu et al. 2000; Jenkins et al. 2000a; Laville, 2004). 
These indicators have mainly been studied by metabolic risk factors for CHD rather 
than assessing the direct effect on incidence of CHD. The most frequently studied 
risk factors of CHD are lipid profile, (e.g. TAG, total, HDL and LDL cholesterol), 
insulin-related parameters (e.g. glucose, insulin, and insulin sensitivity index) and 
inflammatory markers (e.g. C-reactive protein).
1.8.2.1 Lipid risk factors
These associations have been examined tluough epidemiological and intervention 
studies. High-Gl diet has been shown to be associated more with higher CHD risk 
(Frost et al. 1999; Jenkins et al. 2000a). Dietary GI is associated positively with 
TAG concentrations, negatively with HDL levels (Liu et al. 2000), inversely 
associated with satiety through short-term feeding and with weight loss (Leonetti et 
al. 2002; Pawlack et al. 2004). Food form, particle size, food processing and cooking 
and structure of carbohydrate affect the GI. In addition, glucose and insulin 
responses vary by amount and type of carbohydrate (Wolever et al. 1988; Brand- 
Miller et al. 2003) and various metabolic effects could be expected (Laville, 2004). 
Slow release of insulin as a result of slowly absorbable carbohydrate seems to
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modulate lipid concentrations (Riccardi et a l 2003). Increase in carbohydrate intake 
and particularly higher intake of simple sugars than starches can induce 
hypertriglyceridemia. Plasma TAG levels increase in a dose-dependent mamier 
(Leeds, 2002; Ludwig, 2002; Brand-Miller et al 2003; Fried and Rao, 2003). Low 
GI carbohydrates is supposed to improve lipid profile in hyperlipidémie patients by 
increasing HDL cholesterol concentrations because they are slowly absorbed and 
form lente or sustained release carbohydrates by providing a substrate for colonic 
fermentation (Jenkins et a l 2002).
However, not only no protective effect of dietary GI has been shown on lipid profile 
and risk of acute myocardial infarction (Tavani et al 2003; Frost et al 2004) or even 
increased risk of CHD (Brynes et a l 2003). The most important effects of GI on 
lipid profile are low plasma HDL concentrations and elevated fasting TAG 
concentrations (Liu et a l 2000; Liu et a l 2001). Among 280 postmenopausal women 
in the Nurses’ Health Study, dietary GL was associated with low plasma HDL 
cholesterol and elevated fasting TAG concentrations (Liu et a l 2001). A similar 
effect on HDL cholesterol was found by Frost et a l (Frost et a l  1999) on British 
healthy adults.
Results from a meta-analysis of 17 population-based studies showed a 76% increase 
in CVD risk in women and a 31% increase in men associated with a 1 mmol/L 
increase in TAG levels (Opperman et a l 2004). It could be partially explained by 
hormonal difference between women and men as menstrual cycle has an important 
influence on TAG levels but not on cholesterol concentrations. The risk of CFID 
increases after menopause (Rich-Edwards et al. 1995; Tremollieres et al. 1996; 
Jeppesen <2 /. 1997; Woods e /ût/. 1998).
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Insulin seems to be a good predictor for HDL cholesterol concentrations in healthy 
populations and diabetic patients whereas type and amount of fat failed to show it 
(Ford et a/. 1999). Insulin is at the centre of metabolism of ingested nutrients, in 
particular dietary carbohydrate. Insulin by reducing gluconeogenesis, glycogenolysis 
and suppressing lipolysis and the release of NEFA, stimulates the disposal of 
ingested glucose into muscle and adipose tissue (Frayn et al. 1997; Kraegen et a l 
2001).
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Low GI diet has shown to improve insulin sensitivity while high GI diet is supposed 
to be associated with insulin resistance (Salmeron et a l 1997a; Salmeron et al. 
1997b; Ludwig, 2002). In addition, LPL is activated by insulin in adipose tissue. 
Thus, in postprandial condition, because of an increase in TAG level, the clearance 
of TAG-containing lipoprotein increases. The mechanisms for hypertriglyceridemia 
following consumption of high GI diet are what were described earlier in the effect 
of HC diet. Because there is a strong interrelationship between TAG and HDL 
cholesterol concentrations (Figure 1.4 and 1.5), similar mechanisms are supposed for 
HDL cholesterol as well.
1.8.2.2 Insulin-related parameters
Insulin resistance is a metabolic disorder and associated with obesity, hypertension, 
diabetes and CHD. Alteration in diet is supposed to influence insulin sensitivity 
however, other factors may contribute to its progression. Associations between 
insulin resistance and disease such as CHD have obseived in some but not all 
populations (Bessesen, 2001). Plasma glucose, insulin, and insulin sensitivity 
indicators (such as homostatic model assessment (HOMA) or euglycemic
I
hyperinsulinémie clamp technique) are a number of insulin-related factors. Although 
large-scale epidemiological studies such as the Health Professional Follow-up Study, 
the Iowa Women’s Health study and the Nurses Health Study failed to establish the 
association between diet composition and diabetes (Salmeron et ah 1997a; Salmeron 
et al. 1997b; Meyer et al. 2000); results of studies have shown that HC diet does not 
adversely influence insulin sensitivity compared with HF diet (Jeppesen et al. 1997; 
Bessesen, 2001).
Low GI diet has shown to improve insulin sensitivity (Ludwig et al. 1999) and 
reduce the risk of type 2 diabetes (Salmeron et al. 1997a; Salmeron et al. 1997b). 
Nevertheless, using the euglycemic hyperinsulinémie clamp as a gold standard 
technique for measuring insulin sensitivity failed to show the association with dietary 
GI in healthy and highly active young men (Wolever, 2000). Low GI starches seem 
to improve insulin sensitivity but variations in the type, amount and rate of 
absorption of dietary carbohydrate are other determinants of glucose and insulin 
responses (Lineback and Miller Jones, 2003). Four-week consumption of low GI diet 
resulted in reduction in aiea under the glycaemic response curve (AUC) in response 
to oral glucose and improved insulin sensitivity among patients with CHD (Frost et 
al. 1996). In another study of Frost et al, they found that low GI diet improved in 
vitro insulin sensitivity measured by reduction in glucose after insulin injection 
(Frost et al. 1998) and also decreased HDL cholesterol concentration following low 
GI diet was due to the improving effect of low GI diet in insulin sensitivity (Frost et 
al 1999). Similar results in HDL level was also found by one month following HC- 
high GI diet in type 2 diabetic patients (Luscombe et al. 1999).
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1.8.2.3 Inflammatory markers
C-reactive protein (CRP) belongs to the Pentraxin protein family. It consists of 5 
identical subunits of 206 amino acid residues. Five non-covalently associated 
protomers are airanged symmetrically around a central pore determined by X-ray 
crystallography (Shrive e to l  1996).
CRP is a plasma protein that is an essential part of the inflammatory process. It rises 
rapidly in serum in response to inflammatory stimuli (Volanakis and Kaplan, 1971; 
Volanakis, 2001). CRP is regulated by proinflammatory cytokines including 
interleukin-1 (IL-1), tumor necrosis factor-a (TNF-a) and interleukin-6 (IL-6) and 
biosynthesised in the liver (Hardardottir et a l 1994; Baumann and Gauldie, 1994). 
The main biologic function of this molecule is the recognition of pathogens, 
damaged cells and their elimination (Volanakis, 2001). Fleinrich showed that in liver, 
the synthesis of CRP is largely regulated by IL-6 (Heinrich et a l 1990). In turn, it 
originates largely from activated leukocytes in the vessel wall (Danesh et a l 1997). 
CRP, along with other elements of the immune system, not only has protective 
characteristics but also may have harmful effects including atherogenic effects 
(Ridker et a l 2002). The mechanism underlying the relationship between 
inflammatory processes and CHD is poorly understood. However, a number of 
studies including the longitudinal Physician Health Study in the USA (Ridker et a l 
1997; Ridker et a l 2002) have indicated that higher levels of plasma CRP and IL-6 
are associated with higher CHD risk (Mendall et al. 1997; Yudkin et al. 1999; 
Ridker et al. 2002).
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The lesions developed in atherosclerosis represent cellular responses to inflammatory 
diseases (Ross, 1999). Increased plasma CRP, a marker of systemic inflammation, is 
suggested to be a stronger risk marker of cardiovascular disease and sudden death 
than LDL cholesterol concentration confirmed by multivariable analysis after 
adjusting for common cardiovascular risk factors (Ridker et al. 1997). CRP levels 
have been reported to predict cardiovascular events and CHD mortality (Kuller et al. 
1996; Koenig et al. 1999).
CRP also contributes to the insulin response as it is modulated by insulin (Campos 
and Bauman, 1992). This cytokine inhibits insulin signalling (Hotamisligil and 
Spiegelman, 1994). Insulin sensitivity was inversely associated with plasma CRP 
levels and total body fat (Sites et a l 2002). In addition, treatment with insulin 
accompanied by diet restriction among type 2 diabetic patients resulted in lower 
plasma CRP concentration (Yudkin et a l 1999).
The results of the Women’s Health Study showed that plasma CRP concentration 
varied from 1.9 mg/L to 3.7 mg/L in the lowest up to the highest quintile. Those 
with the highest GL value had 9.4 times greater risk of having a higher value of 
plasma CRP. Dietary GL was positively and significantly correlated with CRP. The 
possible mechanism for the effect of high GL on CRP could be tluough stimulation 
of IL-6 secretion (Liu et al. 2002). IL-6 is as another inflammatory factor and 
modulator of fat metabolism in human and may predict CHD (Choi et al. 2004). IL- 
6 increases lipolysis and fat oxidation without causing hypertriacylglycerolaemia 
(van Hall et a l 2003) and enhancing endogenous glucose production (Pedersen et al 
2004). Although combined healthy eating recommendations (i.e. high fibre and LF
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diet) and exercise have been shown to lead to significant reductions in plasma CRP 
level (Wegge et a l 2004), the direct effect of a change in dietary macronutrients or 
glycaemic index on CRP is not clear (Clifton, 2003).
1.8.2.4 Plasma antioxidant activity
Although there may not be much evidence for the benefits of a high carbohydrate 
diet, one consequence of such dietary advice is an increase in the intake of fruit and 
vegetables. Most of the UK population do not ingest the recommended 5 portions of 
fruit and vegetables a day.
One of the main benefits of increasing fruit and vegetable intake in relation to CHD 
is the increased intake of dietary antioxidants, which protect against free radical 
damage to plasma lipids increasing the resistance of low-density lipoprotein (LDL) 
to oxidation (Diaz et a l 1997, Luo et a l 1994) that facilates the process of 
atherosclerosis (Fig 1.17).
Free radicals are any species capable of independent existence that contain one or 
more unpaired electron. They are produced during the normal metabolic pathways in 
the cell and particularly in the mitochondria. These very reactive and unstable 
molecules include the super oxide anion (O2-), hydroxyl (OFI ), peroxyl (LOO'), 
hyperchlorous acid (HOCl), hydrogen peroxide (H2O2) and singlet oxygen ('02). 
Radicals such as nitric oxide (NO) or peroxynitrite (ONOO ) are nitrogen containing 
reactive molecules.
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In order to become more stable, free radicals attempt to take an electron from a 
stable molecule and in doing so, they cause damage to PUFAs, protein and DNA. 
The body normally protects itself from these free radicals by adding another electron 
to the free radical or removing the unpaired electron. This is achieved by enzymes 
such as super oxide dismutase, catalase and glutathione peroxidase.
In addition dietary antioxidants such as water-soluble Vitamin C, pyridoxal 
phosphate, flavonoids and lipid soluble antioxidants such as Vitamin E and 
caretenoids work together to protect membrane lipids, protein and DNA. Vitamin C 
works in the cytoplasm but also regenerates Vitamin E which is situated in the 
membranes and protects PUFAs by donating a H from OH groups on its ring 
structure to a free radical, by donating a H. a  -tocopherol becomes an unreactive free 
radical as the unpaired electron can be delocalized into the aromatic ring structure 
increasing its stability (Duvall, 2005).
Oxidation of LDL is critical to the formation of atherogenic plaques in blood vessels. 
Goldstein et aL (1979) showed that chemically modified (oxidised) LDL was taken 
up by macrophages resulting in the formation of foam cells which accumulated in 
atherosclerotic lesions (Itabe, 2003). This work led to them being awarded the 
Nobel prize.
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Figure 1.1.6 Schematic processes for the formation of foam cell in vessel wall and 
contribution of macrophages.
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Excessive fullness of macrophages with modified LDL cholesterol is the main 
characteristic of atherosclerotic plaques that cause most heart attacks and strokes 
(Kruth et a l 2002; Itabe, 2003).
Epidemiological studies strongly suggest that diets rich in fruit and vegetables, 
containing antioxidants such as vitamins C and E, carotenoids and flavonoids, 
protect against CHD (Leenen, 2001) and most evidence indicates that diets rich in 
antioxidants may reduce the risk of CHD by protecting against the adverse effects of 
free radicals (Ness et a l 1996). However it is not certain that advice to increase fruit 
and vegetable intake results in an increase in the antioxidant potential of plasma. 
This possibility is explored in one of the study described in chapter 3 of this thesis. 
Moreover, to date large scale randomized control trials o f antioxidant vitamin 
supplements have failed to show a protective effect on CVD (Asplund et al 2002).
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1,9 Rationale for the thesis
Carbohydrates are not only a main source of energy for the body but also interact 
with other macronutients (i.e. lipids and proteins) in human metabolism. The 
structure of dietary carbohydrates plays an important role in their digestion and 
absorption and glycaemic response. It is important that the quality and quantity of 
carbohydrates in the diet and their role in promoting health and and reducing risk of 
cardiovascular disease are studied. There is evidence indicating that the use of 
dietary GI (quantitative indicator) and GL (qualitative and quantitative indicator) is 
more advantageous than the traditional classification of dietary carbohydrates for 
management of a number of conditions such as type 2 diabetes. Results of large- 
scale population studies have revealed the probable association between dietary GI 
and GL with a number of chronic diseases as well as metabolic risk factors for CHD 
(e.g. plasma HDL cholesterol and TAG concentrations).
The cuiTent dietary recommendation is to provide at 50% (45%-65%) of dietary 
energy from carbohydrates, although results of the National Diet and Nutrition 
Survey indicates that less than half of energy intake is derived from carbohydrates in 
the UK. However, several short-term studies have shown possible adverse effects of 
a high carbohydrate diet on plasma HDL cholesterol and other risk factors for CHD. 
It was therefore decided to investigate the effect of these dietary guidelines on the 
eating habits and CHD risk factors of freeliving postmenopausal women. It is 
important to check that these dietary guidelines are appropriate.
Following on from this, it was decided to check if there was any relationship 
between GI and the GL of the diet of offspring of patients with type 2 diabetes and
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matched controls, and their risk factors for CHD. Finally the relationship between 
GI and GL on these risk factors was studied in a short term intervention study in 
healthy adults.
These studies should show if the level of carbohydrate in the diet is detrimental to 
CHD risk factors in a range of individuals and whether the glycaemic response is 
more important than the amount of carbohydrate eaten.
1.10 Aim of the thesis
The aim of the thesis was to test the hypotheses
• A high carbohydrate diet increases CHD risk factors under freeliving 
conditions in post menopausal women
• GI and GL are more important factors in deteimining CHD risk factors than a 
simple measui'e of the amount of carbohydrate in the diet.
The objectives of the present thesis were
« To investigate the effect of advice to increase carbohydrate intakes as part of
dietary advice to follow the UK dietary guidelines on some metabolic risk 
factors for CHD in healthy free-living postmenopausal women,
® To assess habitual dietary intake, GI, GL and the metabolic risk factors for
CHD and type 2 diabetes,
• To examine the relationships between habitual dietary intake, GI, GL and
metabolic risk factors in offspring of patients with type 2 diabetes and in 
control subjects,
« To examine the influence of high carbohydrate, isocaloric, high and low GI
and GL diets for three days on metabolic parameters in the fasted state 
including plasma lipids, glucose, insulin, NEFA and inflammatory markers in 
healthy male subjects.
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Chapter 2
Methodology
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2.1 Introduction
This chapter details the methods of the tlrree different studies that make up this 
thesis. Each study had its own design and subjects but many of the methods 
including dietary assessment, biochemical and anthropometric measurements were 
similar. The common methods are described in this chapter and experimental details 
specific to the different studies are included in the relevant chapters.
2.2 Summary of study protocols
2.2.1 First study: Effect o f increased carbohydrate intake (as part o f  
advice to follow the UK dietary guidelines) on metabolic risk factors 
for CHD in healthy postmenopausal women
This was a dietary intervention trial in which healthy postmenopausal women were 
given detailed dietary advice on how to change their habitual diet to increase 
carbohydrate intake in line with the cmTent dietary guidelines. A fasting blood 
sample was taken at screening, baseline, and after 1 and 4 weeks of the dietary 
intervention to measure a number of metabolic parameters.
2.2.1.1 Objectives of the study
* To investigate the effect of advice to increase carbohydrate intake as part of 
the UK dietary guidelines on metabolic risk factors for CHD in healthy, free- 
living postmenopausal women.
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2.2.2 Second study: Relationships between dietary glycaemic index and 
metabolic parameters in offspring o f patients with type 2 diabetes and 
control subjects
A case-control study was carried out on thirty-four healthy subjects, 17 offspring of 
patients with type 2 diabetes mellitus (4 men and 13 women) and 17 age and sex- 
matched control subjects. Control subjects had no history of diabetes mellitus in the 
family.
2.2.2.1 Objectives of the study
The objectives of the study were to:
• Assess habitual dietary intake, glycaemic index (GI), glycaemic load (GL)
and some common metabolic risk factors for CHD and type 2 diabetes.
« Examine relationships between habitual dietary intake, GI, GL and metabolic
risk factors in offspring of patients with type 2 diabetes and in control 
subjects.
2.2.3 Third study: Effect of high carbohydrate^ isocaloric high and low 
glycaemic index diets on fasting plasma metabolic parameters in 
healthy male subjects
A randomised-crossover dietary intervention trial of high carbohydrate, isocaloric 
high and low GI diets was conducted on healthy male volunteers. The duration of the 
intervention was three days on each trial with at least a two week washout period 
between trials.
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2.2.3.1 Objectives of study
• To examine the influence of high carbohydrate, isocaloric, high and low GI 
diets for three days in healthy male subjects on a number of metabolic 
parameters.
2.3 Measurements
2.3.1 Anthropometric Measurements
All anthropometric measurements including height (m), weight (kg), waist 
circumference, hip circumference (cm) and mid-upper arm circumference (cm) 
(MUAC) were conducted in the fasted state. Height was measured using a 
stadiometer (Holtain Ltd, Ciymych, Dyfed UK). The subjects’ body weight was 
measured (SEGA scales, Germany) in light clothes and no shoes. Body mass index 
(BMI) was calculated from weight and height (weight (kg)/ height (m^)). Waist 
circumference was evaluated as an indicator of central obesity (Lean et al. 1995; 
Gray et a l 2000). It was measured midway between the lower margin of the last rib 
and the crest of the ilium, in the horizontal plane using a non stretch tape without 
compressing any soft tissues to the nearest 0.1 cm. Hip circumference was measured 
at the top of iliac crest using a tape measure to the nearest 0.1 cm (Ganow et al 
2000).
Body fat was estimated by skinfold thickness measurements. The skinfold 
measurement was made using calipers (Holtain Ltd. Crymych, UK), which measure 
the thickness of a fold of skin with its underlying layer of fat. Skinfold thickness was 
measured at four different sites; biceps; triceps; subscapular, and suprailliac. 
Subcutaneous fat is not uniformly distributed on the body. Thus, taking skinfold
84
measurement at different sites on the body (such as triceps, biceps, subscapular and 
suprailiac) will help to account for the differing distribution of subcutaneous fat. 
Three measurements were taken at each site and averaged. Then, the sum of the four 
values was used to calculate the percent of body fat for each subject using the 
equations of (Durnin and Womersley, 1974).
2.3.2 Dietary assessment
Dietary assessment is an essential tool for studying relationships between dietary 
exposure and disease causation. A number of methods are available to assess 
individual dietary intake. None will provide a truly accurate picture of the habitual 
dietary intake of an individual because of the complex nature of diet (Willett, 1998). 
There is no ideal or gold standard method and therefore, the choice of method 
depends on the design and objectives of the study (Nelson and Bingham, 1997).
Dietary assessment methods can be classified as prospective or retrospective 
techniques that assesses food intake in the present or past (Nelson and Bingham, 
1997), Retrospective methods include 24-hi' diet recall, food frequency questionnaire 
(FFQ) and the diet histoiy method (Bingham et al 1994) Prospective methods 
include keeping a food diary and either weighing actual foods consumed or 
estimiating the weights of the foods. A 24-hi’ diet recall is an inteiview in which 
respondants describe all of the foodstuffs they consumed in past 24 hours. A FFQ is 
questionnaire containing a list of foods with questions on the frequency of 
consumption, such as per day, per week, per month or rarely. Subjects can complete 
a FFQ themselves or the questionnaire can be administered by an interviewer 
(Schatzkin et a l 2003). FFQ tend to be used in large-scale epidemiological studies
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where the researchers want to rank individuals by dietary intake or compare dietary 
intake of specific nutrients by group.
A diet history is an interview by a trained person who tries to build up a picture of a 
typical pattern of food intake during a recent week. Food intake is usually quantified 
either by using household measm'es or food photographs. There are advantages and 
disadvantages of both prospective and retrospective methods. The advantages of 
retrospective methods ai'e that they do not require a lot of effort from the subjects. 
Another advantage of retrospective methods, especially the FFQ, is that these 
questionnaires can in some cases be coded by machine and this substantially reduces 
the cost involved of analysing this data. The main disadvantage of retrospective 
methods is that they are reliant on the respondent’s memory. Difficulty in accurately 
remembering previously consumed foods and beverages is the main weakness of 
these methods. Also, accurate memory of past diet can be influenced by the subject’s 
cun’ent eating habits (Bingham et a l 1994).
Prospective methods that involve keeping records of foods and beverages consumed 
at the time of eating were for a long time considered to be the gold standard of 
dietary assessment. These methods involve the subject recording everything that they 
eat and drink during a specified period of time, usually between 1-7 days (Gibney et 
a l 2002). Subjects should be given clear and detailed instructions on how to do this 
and this will minimise the errors involved. These methods, if carried out properly, 
can provide highly detailed information on foods consumed. Sometimes subjects are 
asked to weigh foods before eating, while in other studies subjects are asked to 
quantify the amount of foods consumed by household measures or photographs.
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The main advantage of these methods as a way of assessing diet is that they are in 
general more reliable and precise for estimating mean intake of nutrients as they are 
less influenced by the subjects’ memory (Lee-Han et al. 1989). As regards the length 
of time for which subjects need to record their food intake, it has been suggested 
(Gibson, 1993) that a minimum of two week days and one weekend day should be 
included to take account of potential differences in food intake patterns. However, 
(Bingham et al. 1994) have recommended that 7 days are needed to accurately assess 
macronutrient intake.
There are disadvantages of food records as a dietary assessment method, including 
the fact that they require a high level of respondent literacy and subjects need to be 
able to read and write i.e. therefore not suitable for using in a study on young 
children. Another disadvantage is that subjects need to to be very well motivated as 
keeping food records for a number of days is quite a lot of work and effort. Carrying 
out a weighed food record can be very inconvenient for the subject, especially for 
meals that are consumed outside of the home, ie. restaurant or party. Furthermore 
these methods place a great burden on the respondents and are very time consuming. 
The food records are expensive to analyse, and therefore their use tends to lead to 
higher dropout rates. For these reasons, food records tend not to be used in large- 
scale studies (National Institute of Health Guide, 1992; Bingham et al. 1994). Also, 
it well known that underreporting is a common problem associated with these 
methods (Bingham et al. 1994).
In the studies in this thesis, weighed food records were the chosen method for dietary 
assessment. This method was also used to assess compliance to dietary interventions. 
Subjects were asked to keep a record of all food and drink consumed. Each food item
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was -weighed immediately prior to consumption using a portable battery operated 
food weighing scales (Slater Household Ltd, Tonbridge, UK). In the first study, 
postmenopausal women were asked to keep a 7-day weighed food record for the 
assessment of habitual diet and a 3-day weighed food record for each week over the 
4-week dietary intervention to assess compliance to the dietary advice. In the second 
study, subjects carried out a 7-day weighed food record to assess their habitual diet. 
In the third study, volunteers earned out a 3-day weighed food record to assess their 
habitual diet and they also weighed their food consumption according to the amounts 
specified on their individualised menu plan. They were also asked to note changes, if 
any, in their food consmnption on the menuplan. This was then anslysed for 
complance to the intervention diets.
The information recorded in the food diaries was imputed and analysed using a 
computerised version (Diet Robert Gordon University, Aberdeen) of the food 
composition tables (Holland et a l 1991). The dietary records were analysed for 
energy intake, absolute amounts of carbohydrate, fat, protein, alcohol and a some 
vitamin and minerals and also for the proportion of energy from the main energy 
providing nutrients.
Biomarkers are a very important part of dietary assessment because they are 
objective, which means that do not have the errors and bias that are associated with 
self-reporting diet. An example of a useful biomarker for assessing energy intake is 
the use of doubly labelled water to estimate energy expenditure. Also, 24-h urinary 
sodium excretion is reported to be a reliable measure of sodium intake. Serum 
carotenoid concentrations could be used to confirm if subjects followed advice to 
increase their fruit and vegeable intake in an intervention study. However, there are
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some nutrients for which there are no biomarkers cunently available, e.g. total fat 
intake. Obviously using biomarkers in dietary studies adds to the cost of doing a 
study and depending on the biomarker needed may not be feasible to use in some 
studies. Another consideration is that body tissues may be needed (e.g. blood or 
urine) and depending on the resources available, it may not be feasible to carry out 
this biomarker analysis. In spite of these problems associated with the use of 
biomarkers, there is increasing awareness of the importance of using biomarkers to 
help with the inteipretation of results in studies that rely on self-reported diet 
(Gibney et al. 2002).
Studies which have used doubly labelled water as a biomarker for energy intake have 
highlighted the problem of under-reporting of dietary intake by showing that some 
reported energy intakes were biologically implausible. It also seems to be the case 
that certain people are more likely to underestimate their dietary intake, and in 
particular women, obese indivuals, people who are conscious about their weight, and 
people who are not very motivated to do the study in the first place (Samaras et al. 
1999). It has also been suggested that people under-estimate or under-report some 
foods such as fat-rich foods or desserts more than other foods. However, it is 
possible to eliminate dietary intake estimates that fall below a certain cut-off point of 
biological plausibility. For example, energy intakes estimated by FFQ are usually not 
used if the energy intake values are above 5,000 kcal or below 1,000 kcal as it 
assumed that these FFQ had not been completed properly (Date et al. 2005). If 
measures of weight are available, it is possible to estimate basal metabolic rate 
(BMR) using the Schofield equations (Schofield et al. 1985) and this allows 
investigators to identify and eliminate under- or over-reported data. In this thesis, the 
Schofield equations (Schofield et al. 1985) were used to estimate BMR, and
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subjects’ diet records were not included in the statistical analysis if their reported 
energy intakes were less than their estimated BMR multiplied by 1.1 (under­
reporters) or greater than 2.0 (over-reporters). These cut-offs are used as it is highly 
unlikely that habitual energy intake would be < 1.1 x BMR or > 2.0 x BMR (Black 
et a l 1991; Goldberg et a l 1991). However, it must be admitted that the use of these 
cut-offs are limited and imperfect as they only exclude individuals who have 
reported biologically implausible energy intakes and do not identify individuals who 
mis-report to a lesser degree.
2.3.3 GI and GL calculation
In each study, we estimated the GI and GL of the diet. GI values were taken from the 
The International Table of GI and GL (Foster-Powell et a l 2002). The following 
steps were applied for each subject to determine the appropriate average GI and GL:
• A description of the foods that subjects consumed and the amount in grams 
were provided in the subjects’ food records.
• The carbohydrate content of each food was determined using Diet 5™
software.
® The appropriate GI for each food was found in the International Table of GI
and GL (Foster-Powell et a l 2002).
® If GI values for a specific food was not available in the table, where possible
a value for a similar and appropriate food was used.
In general, the GI value for foods was an average from a number of studies involving 
healthy individuals as well as patients with type 1 and type 2 diabetes. The 
similarities in GI values derived in subjects using healthy individuals and patients
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with diabetes has been discussed by Wolever et a l (1987). It has been shown that GI 
values determined in healthy subjects correlate well with those found for diabetic 
subjects (Wolever et a l 1987). Even though individuals with diabetes have higher 
blood glucose values, they are members of the same human species and they show 
the same differences in rates of digestion and absorption of carbohydrates.
The International Table of GI and GL contains relevant GI values data published 
from 1981 to 2001 and contains nearly 1300 separate entries (more than 750 
different types of foods) (Foster-Powell et a l 2002).
(Laville 2004) suggested that differences in testing methods such as different types 
of blood sampling (venous or capillary), the variation for the same food due to 
inherent botanical differences from country to country, differences in amylose to 
amylopectin ratio, type of cooking method, and differences in methods of food 
processing could explain the variations in GI observed for a single food item.
The glycaemic load of individual foods was calculated by multiplying the amount of 
carbohydrate, in grams in each food (obtained from Diet 5^”^ , Robert Gordon 
University, Aberdeen) with their respective GI value, and dividing by 100. The GL 
for each diet was obtained by finding the sum of each individual GL value. The GI 
of each diet was calculated by dividing the GL of the diet by the total amount of 
carbohydrate in the diet (obtained from Diet 5™) then multiplying by 100.
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2.4 Outcome measures
2.4.1 Laboratoiy analysis
2.4.1.1 Fasting blood samples
Subjects were asked to refrain from alcohol and vigorous physical activity for 24h 
before visit and fasting blood samples were collected by an experienced person (after 
a 12 hr over night fast) into vacutainers containing ethylenediamintetra-acetic acid 
(EDTA), lithium heparin or fluoride oxalate.
2.4.1.2 Oral glucose tolerance test (OGTT)
In order to assess the insulin sensitivity and insulin resistance indices in the second 
study, subjects had an OGTT. They arrived at the laboratory after an overnight fast 
(12 h). At the beginning of the test, each subject had a caimula that inserted in the 
ante-cubital fossa vein in the non-dominant arm. Blood samples were taken before 
and 15, 30, 60, 90, and 120 minutes after subjects consumed a 75g oral glucose load 
(75g glucose dissolved in 250 ml water). Sterile saline (9g/l NaCl, 5 ml) was used to 
prevent blood from clotting in the cannula throughout the test period.
Blood samples were kept on ice, and plasma was separated as soon as possible and 
idealy within 10 minutes of collection. The blood samples were centrifuged at 3500 
revolutions per minute (rpm) for 10 minutes at 4°C using a clinical centrifuge 
(Mistral 3000i, Sanyo Gallenkamp pic, Leicester, UK). Plasma was divided into 
aliquots and stored at -70° C until analysis.
Plasma samples, collected in EDTA, were used for triacylglycerol (TAG), total and 
HDL cholesterol, C-reactive protein (CRP), non-esterified fatty acids (NEFA) and
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adiponectin analysis and plasma collected in lithium heparin was used for insulin 
determination. In the postmenopausal women study (study 1) and the diabetic 
relatives study (study 2), plasma collected in fluoride oxalate was used for glucose, 
but in the intervention study (study 3) glucose was analysed from EDTA plasma.
2.4.2 Lipid parameters
Lipid parameters in the first study were assessed using kits and the methods are 
briefly described below. The lipid measurements related to the second and third 
study were measured in the Department of Pathological Biochemistry at the 
University of Glasgow. Fasting plasma lipids including total and HDL cholesterol, 
and triacylglycerol concentrations were determined using an automated Hitatchi 197 
multichannel analyser (Roche Diagnostics, Lewes, East Sussex, UK) using standard 
procedures. LDL cholesterol concentrations were calculated using the Friedewald 
formula (Friedewald c/ ^7 1972).
2.4.2.1 Triacylglycerol (TAG)
Methods for assessing TAG usually involve enzymatic or alkaline hydrolysis to 
glycerol and fatty acids followed by the chemical or enzymatic measurement of the 
glycerol component. The kit that was used involved the hydrolysis of TAG by the 
enzyme lipase to glycerol and free fatty acids. The glycerol produced was coupled by 
enzyme reactions catalyzed by glycerol kinase (GK), glycerol-1-phosphate 
dehydroenase (G-l-PDH) and diaphorase. The formazan produced is highly coloured 
and has an absorbance maximum at 500 nm. The intensity of the color produced is 
directly proportional to the TAG concentration of the sample. The enzymatic 
reactions involved in the assay are as follows:
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Lipoprotein Lipase
TAG ^  Glycerol + Fatty acids
GK
Glycerol + ATP ^ G -l-P  + ADP
G-l-PDH ►G-l-PH-NAD DAP NADH
Diaphorase
(Enzyme)
NADH + INT Formazan (dye) + NADH
The procedure (Sigma, procedure no. 336) briefly involved mixing 1 ml of 
triglyceride reagent (provided in the kit) to 0.01 ml of sample or standard, which are 
then incubated at 15 min at 37°C. The absorbance of the samples and standard were 
then read using a spectrophotometer (Thermo Labsystems Multiscan, Vaanta, 
Finland) at 500 nm. A standard curve was constructed and the equation of the line 
was used to calculate the concentration of the TAG in the plasma samples in mg/L. 
TAG values were then converted to mmol/L by multiplying by the conversion factor 
of 0.0113. A coefficient of variation (CV) of 2.2% was obtained for TAG 
determination.
2.4.2.2 Total cholesterol
Methods for assessing total cholesterol usually involve enzymatic reactions followed 
by the chemical or enzymatic measurement of the developed and coloured adducts. 
The kit that was used involved the enzymatic hydrolysis of cholesterol esters by 
cholesterol esterase (CE) to free cholesterol and free fatty acids. Oxidation of free 
cholesterol by cholesterol oxidase (CO) to cholest-4-en-3-one and hydrogen peroxide 
and at the end, combination of hydroxylbenzoic acid (HBA) and 4-aminoantipyrinr
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(4AAP) in the presence of peroxidase (POD) to form a chromophore (quinoneimine 
dye) which has its is 500 nm are the major steps in the determination of plasma 
or plasma or serum cholesterol level. The enzymatic reactions involved in the assay 
are as follows:
Cholesterol Esters----------- >■ Cholesterol + Fatty Acids
CO
Cholesterol + 02  Cholest-4~en-3-one + H2 O2
POD
2 H2 O2 + 4AAP Quinoneimine Dye
The procedure (Sigma, procedure no.401) briefly involved mixing 1 ml of the 
reagent (provided in the kit) to 0.01 ml of sample or standard, which are then 
incubated for 15 min at 37^C. The absorbance of the samples and standard were then 
read using a spectrophotometer (Thermo Labsystems Multiscan, Vaanta, Finland) at 
500 nm. A standard cuiwe was constructed and the equation of the line was used to 
calculated the concentration of the cholesterol in the plasma samples in mg/L. 
Cholesterol values were then converted to mmol/L by multiplying by a conversion 
factor of 0.0259. A coefficient of variation (CV) of 1.6% was obtained for 
cholesterol determination using the Sigma kit in the first study.
2.4.2.3 HDL-cholesteroI
The method for assessing HDL-cholesterol involves the precipitation and removal of 
apo-B containing lipoproteins, so that the apolipoproteins of HDL which are apo A-I 
and apo All remain, and then the cholesterol component is measured. The kit that I 
used in my first study involved phosphotungstic acid (30.3 mmol/L) and magnesium 
chloride (100 mmol/L) (PTA/ Mg CI2) as active ingredients. HDL cholesterol was
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assessed after precipitation of apolipoprotein B-containing lipoproteins with PTA/ 
Mg CI2 mixture by Sigma diagnostics kit No. 352-4. The precipitated lipoproteins 
are removed from tube by centrifuging at 500g for 10 min by micro-centrifuge (MSB 
micro-centrifuge, UK).
Then the cholesterol precipitated is measured using same kit for cholesterol that was 
already been described. The procedure (Sigma, procedure No. 352.4) briefly 
involved mixing 1 ml of ready to use reagent (provided in the kit) with 0.05 ml 
supernatant of the extracted plasma after precipation of the other lipoproteins of 
plasma samples (EDTA as anticoagulant reagent) and which are then incubated at 15 
min at 37°C. The absorbance of the samples and standard were then read using a 
spectrophotometer (Thermo Labsystems Multiscan, Vaanta, Finland) at 500 nm. A 
standard curve was constructed and the equation of the line was used to calculate the 
concentration of the HDL-cholesterol in the plasma samples in mg/L. Cholesterol 
values were then converted to mmol/L by multiplying by a conversion factor of 
0.0259. A coefficient of variation (CV) of 2.8% was obtained for HDL-cholesterol 
determination using the Sigma kit in the first study.
2.4.2,4 Low-density lipoprotein (LDL) cholesterol
Low-density lipoprotein (LDL) cholesterol concentration was estimated by the 
Friedewald equation (Friedewald et al. 1972) using the following equation:
LDL-cholesterol(mg/dl) = total cholesterol - (HDLcholesterol + triacylglyceride/5).
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2.4.3 Non-essential fatty acids (NEFA)
NEFA was assessed in plasma samples using an in vitro enzymatic colorimetric 
method (Wako Diagnostics Richmond Virginia, USA). This assessment was done at 
the department of Pathological Biochemistry at Glasgow Royal Infirmary using an 
automated Hitatchi 197 multichannel analyser. The Wako enzymatic method relies 
upon the acylation of coenzyme A (CoA) by the NEFA catalysed by acyl-CoA 
synthetase. The acyl-CoA thus pro ducted is oxidized by added acyl-CoA oxidase 
with generation of hydrogen peroxide. Hydrogen peroxide in the presence of 
peroxidase permits the oxidative condensation of 3-metyhl-N-(p-hydroxyethy 1)- 
aniline with 4-amino antipyrine to form a purple colored adduct which can be 
measured colorimetrically at 550 nm. The formation of this purple colour is directly 
proportion to concentration of NEFA in plasma samples.
2.4.4 Glucose
Glucose concentrations in plasma samples for the first study were assessed using a 
commercial kit (Glucose GOD-PAP, BioStat Diagnostic Systems, Cheshire, UK). 
This ‘’GOD-PAP” enzymatic colorimetric test involved the determination of 
glucose concentrations after enzymatic oxidation with glucose oxidase (GOD). The 
colorimetric indicator is quinoneinine, which is generated from 4-aminoantipyrine 
and phenol by hydrogen peroxide under the catalytic action of peroxidase (POD). 
The enzymatic reactions involved in the assay are as follows:
GOD
Glucose 4- O2 -----------------► Gluconic acid + H2O2
POD
2 H2O2 + 4-Aminoantipyrine + Phenol------------>■ Quinoneimine + 4 H2 O
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The procedure briefly involved mixing 1 ml of glucose reagent (provided in the kit) 
to 0.01 ml of sample or standard, which are then incubated for 10 min at 37”C. The 
absorbance of the samples and standard were then read against a blank (0.01 ml 
distilled water + 1 ml reagent) using a spectrophotometer (Thermo Labsystems 
Multiscan, Vaanta, Finland) at 500 mn. A standard curve was constructed and the 
equation of the line was used to calculate the concentration of the glucose in the 
plasma samples in mg/L. Glucose values were then converted to mmol/L by 
multiplying by the conversion factor of 0.0551. A coefficient of variation (CV) of 
1.8% was obtained for this assay.
Plasma glucose concentrations for the second and third studies were determined at 
the Department of Pathological Biochemistry at Glasgow Royal Infirmary using 
standard procedures. Briefly, this method (Gluco-quant Glucose/HK, Roche 
Diagnostics Coiporation, Lewes, UK) involved the phosphorylation of glucose with 
ATP by hexokinase to produce glucose-6-phosphate (G-6-P). The produced G-6-P, 
which then reacts with NADP^ catalyzed by glucose-6-phosphate dehydrogenase (G- 
6-PDH) to produce gluconate-6-phosphate and NADPH. The formation of 
gluconate-6-phosphate during the reaction is directly proportional to the glucose 
concentration, which is measured photometrically using an automated Hitatchi 197 
multichannel analyser.
2.4.5 Insulin
Insulin is a polypeptide hormone (MW 6000) composed of two joined non-identical 
chains A and B, which are joined by disulfide bonds. Insulin is formed from a
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precursor, proinsulin in the beta cells of the pancreas. Insulin is stored in the 
secretory granules of the islet cells of the pancreas and is then secreted. Insulin is 
secreted in response to an increase in blood glucose concentration.
Insulin measurements for the studies described in this thesis were carried out by the 
Department of Biochemistry at Glasgow Royal Infirmary. Insulin was measured in 
plasma using the Abbot IMx Insulin Assay kit (Abbot Laboratories, Tokyo, Japan) 
which is a Microparticle Enzyme Immuno Assay (MEIA).
Briefly, to carry out the IMx Insulin assay, the reagents in the kit and samples are 
added to cells in the following order:
■ The sample, the antibody (anti-insulin, Mouse, Monoclonal coated 
microparticles) and the assay buffer are added to the incubation wells, and a 
reaction takes place in which an antibody-insulin complex is formed.
“ An aliquot of the reaction mixtme containing insulin bound to the anti-insulin
coated microparticles is transferred to the glass fiber matrix.
■ The matrix is washed to remove unbound materials.
“ An anti-insulin: alkaline phosphatase conjugate is dispensed onto the matrix
and binds to the antibody-antigen complex.
« The matrix is washed to remove unbound materials.
® The substrate, 4-methylumbelliferyl phosphate, is added to the matrix and the
fluorescent product is measured by the MEIA optical assembly.
The sensitivity of the IMx analyser insulin assay was calculated to be 1.0 pU. 
Results of a study on 148 normal fasting plasma showed a mean ± 3SD
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concentration equal to 7.1+ 15.6 pU/ml. The reference range for fasting subjects was 
<13 pU.L"* and there was a mean interassay imprecision (CV) of 5.0% across the 
range 4-120 pU .L '\
2.4.6 C-reactive protein (CRP)
CRP is defined as a marker of systemic inflammation (Volanakis, 2001). It has 
recently gained more reognition as a predictor of cardiovascular disease (CVD) 
(Clifton, 2003). The results of the Physicians Health Study (Ridker et al. 1997; 
Ridker et a l 2002) in the USA revealed that higher levels of CRP and IL-6 were 
associated with higher CHD risk (Mendall et a l 1997; Yudkin et al. 1999; Ridker et 
al. 2002). CRP level has been reported to predict CVD events and CHD mortality 
over 2 and 17 year follow up in the MONICA-Ausburg cohort (Multinational 
MONItoring trends and determinants of CArdiovascular diseases) study (Koenig et 
a l 1998) and the MRFIT study (Kuller et a l 1996), respectively. It is also suggested 
that CRP is a stronger predictor of CVD than LDL cholesterol concentration after 
adjusting for a number of risk factors (Ridker et a l 1999; Ridker et al 2002; 
Guerrero-Romero and Rodriguez-Moran, 2003; Ridker et a l 2003b). The advantage 
of CRP compared to the other inflammatory markers is that the relationship with 
CHD risk for inflammatory factors such as interleukin-6 was not as strong after 
controlling for common risk factors, while CRP remained a significant predictor 
even after controlling for these confounding factors (Ridker et a l 2002).
There are no intervention studies that have investigated the direct effect of glycaemic 
index (GI) or glycaemic load (GL) on CRP or any other inflammatory markers 
(Clifton, 2003). In the first and third studies in this thesis, subjects increased their
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carbohydrate intake and their dietary GI and GL were altered and this provided an 
opportunity to investigate this issue. We could only find one published study (Liu et 
al 2002) which was an analysis on a sub sample of the Women’s Health Study 
Cohort and reported a strong statistically significant positive association between GL 
and CRP levels, with the odds ratio for the highest GL quintile compared to the 
lowest being 9.43 (95% Cl 1.92, 46.23), suggesting that diets with higher GL are 
associated with higher CRP levels.
The Department of Pathological Biochemistry laboratory at Glasgow Royal 
Infimiary carried out the assessment of CRP using an in house ELISA (Highton & 
Hessian, 1984). CRP was measured using a highly sensitive double antibody 
sandwich ELIZA with rabbit anti-human CRP and peroxide conjugated rabbit anti­
human CRP. The substrate for the colour development was 1,2 phenylaminediamine 
and the standard used was human CRP calibrator.
Median CRP concentrations for subjects who appear clinically well are in the region 
of 0.7- 0.8 mg/1 with 90% having values of < 3.0 mg/1.
2.4.7 Interleukin-6 (ÏL-6)
IL-6 is another marker of inflammation, which is associated like CRP with increased 
risk of CHD (Ridker et a l 2000; Pradhan et al 2002) and type 2 diabetes (Hu et a l 
2004). It’s level in the circulation has been shown to be associated with insulin 
sensitivity, and this association is independent of BMI (Fernandez-Real et al 2001). 
Elevation of glucose levels has been shown to significantly increase IL-6 and other
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inflammatory cytokines (IL-18, TNF-a) in both normal and impaired glucose tolerant 
(IGT) subjects (Esposito et al. 2002).
In my third study, IL-6 was determined using a quantitative sandwich ELIZA kit 
(R&D Systems, Europe Ltd). The Quantikine High Sensitivity kit was chosen as all 
of the subjects were healthy and no extreme values were expected. IL-6 was 
measured by a trained technician at the Department of Human Nutrition. This ELISA 
was designed to measure human IL-6 in serum, plasma and urine. A monoclonal 
antibody specific for IL-6 is precoated to the wells. Standards and samples are 
pipetted into the wells and the immobilized antibody binds IL-6. After incubation 
period of two hours any unbound substances are washed away and an enzyme-linked 
polyclonal antibody specific for lL-6 added to the wells. After another incubation 
period of two hours any unbound antibody-enzyme reagent is washed and a substrate 
solution is added to the wells. Another incubation period of 60 minutes at room 
temperature follows and after that an amplifier solution is added to the wells and 
colour develops in proportion to the amount of IL-6 bound in the first step of the 
assay. Within 30 minutes, a stop solution is added to each well and colour 
development stops. Finally the samples are read at 490 nm with a wavelength 
correction set to 650nm or 690nm using a plate reader (Thermo Labsystems 
Multiscan, Vaanta, Finland). A standard cuiwe is constructed using the values of the 
standard solutions while the mean value of the duplicate samples is used to 
determine IL-6 concentration in pg.mf*. The R-squared of the reference cuiwe for 
this assay was 0.9996 while the mean CV of the duplicates was 4.1%.
102
2.4.8^  Adiponectin
Adiponectin is a plasma protein secreted specifically by adipose tissue (Maeda et al. 
1996). Higher levels of adiponectin in the body are associated with improved insulin 
sensitivity, reduced inflammation and better glycaemic control. Although there are 
very few studies that have evaluated wheter diet has any effect on plasma 
adiponectin concentrations, Qi et al. (2005) studied this in male subjects with type 2 
diabetes. Results of this cross-sectional study among 780 diabetic men from the 
Health Professionals’ Follow-up Study showed that after adjustment for age, BMI, 
smoking and a number of other risk factors for CHD, dietary GI and GL were 
inversely associated with plasma adiponectin concentrations. P for trend was 0.005 
for GI and 0.004 for GL, Circulating levels of adiponectin were 13% lower in the 
highest quintile of GI than its level in the lowest quintile. Assessment of dietary GL 
showed the similar trend and adiponectin levels were 18% lower in the highest 
quintile of GL than in the lowest GL. Furthermore dietary fibre intake was 
positively associated with the circulating level of adiponectin.
In the second study (chapter 4), adiponectin concentration was measured in EDTA 
plasma using an ELISA at the Pathological Biochemistry Department of Glasgow 
Royal Infirmary. Pre-treated samples and serially diluted standard (recombinant 
human adiponectin) solutions were added to an appropriate number of wells of the 
microtiter plate and incubated at room temperature for 60 mins. After washing, the 
secondary rabbit anti-adiponectin antibody was added to each well and incubated at 
room temperature for 60 mins. After washing, a conjugate of horseradish peroxidase 
and goat anti-rabbit IgG was added to each well and again incubated at room 
temperature for 60 mins. After washing, the colorimetric substrate for the enzyme
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was added to the wells and incubated at room temperatme for 15 mins. The colour 
development was terminated by the addition of a stop solution. The intensity of the 
colour was measured at 450nm on a VERS Am ax Tm plate reader. The concentration 
was calculated using the absorbance values of the adiponectin standard solutions 
assayed at the same time. Results were quoted as m g .l'\ The CV value was 3.5% for 
this assay.
2.4.9 Ferric reducing ability of plasma (FRAP) assay
Antioxidants are compounds that can protect the body or foods against the 
potentially harmful effects of free radicals or reactive oxygen species (ROS) 
(Halliwell and Gutteridge, 1995). The human body is constantly under attack from 
free radicals and ROS which are produced endogenously in the body as by products 
of normal aerobic metabolism and enzyme systems as well as being supplied from 
sources outside the body such as cigarette smoke, lipid peroxidation products in 
foods or pollutants. In order to protect the body from inappropriate exposure to these 
free radicals and ROS, the human body has developed a powerful and complex 
antioxidant defence system. Enzymatic antioxidants within the cell, such as 
superoxide dismutase function by inactivating or removing free radicals and ROS 
from the cell before they can cause damage. Non-enzymatic protein antioxidants 
function by controlling the storage and release of metal ions which are needed for the 
enzymatic antioxidants to function but can also convert relatively unreactive radicals 
such as superoxide to the much more reactive hydroxyl radical. However, 
antioxidants such as vitamin C, a-tocopherol, carotenoids and phenolic compounds 
such as flavonols act by donating electrons to free radicals in order to stabilise them 
and in this way behave as reducing agents. It is this ability to donate an electron or to
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act as a reducing agent that is used to measure 'antioxidant potential' in the FRAP 
assay.
The FRAP assay offers a simple index of 'antioxidant or reducing power', and the 
results are reported to be highly reproducible (Benzie and Strain, 1996). However, 
there are also a number of limitations associated with the use of this assay for 
measuring 'antioxidant power'. The most obvious limitation of the FRAP assay is 
that while it claims to measure 'antioxidant power', it actually only measures 
'antioxidant power' of non-enzymatic antioxidants that act as reducing agents. While 
the FRAP assay can be used to measure the 'antioxidant power' of foodstuffs, the 
results do not give us any information on the bio availability of these antioxidants in 
the body and thus about their actual physiological 'antioxidant power' in vivo. In 
addition, substances that bind with either Fe^ "^  or Fe^^ could in theory interfere with 
the results of the assay (Benzie and Strain, 1996).
The method measures the ability of antioxidants in plasma or in foods to reduce the 
ferric component (Fe^ "^ ) of a ferric tripyridyltriazine (Fe^^-TPTZ) complex (which is 
contained in the FRAP reagent) to the ferrous form (Fe^^). During this reaction 
which takes place at a low pH, the reduction of ferric iron (Fe^^) to the ferrous form 
(Fe^^) is accompanied by the formation of a blue colour which can be measured at an 
absorption maximum of 593nm using a spectrophotometer (Benzie and Strain,
1996).
The FRAP assay was canied out according to the methods of Benzie and Strain, 
(1996). It is a simple spectrophotometric assay that assay involves making up a
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FRAP reagent, making up the 1.0 mM ferrous sulphate (FeS0 4 , Fe^^) standard 
solution, then making dilutions of the stock standard to produce standards of range 0- 
1.0 mM FeS04, and then carrying out the FRAP assay with the plasma samples.
The FRAP reagent (120 ml) was prepared freshly on each working day and should 
be orange-brown in colour. It was prepared by mixing the following solutions 
together:
9 100 ml acetate buffer (300 mM acetic acid, pH 3.6)
• 10 ml XPTZ solution (10 mM, made up with 40mM HCl)
• 10ml feme chloride solution (20 mM, made up in distilled water)
A standard curve was prepared according to the following table from FeSCfi (1 mM).
Table 2.1 Standard solutions of FeS0 4  (ImM) preparation
Final concentration of 
FeS0 4 , (mM)
Volume (ml) of 1 
mM FeSCfi to be 
added
Volume (ml) of 
distilled H2O to be 
added
0.0 (Blank) 0.0 5.0
0.2 1.0 4.0
0.4 2.0 3.0
0.6 3.0 2.0
0.8 4.0 1.0
1.0 5.0 0.0
The FRAP solution and distilled water were kept warm thi’oughout the procedure by 
keeping in a waterbath at 37°C. As shown below, lOOpl of each concentrations of
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standard or plasma sample was pipetted into into a cuvette. 300pl of distilled water 
was then pipetted into the cuvette. Then, at 30-second inteiwals, 3ml freshly prepared 
warmed FRAP solution was then pipetted into the cuvette. Only six standards or 
samples were prepared at a time. The standards were analysed in triplicate and the 
plasma samples in duplicate. The contents of the cuvettes were then mixed by 
inverting (with lids on). The cuvettes were then incubated for exactly 4 min at 37 C 
in an incubator.
The absorbance of each standard, and plasma sample was then measured at 593mn 
using the plate reader. A standard curve was constructed from the concentrations of 
the standards and the absorbance values using Microsoft Excel, and the equation of 
the line was was found. The equation of the line was then used to calculated the 
FRAP concentration of the plasma samples (in mM FeSO^). The CV for the analysis 
of the plasma samples was 2.7%.
2.4.10 Homeostatic Model Assessment (HOMAir) Score
There are a number of techniques available to measure insulin sensitivity such as the 
euglycemic clamp method, the insulin tolerance test (ITT), the oral glucose tolerance 
test (OGTT), the intravenous glucose tolerance test (IVGTT), the insulin suppression 
test (1ST), and the homeostatic model assessment of insulin resistance (HOMAir). 
Each technique has advantages and disadvantages and various tests can be validated 
against each other. However, it has now been generally accepted that the euglycemic 
clamp technique is the ‘gold standard’ method for assessing insulin action in vivo 
(Isomaa, 2003). This method involves the infusion of glucose to provide a constant 
blood glucose concentration (euglycemia) in all subjects, and provides a scale to 
compare insulin sensitivity. The greater the quantity of glucose needed to produce
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euglycaemia the greater sensitivity to insulin. Although this method is an important 
and precise procedure for assessing insulin sensitivity, it is a demanding, 
complicated and expensive technique involving intravenous insulin infusion (Scheen 
et a l 1994; Isomaa, 2003). Other methods used to assess insulin sensitivity are 
simpler, less costly and invasive compared with the euglycemic clamp technique and 
have been validated against this gold standard method.
Matthews et a l  (1985) also presented another method, which is a calculation using 
fasting glucose and insulin, the haomostatic model assessment for assessing insulin 
resistance (HOMAir). The HOMAir model was developed and validated against the 
hyperinsulinémie-euglycemic clamp (for insulin resistance) and the hyperglycemic 
clamp (for insulin secretion). In this thesis insulin resistance was estimated using the 
HOMAir technique. HOMAir was estimated as follows:
HOMAir score = Fasting insulin (pU/ml) X fasting glucose (mmol/L) Z22.5
2.4.11 Insuliu-sensitivity index {ISI) and insulin-resistance index {IRI)
In the second study (Chapter 4) insulin sensitivity was assessed using the Belfiore et 
al (2001) method. This method was used to determine the insulin sensitivity because 
of its feasibility and accuracy compared with the gold standard technique. This 
method for assessing insulin sensitivity uses fasting and oral glucose tolerance test 
(OGTT), glucose, insulin and NEFA concentrations, has been validated against the 
euglycemic clamp teclmique.
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The insulin sensitivity index for glycemia (ISI (giy)) and insulin sensitivity index for 
blood free fatty acids (FFA) (ISI (ffa)) were calculated as follows (Belfiore et al.
2001):
ISI ( g i y )  =  2/[(Insulin a u c   ^Gly Auc) + 1 ] ,  and IRI ( g i y )  =  2/[l/ (Insulin a u c  x Giy a u c ) ]  + 1
ISI ( f f a )  = 2/[(Insulin a u c   ^FFA a u c )  + 1 ] ,  and IRI { f f a )  = 2 /[l/ (Insulin a u c   ^FFA a u c ) ]  + 1
Insulin a u c , Gly a u c and FFA a u c indicate insulinémie, glycémie and 
blood free fatty acid areas under the curve (AUC), respectively during 
oral glucose tolerance test. IRI is the abréviation for insulin resistance 
index. AUC was calculated geometrically using trapezoidal rule.
2.5 Statistical analysis
Statistical analyses were carried out on Statistical Package for Social Sciences (SPSS 
for Windows, release 11.0, 2002, SPSS, Chicago, IT, USA). In each study, the data 
was checked for normality by examining the histograms for any skewness, and by 
using Q-Q plot. The distribution was considered as symmetrical and normal when 
the value was very close to zero. Diversion from this condition was defined as non- 
symmetrical or not normal distribution. When data was found to be normally 
distributed, the results were expressed as means and standard deviation and 
parametric statistical test were carried out. In situations where the data was found to 
be not normally distributed, the results were expressed as median and range, and 
non-parametric statistical tests were performed. Details of the statistical test used in 
each study are discussed the relevant chapter. P values of less than 0.05 were 
considered to be statistically significant. Power calculations were carried out for 
studies one and thi'ee, and the details are given in the chapters.
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Chapter 3 
Effect of increasing carbohydrate 
intake (as part of advice to follow the 
UK dietary guidelines) on metabolic 
risk factors for CHD in healthy 
postmenopausal women
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3.1 Introduction
Coronary heart disease (CHD) remains the major leading cause of premature 
death in the world and the global burden of CHD is increasing in association with 
increasing prevalence of type 2 diabetes mellitus, obesity and metabolic syndrome 
(FAO/WHO 2003). In fact, CHD mortality data collected by WHO show that the 
mortality rate in the UK, particularly in Scotland, is one of the highest in the 
world (The Scottish Office 2000; FAO/WHO 2003). In the UK, CHD resulted in 
one in four male deaths and one in six female deaths, and caused around 125,000 
deaths in 2000. CHD costs the National Health Service around £1.6 billion each 
year, only 1% of which is spent on primary prevention. The overall cost of CHD 
to the UK economy is around £10 billion each year (British Heart Foundation,
2002). Although in the UK there are high risk factors for CHD, there are not 
many published data on the effectiveness of CHD interventions in preventing or 
reducing these risk factors in the UK, particularly in women.
A number of risk factors for CHD have been identified as reversible and 
irreversible risk factors (Bittner, 2002). Factors such as age, gender, ethnicity (i.e. 
African-Americans) and genetic background are non-modifiable risk factors but 
diet, lack of regular physical activity, obesity, tobacco use, high level of alcohol 
consumption, dyslipidemia, high blood pressure and diabetes mellitus are among 
the more than 300 suggested risk factors for CHD and related diseases that could 
be modified (FAO/WHO, 2003).
Women at any given age are generally at lower risk than men for CHD until their 
menopause. Women after menopause lose the supportive effects of sex hormones
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I(Rosenberg et al. 1981). Steroids have important biological effects on vascular 
function and beneficial effects of oestrogens are caused by modulation of lipid 
metabolism (Suzuki et al. 2003). There are three main types of oestrogens in 
human metabolism;
(1) Oestrone (E l) is an oestrogen formed from oestradiol and is the 
predominant kind of steroid after menopause.
(2) Estradiol (E2) is the primary oestrogen produced by the ovaries. E2 is a
' weak oestrogen and the most abundant form found in the body before
menopause.
(3) Estriol (E3) is produced in large amounts during pregnancy and is a 
breakdown product of estradiol. E3 is also a weak oestrogen and may 
have anti-cancer effects (Mueck et al. 2002). Before menopause, 
estradiol is the predominant oestrogen but after menopause estradiol 
levels drop more than oestrone. Oestrone would be the predominant 
oestrogen in postmenopausal metabolism (Seed and Knopp, 2004).
When confounding variables for lipid profile such as body mass index (BMI), g
smoking and age are matched, the natural menopause is associated with 
aggravated postprandial lipemia. The progression of higher postprandial lipemia 
may explain the link between TAG level and CHD mortality risk in 
postmenopausal women (van Beek et al. 1996; Durrington 1998). TAG levels are 
very important risk factors for CHD (Williams, 2004).
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Results from a meta-analysis of 17 population-based studies showed a 76% 
increase in CHD risk in women and a 31% increase in men associated with a 1 
mmol/L increase in TAG levels (Austin et a l 1999). The menstrual cycle phase 
has been reported to have a significant effect on plasma TAG levels but not on 
plasma cholesterol (Woods et al. 1987). When oestrogen levels are high, TAG 
concentrations are low. After menopause when oestrogen levels decline, LDL 
cholesterol and TAG increase while HDL cholesterol decreases (Rich-Edwards et 
al 1995; Tremollieres et a l 1996; Jeppesen et a l  1997). Oestrogen also 
influences chylomicron metabolism in postmenopausal women. Deficiency of 
endogenous oestrogens may lead to a decreased chylomicron clearance capacity 
(Westerveld et a l 1995). This will also increase risk of CHD.
It has been well established that diet plays a prominent role in the aetiology and 
development of CHD (Hu et a l 1997; Williams et al. 1999; Hu et a l 1999; 
Joshipura et a l 2001; Hu et a l 2001; Fung et a l 2001; Poulter, 2003). A 
‘prudenf dietary pattern characterized by higher intakes of fruits, vegetables, 
legumes, fish, poultry, and whole grains was associated with a lower risk for CHD 
(RR=0.76, 95%CI: 0.60-0.98) while the ‘Western dietary pattern’ characterized 
by higher intakes of red and processed meats, sweets and desserts, french fries, 
and refined grains significantly increased the risk of CHD (Fung et al 2001). 
Increased whole-grain intake was associated with decreased risk of CHD after 
adjustment for age and smoking (Liu et al. 1999). The protective effects against 
CHD have been shown by increasing consumption of fruits and vegetables, 
particularly green leafy vegetables and vitamin C-rich fruits and vegetables 
(RR=0.80, 95% Cl: 0.69 to 0.93; Joshipura et a l 2001). All these results have led
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to dietary recommendations for the general public including postmenopausal 
women.
The current dietary guidelines are to eat a high carbohydrate diet which is low in 
fat and to consume at least five portions of fruit and vegetables per day. This is 
supposed to reduce risk of CHD (Ullmann et a l 1991; Rimm et a l 1996; Dreon et 
a i  1999; Hu et a l 1999; Liu et a l 1999; Fung et a l 2001; Hu et a l 2001; 
Joshipura et a l 2001; Cernea et a l 2003). However, several studies have shown 
that a high carbohydrate diet rather than decrease plasma lipids and increase HDL 
cholesterol actually had the opposite effect in postmenopausal women. For 
instance, controlled feeding of a high carbohydrate diet in 14 healthy 
postmenopausal women for 4 months resulted in hypertriglyceridemia but was not 
associated with a reduction in LDL particle size (Kasim-Karakas et ah 1997). The 
effect of following the American Heart Association Step 1 diet (i.e. low fat, low 
saturated fat, low cholesterol and high carbohydrate diet) for 10 weeks among 55 
overweight and obese postmenopausal women showed reductions in body weight, 
total cholesterol, LDL and HDL cholesterol concentrations (Bunyard et al. 2002). 
The effect of variation in carbohydrate and fat intake using two experimental 
isoenergetic diets (i.e. 60% and 25% vs 40% and 45% energy from carbohydrate 
and fat, respectively) was investigated in postmenopausal women (each diet for 
thi'ee weeks). Results showed that fasting TAG and VLDL cholesterol 
concentrations were higher after the high-carbohydrate diet while HDL 
cholesterol level was lower compared with the high-fat diet (Jeppesen et al.
1997). These studies are mostly very short term and the effects may not be 
sustained over a longer time.
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When a high carbohydrate diet is followed by an individual under free living 
conditions, they can chose from simple and complex carbohydrates. The 
proportion of sugars eaten may be important in determining the plasma lipid 
profile as sugars have been reported to have more adverse effects on TAG than 
other forms of carbohydrate such as starch (Parks and Hellerstein, 2000) and high 
fructose intake has also been related to increased TAG (Gross et al 2004). This 
may also be related to the GI of the diet chosen and several epidemiological 
studies have suggested that high GI diets increase the risk factors for CHD (Liu et 
ah 2000) and type 2 diabetes (Salmeron et al. 1997a; Salmeron et al. 1997b) and 
in the control of risk factors for these diseases (Frost et al. 1999; Ford & Liu, 
2000; Liu et al. 2001; Brand-Miller et al. 2003). However, not all studies have 
shown that GI is important in risk of chronic disease (van Dam et al. 2000).
Thus the way that an individual inteiprets the guidelines may be as important in 
determining their lipid profile as a choice to change their diet. It is therefore very 
important to consider the effects of the guidelines under free living conditions to 
take this into account.
In summary, it is not clear whether complying with current dietary guidelines 
makes postmenopausal women more susceptible to CHD. There is no published 
evidence on the effects of following UK dietary guidelines on metabolic risk 
factors for CHD in free-living healthy postmenopausal women. In the study 
described in this chapter, therefore, the effect of dietary advice based on the UK 
recommendations on plasma lipids was investigated in free-living postmenopausal 
women over 4 weeks
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3.2 Objectives
To investigate the effect of advice to increase carbohydrate intake, as part of 
advice to follow the UK dietary guidelines, on metabolic risk factors for CHD in 
healthy free-living postmenopausal women
3.3 Materials and methods
In this study, I organised the day-to-day running of the study, carried out the 
analysis of total and HDL cholesterol, triaclyglycerol, glucose and ferric reducing 
ability of plasma (FRAP) assay, the dietary (Diet 5) analysis, calculations of GI 
and GL and statistical analysis.
3.3.1 Subjects
Twelve subjects were recruited to take part. However, two subjects dropped out 
after the first week of the intervention and did not complete the whole study. 
Therefore, the subject numbers are 12 for baseline and week 1 measurements, and 
10 for the week 4 measurements.
The volunteers, apparently healthy postmenopausal women, were recruited by 
various methods including: an advertisement in the university newsletter and in a 
local newspaper, posters, and via friends and family of Department of Human 
Nutrition employees. The study received ethical approval from Glasgow 
University Ethics Committee and written informed consent was obtained from 
each volunteer before being enrolled into the study.
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To take part in the study, subjects were required to fiilfil a number of criteria 
including: to be healthy, to be postmenopausal, to have had their last menses at 
least three years before starting the study, not to have had a hysterectomy or ovary 
surgery, not receiving hormone replacement therapy (HRT), not to be obese (i.e. 
BMI less than 30 kg.m'^, not taking any medication known to affect carbohydrate 
or lipid metabolism, not trying to lose weight, taking any antibiotics or dietary 
supplements.
As subjects were required to be healthy they completed a health history 
questiormaire.
3.3.2 Expérim entai design
This study was a four-week dietary advice intervention of free-living subjects 
with measurements taken at baseline, after one week and four weeks of the dietary 
intervention. Subjects were involved in the study for approximately five weeks in 
all. Subjects attended the Department of Human Nutrition at Yorkhill Hospital for 
four visits including: at the screening, baseline, end of the first week, and at the 
end of week four of the dietary intervention.
At the screening visit, subjects were given the opportunity to ask questions about 
the study before signing the consent form. The information sheet was posted to 
potential subjects in advance to give them time to read it and to discuss with 
family and friends, if necessary. At this visit, subjects provided their contact 
details, the inclusion criteria for the study were checked and subjects completed
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the health history questionnaire. In addition, anthropometric measurements were 
carried out and a fasted blood sample was taken. At this visit, subjects were asked 
to carry out a 7-day weighed intake of their habitual dietary intake. It was stressed 
that subjects should try as much as possible not to change from their usual dietary 
habits and that this measurement should reflect their habitual diet as much as 
possible. Subjects were provided with oral and written instructions, a digital food 
scales and an A3-sized diary, which they were asked to post back to the 
Department for analysis before the next visit. Subjects were provided with a 
simple breakfast before leaving the study room.
Subjects were required to attend the baseline visit usually within a couple of days 
of receiving the returned completed 7-day weighed intake dairy to allow for time 
to analysis the diary and preparation of the individualised dietary advice. Subjects 
were required to attend this visit after at least a 12 hour fast and anthropometric 
measurements were taken and a fasted blood sample obtained before the subject 
was provided with a light breakfast before leaving. At this visit, subjects were 
shown the results of the habitual dietary intake compared to the current dietary 
reference values (Department of Health, 1991) and advice on the basis on this on 
how to make practical changes to their diet in order to better comply with the 
recommendations. Subjects were asked to follow this advice for four weeks in a 
free-living situation and were not provided with food or funds to purchase 
particular foods. During the dietary intervention period subjects were required to 
keep a 3-day dietary diary (one weekend and two weeks days) of all food and 
beverages consumed. This was used to assess compliance to the dietary advice 
given.
118
Subjects were required to return after one week and after four weeks of following 
the dietary advice to give a fasted blood sample and to have anthropometric 
measurements taken. During the visit after the first week of the dietary 
inteiwention, subjects were required to bring their 3-day diet diary for inspection 
and were encouraged to maintain the dietary changes for a further three weeks. 
Subjects were given three more 3-day diet diaries to complete during each 
subsequent week of the dietary intervention with stamped addressed envelopes to 
post back to AH for analysis. Subjects were contacted a number of times during 
the subsequent three weeks via email and post and encouraged to keep following 
the dietary advice given at the baseline visit.
3.3.3 Anthropometric measurements
Anthi'opometric measurements were made in the fasted state, in light clothing and 
without shoes using. Body weight was measured at each visit while height, waist 
circumference, hip circumference, mid-upper arm circumference and body fat 
were measured at the screening and baseline visits only. Weight was measured 
with a digital scales (SEGA scales, Germany), height (m) using a stadiometer 
(Holtain Ltd, Crymych, Dyfed) with subjects in a relaxed position and arms 
hanging freely. Body mass index (BMI) was calculated by dividing weight (kg) 
by height squared (m^). Waist, hip and mid-upper arm circumferences were 
measured by standard recommended procedures (described in the methods 
chapter). Body fat was estimated by skinfold thickness using calipers (Holtain 
Ltd. Crymych, UK). Skinfold thickness measmements were taken at four different 
sites; biceps; triceps; subscapular; suprailliac. Three measurements were taken at 
each site and averaged, and the sum of the four values was used to calculate the % 
body fat of each subject using the equations of Durnin & Woimersley, (1974).
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3.3.4 Dietary intervention
Dietary targets for 2005 in Scotland (The Scottish Office, 1993) have been 
defined:
1) To increase consumption of starchy foods such as breads, cereals, potatoes 
(>40% of energy),
2) To increase non-starch polysaccharides e.g. fruits and vegetables (>16g),
3) Reduction in total and saturated fat intake (less than 35% and 11% of energy, 
respectively) by consumption of low fat products and decreasing intake of high- 
fat foods such as chips.
Table 3.1 Department of Health (1991), Scottish Diet Report and Dietary
Targets for 2005
Macronutrient Current average intake Proposed average
% Energy from:
Carbohydrates
Starch 25.3 >40
NSP (g) 10.5 >16
Sugar 16.3 <10
Total fat 40.7 <35
Saturated fat 16.6 <11
Subjects were advised to alter their habitual diet to include 55%, 30% and 15% of 
from carbohydrate, fat and protein, respectively. The subjects were advised:
1) To consume more complex carbohydrates especially more starchy foods such as 
pasta, boiled rice, boiled and baked potatoes and breakfast cereals,
2) To replace the intake of saturated fat with carbohydrate,
3) NSP more than 16g/day,
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4) - To avoid fried and high-fat foods and high intake of saturated fatty acids (Details 
in Table 3.2)
Each subject was advised on their diet in an individual manner based on their 
habitual diet records,
3.3.5 Dietary assessment
During the course of this study, subjects were asked to caiTy out a 7-day weighed 
intake to assess their habitual diet prior to starting the dietary intervention and 
were also asked to carry out four 3-day weighed intakes during each week of the 
four weeks of the dietary intervention. Subjects were asked keep a record of all 
foods and drinks consumed and asked to weigh each food item immediately prior 
to consumption. Subjects were provided with a portable electronic food scales 
(Slater Household Ltd, Tonbridge, UK), a food diary (with the appropriate 
number of pages depending on whether they were required to record food intake 
for seven or three days). Subjects were provided with both verbal and written 
instructions on how to record their food and beverage intake, and on correct use of 
the scales. At the baseline visit, subjects were shown how to use the digital scales 
including use of the ‘tare’ facility to allow weighing of foods cumulatively on to a 
plate. The completed diet records were inspected on their return to ensure that the 
subjects’ diaries were complete, and that sufficient detail had been recorded.
Table 3. 2. Dietary goals and practical advice given to achieve these goals
Goals Advice
Increase intake of carhohydrate (55% of Increase intake of starchy foods (e.g.
total energy intake) breads, breakfast cereals, potatoes, pasta,
rice), fruits, vegetables, legumes
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Increase intake of more complex 
carbohydrates such as starchy foods 
(>45% of total energy)
Decrease intake of simple sugar (<10% 
total energy)
Increase intake of non-starch 
polysaccharides (>16g/day)
Reduce intake of total fat and saturated 
fatty acids (less than 30% and 10% of 
total energy, respectively)
Increase consumption of breads, 
particularly wholemeal and brown breads, 
cereals and potatoes, such as 
baked/mashed/boiled potatoes, pasta, 
filling lettuce, tomato, cucumber or cooked 
vegetables
Decrease intake of sugar, sweets or food 
products with added sugar 
Eat fruit and vegetables daily (5 portions 
of fruit and vegetables including fresh, 
frozen, canned, or dried fruits, vegetables 
and pulses)
Increase fruit and vegetable intakes to at 
least 400g per day
Choose less-refined breads and cereals 
Choose low-fat milk, low-fat cheese, low- 
fat meat and meat products (e.g. lean 
cooked ham, chicken, beef or turkey) 
Choose steamed, boiled, grilled or micro- 
waved meat and fish
Decrease intake of fried foods (e.g. 
French fries) and high-fat meat products 
(e.g. sausages and meat pies)
Choose oily fish such as salmon, tuna
Dietary analysis was carried out using a computerised version of Diet 5™ (Robert 
Gordon University, Aberdeen) of the food composition tables (Holland et al. 
1991). Diet diaries were analysed for daily energy and macronutrient intakes in 
absolute amounts as well as the percentage of energy derived from the main 
macronutrients.
Subjects’ habitual diet records were not included in the statistical analysis if their 
reported energy intakes were less than their estimated basal metabolic rate (BMR)
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multiplied by 1.1 (under-reporters) or greater than 2.0 (over-reporters). BMR was 
estimated using the Scofield equations (Schofield et a l 1985). These cut-offs are 
used as it is highly unlikely that habitual energy intake would be < 1.1 x BMR or 
> 2.0 X BMR (Goldberg et a l 1991). One subjects’ diet records were excluded as 
she was found to have under-reported.
3.3.6 Calculation of GI and GL
GI and GL were estimated from subjects’ 7-day and 3-day weighed intake diaries. 
The GL of each carbohydrate-containing food recorded in the diet diary was 
estimated by multiplying the carbohydrate content of the serving of food 
(obtained from Diet 5) by the GI of that food item (obtained from the 
International Table of GI and GL; (Foster-Powell et a l 2002) divided by 100 
(Brand-Miller et al. 2003). The GL values, calculated in this way, for each 
carbohydrate-containing food consumed was summed to give the GL for seven or 
tluee days, and this value was then divided by seven or tluee to give the daily GL. 
The daily GI value was then calculated by dividing the daily GL by the total daily 
carbohydrate intake (obtained from Diet 5), and by multiplying by 100 (Brand- 
Miller et al. 2003).
3.3.7 Blood Sampling
A fasted blood sample was obtained from subjects at each of the four visits. 
Subjects were advised to come to the laboratory early in the morning (before 
breakfast) and after fasting for at least 12 houis beforehand. Subjects were asked 
to not to consume any alcohol or to participate in any vigorous physical activity 
for at least 24 hours before this visit. A venous blood sample was taken from the
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ante-cubital fossa vein in the non-dominant arm into vacutainers containing 
EDTA and sodium fluoride. The blood samples were immediately placed on wet 
ice and centrifuged at 3,000 ipm for 10 minutes at 4° using clinical centrifuge 
(MSE Leicester, U.K.). Plasma was divided into pre-labelled aliquots and stored 
at -80°C.
Blood samples taking in EDTA vacutainers were used for lipid, insulin, C- 
reactive protein and non-esterified fatty acid concentration analysis while blood 
samples taking into sodium fluoride were used for the analysis of glucose 
concentrations.
3.3.8 Laboratory analysis
The full details of the methods used for these laboratory analyses are described in 
Chapter 2, and therefore only a brief indication of the method is given here. Total 
cholesterol concentration was determined using a colorometric enzymatic assay 
(SIGMA Chemical Co., St. Louis, U.S.A) with the coefficient of variation of 
1.63%. HDL cholesterol concentration was assessed using the same kit after the 
precipitation of apolipoprotein B-containing lipoproteins with magnesium- 
chloride and sodium-tangestate mixture at 500g for 10 min. by micro-centrifuge 
(MSE micro-centrifuge, UK). The coefficient of variation for the measurement of 
HDL cholesterol was 2.78%. Fasting triaclyglycerol concentrations were 
determined coloromtrically (SIGMA Chemical Co., St.Loius, U.S.A) with a 
coefficient of variation 2.2 %. LDL cholesterol concentrations were estimated 
using the Friedewald equation (Friedewald et al. 1972) as follows:
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LDL cholesterol (mg.dl'') = Total cholesterol -  (HDL cholesterol (mg.dr') + Fasting
triaclyglycerol (mg.dr‘)/5)
Insulin concentrations were determined at the Biochemistry Department at the 
Glasgow Royal Infirmary using an automated analyser technique (Abbot IMX 
Analyser and dry slice technology. The homeostatic model assessment 
(HOMAir) technique (fasting insulin x fasting glucose/22.5) was used as a 
validated surrogate measure of insulin resistance (Mattews et al. 1985). Analysis 
of C-reactive protein (CRP) was carried out in EDTA plasma samples using an 
in house ELISA (Highton & Hessian, 1984) at the Department of Pathological 
Biochemistry at the Glasgow Royal Infirmary.
3.3.9 Ferric reducing ability of plasma assay (FRAP)
The antioxidant power of plasma was determined using the ferric reducing ability 
of plasma (FRAP) assay, as described by Benzie & Strain (1996). This method 
assesses the ‘antioxidant power’ by measuring the absorbance (i.e. optical 
density) of the blue colour developed when a ferric-tripyridyl-triazine (Fe^ "^ - 
TPTZ) complex is reduced to the ferrous form (Fe^ "^ ). The greatest ‘antioxidant 
power’ is associated with the deepest shades of blue. Briefly, the method involves 
adding 3 ml of FRAP reagent (ferrous chloride, TPTZ and acetate buffer at pH 
3.6, made freshly each day) and 400 pi water into individual test tubes (in 
triplicate). Then at 30-second intervals, 100 pi EDTA plasma was added to each 
test tube and vortex mixed for 30 seconds and incubated for to exactly 4 minutes 
before the absorbance was read. The absorbance of the samples was then 
determined at 593 nm using spectrophotometer (Thermo Labsystems Mulitiscan,
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Vaanta, Finland) The FRAP (mmol Fe^^.L) concentrations of the samples were 
calculated against a standard curve ranging from 0.1-1.0 mmol/L of ferrous 
sulphate and results are expressed as mmol Fe^^/L of ferrous iron formed.
The obtained coefficient of variation for the assay was 2.7 %.
3.3.10 Statistical methods
The computerised statistical package SPSS (version 11.0) was used to perform the 
statistical analysis. All data was checked for normality by visual inspection of 
histograms and comparison between mean and median in SPSS. As data was not 
normally distributed, Data are given as median and range. Wilcoxon Sign ranked 
test was used to compare the difference in dietary data between habitual and after 
one week and also habitual and mean of four weeks of dietary inteiwention trial. 
Similarly, metabolic risk factors were compared at two time sections (i.e. baseline 
and after one week as well as baseline and at the end of four weeks dietary 
intervention trial). Spearman’s correlation test was used to explore the 
relationships between dietary and metabolic parameters. Statistical significance 
was accepted at the R<0.05 level.
3.4 Results
3.4.1 Subject characteristics
Postmenopausal women (n=12) in this study were aged from 46 to 66 years old 
and their last period was between 3 to 16 years before joining this study. The 
mean BMI was 24.7 kg.m'^, however the range was 21.6 to 29.3 for study group. 
Waist circumferences and waist to hip ratio were determined for four subjects 
only in this study (Table 3.3).
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Table 3.3. Subject characteristics (u=12)
Characteristics Mean SD Range
Age (years) 56.2 6.5 46-66
BMI (kg.m'^) 24.7 2.8 21.6-29.3
Waist circumference (cm)* 76.0 7.8 66.0-85.0
Waist to hip ratio* 0.73 0.06 0.66-0.78
Last period (years) 7.1 5.0 3-16
n-4
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3.4.2 Daily energy and macronutrient intakes (absolute amount)
Table 3.4 illustrates the daily energy and macronutrient intakes in absolute amounts in 
the habitual diet, after one and four weeks of the dietary intervention of the 
postmenopausal women. There was a significant reduction in daily energy intake 
(kcal and kj) during the first week (jP=0.021) and after a mean of four weeks 
(P=0.011) of the dietary intervention.
There was a reduction in non-milk extrinsic sugar intake following a mean of four 
weeks of the dietary intervention (P=0.015).
On the other hand, there was an increase in non-starch polysaccharide intake, which 
was statistically significant after one week (P=0.05), but not quite statistically 
significant after a mean of four weeks of dietary inteiwention (P=0.086).
There was significant reduction in total fat intakes after one week ( f =0.013) and after 
a mean of four weeks (f=0 .011), saturated and monounsaturated fat intakes after one 
( f =0.026) and four weeks (P=0.011). Polyunsaturated fat intake was not significantly 
reduced after one week (P=0.075) but was significantly reduced after a mean of four 
weeks of the dietary intervention (R=0.021) (Table 3.4).
There was a significant reduction in protein intake following a mean of four weeks of 
the dietary intervention (P=0.003).
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3.4.3 Percentage of energy intake from macronutrients
The subjects significantly increased their percentage of energy from carbohydrates 
and starch ( f =0.026 and R=0.002, respectively) during week one of the dietary 
intervention, and there was a significant increase in the percentage of energy from 
starch after a mean of four weeks of the dietary intervention (P=0.013) (Table 3.5).
There was a significant decrease in percentage of energy from total fat (f=0.008), 
saturated fat (f=0.004 and P =0.008) and monounsaturated fat (P =0.003 and P 
=0.008) during week one and after a mean of four weeks of the dietary intervention, 
respectively (Table 3.5).
3.4.4 Dietary glycaemic load (GL) and glycaemic index (GI)
GI was significantly increased after week one (P=0.026) and after a mean of four 
weeks of the intervention (P=0.011) (Table 3.6).
When GL and GI were expressed per 1000 kcal, GL (P=0.011 and P=0.003) and GI 
(P=0.008 and P=0.011) were significantly increased after one week and after a mean 
of four weeks of the dietary intervention (Table 3.6).
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Table 3.8 Normal ranges and recommended cut-offs for high levels of blood lipids
Lipid Level Concentration (mmol/L)
Total cholesterol Desirable <52
Borderline high 5.2-6.2
High >6.2
LDL cholesterol Optimal <2.6
Near or above optimal 2.6-3.3
Borderline high 3.4-4.1
High 4.2-4.9
Very high >4.9
HDL cholesterol Low <1.0
High >1.6
Triacylglycerol Normal <1.7
Borderline high 1.7-2.3
High 2.4-5.6
Very high >5.6
Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults 
(2001)
Cholesterol concentrations were converted from mg/dL to mmol/L by dividing by 38.7 
Triacylglycerol concentrations were converted from mg/dL to mmol/L by dividing by 88.6
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3.4.5 BMI and biochemical factors
There was no significant change in BMI after one week of dietary intervention 
(R=0.155) but there was a significant decrease after four weeks of dietary 
intervention (P=0.014; Table 3.7).
There was a significant increase in fasting triacylglycerol concentrations after one 
week of dietary intervention (f=0.014) but this difference did not reach statistically 
significance after four weeks of dietary intervention (P=0.083).
HDL cholesterol concentration showed a significant decrease after one week 
(jP=0.014) and also after four weeks of the dietary intervention =0.021). There was 
no statistically significant change in total and LDL cholesterol concentrations after 
one and four weeks of dietary intervention. LDL particle size was significantly 
decreased after one and four weeks of dietary intervention ( f =0.004 and P=0.028, 
respectively).
There was no statistically significant change in fasting glucose and insulin 
concentrations after one and four weeks of dietary intervention. Although HOMA 
score showed an increase after four weeks of dietary intervention but it was not 
statistically significant (P=0.333).
Table 3.8 show the nonnal ranges and recommended cut-offs for high levels of blood 
lipids.
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3.4.& Correlations between simple and complex carbohydrates and plasma 
lipids
The relationships between starch intake and sugar intake with plasma lipids was 
explored to see if the type of carbohydrate was important in determining the lipid 
response.
There was a significant positive association between change in energy from simple 
sugars and the change in TC/HDL-C ratio (r=0.66, R=0.029) after 1 week (Figure 
3.1). There was also a significant relationship between the percent of changes in 
sugar to starch ratio intake and the percent of changes in TC/HDL-C after four weeks
{r = 0.67, P = 0.050) (Figure 3.2). No statistically significant relationships were >
.1-:s;found between the percentage change in GI and GL and fasting lipid concentrations. f
Furthermore, no statistically significant relationships were found between the 
percentage change in fasting lipid concentrations and percentage change in dietary 
intakes of fat.
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Figure 3.1 Relationship between changes in energy from sugar intake and changes in 
TC/HDL-C ratio in 11 postmenopausal women after dietary advice
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Figure 3.2 Relationship between the percent of changes in sugar to starch ratio intake 
and the percent of changes in TC/HDL-C ratio in 9 postmenopausal women after 
four weeks dietary advice
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3.4.7- Changes in FRAP and CRP
There was a significant increase in the antioxidant potential of the plasma as 
measured by FRAP (Tables 3.7) and this was related to the increase in intake of fruit 
and vegetables (Figure 3.3, Table 3.9). There was no significant effect on C-reactive 
protein (Table 3.7). However, it is not likely that the study was sufficiently powered 
to detect a change.
Figure 3.3 The percent change in FRAP capacity and changes in fruit and vegetable 
intake in 9 postmenopausal women after dietary advice
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3.5 Discussion
In order to reduce the risk of atherosclerosis the cun'ent dietary guidelines 
recommend the replacement of a considerable amount of dietary fat with 
carbohydrate (Department of Health, 1991). Most studies on the effect of high 
carbohydrate diets on CHD risk factors have been carried out in short term very 
controlled laboratory style studies. The aim of this intervention study was to assess 
the effect of giving dietary advice based on current guidelines in a more normal and 
relevant situation for free-living postmenopausal women, as a high risk group for 
CHD. The way they changed their diet was noted in relation to starch and sugar 
intake, GI and GL and related to the changes in their plasma lipid profiles.
The findings of the present study revealed that the women changed their diet with 
significant increases in dietary GL and GI and there were significant increases in 
plasma TAG and FRAP levels and reductions in HDL cholesterol concentration and 
LDL particle size.
Subjects significantly reduced the absolute amount and percentage of energy intake 
from total fat, saturated fat, MUFA after one and four weeks of dietary intervention. 
Consequently, they increase their total carbohydrate and starch intake. Energy from 
carbohydrates significantly increased after one week but because two subjects 
dropped out between week one and week four of the dietary intervention, this was 
not statistically significant after the four-week dietary intervention. The increase in 
carbohydrate intake was achieved with significant increases in dietary GI after one 
and four weeks. The dietary GL was non-significantly increased (P = 0.062) after 
one week but was not statistically significantly increased at 4 weeks.
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The-subjects were advised to increase their carbohydrate intake particularly in 
respect of starchy foods. Although they significantly decreased the absolute amount 
of non-milk extrinsic sugar intake after four weeks of dietary intervention, the 
change was not statistically significant in terms of the proportion of energy. The 
decrease in body weight over the dietary intervention resulted from a significant 
reduction in energy intake during the first week and after a mean of four weeks of 
dietary intervention. However, although they were advised to maintain their normal 
lifestyle including exercise, it cannot be ruled out that an increase in physical activity 
was a reason for the weight loss. There was a significant increase in energy from 
carbohydrates only after one week. The lack of a statistically significant change in 
energy from carbohydrate at the end of intervention trial may have resulted from the 
dropping out of two subjects after following one week of the dietary intervention. 
Energy from starch showed a significant increase after one and four weeks of the 
dietary intervention. Although the postmenopausal women increased starch intake 
and decreased the ratio of sugar to starch (0.82 in habitual diet vs 0.71 at the end of 
study), the change in sugar to starch ratio was not statistically significant over the 
dietary intervention. The mean of sugar intake increased from 19.1% at habitual diet 
to 21.2%, and 21.6% after one and four weeks of dietary intervention. This reveals 
that the subjects increased dietary carbohydrates by increasing the intake of both 
sugar and starch. This is not surprising when dietary advice is given to individuals in 
a free-living state, which is not under the control of investigator and is more relevant 
to real life than when complex carbohydrates are given under laboratory style 
conditions. It reflects the need to be more specific in dietary guidelines and the need 
to explain more the differences in the types of carbohydrates in foods and their 
probable effects on health.
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The -advice to increase carbohydrate intake was also associated with significant 
increases in dietary GI and GL, which from the literature would be associated with 
increased risk of CHD (Liu et al. 2000) and type 2 diabetes (Salmeron et al. 1997a 
and b) and a worsening of metabolic risk factors (Frost et al. 1999; Ford & Liu; 
2000; Liu et al. 2001) for these diseases.
There was an adverse effect on fasting plasma lipids including an increase in fasting 
TAG (P = 0.014 and P = 0.083 after one and four weeks, respectively), and a 
decrease in HDL cholesterol concentrations (P = 0.014 and P = 0.021 after one and 
four weeks, respectively). A number of coiaelations were carried out to assess the 
relationships between changes in the type of carbohydrate eaten and the relative 
changes in plasma lipid levels (Figures 3.1, 3.2, 3.3). In general there was a 
protective effect of increasing intakes of complex carbohydrates and starch on 
plasma lipids and an adverse effect of increases in simple sugar intake. This 
approach of looking at the relative changes in individuals with their individual lipid 
profile was more powerful in detecting these changes than looking at group changes 
alone.
Although the median change for TAG between baseline (0.95 mmol/L) and week 1 
(1.01 mmol/L) is statistically significant {P = 0.014), looking at the normal ranges 
and recommended cut-offs for high plasma lipids in Table 3.8, one can see that the 
changes are still within the normal range (<1.7 mmol/L). However, the trend is for 
TAG to increase which is not in a benefical direction, and even though the changes 
might not be clinically significant for the individuals in this study, on a population 
wide basis, it is very likely to be associated with increased risk of CHD. After all the
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results from a meta-analysis of 17 population-based studies showed a 76% increase 
in CHD risk in women and a 31% increase in men associated with a 1 mmol/L 
increase in TAG levels (Austin et a l 1999), On the other hand, median HDL-C 
concentrations decreased statistically significantly (P = 0.021) from 1.72 mmol/L to 
1.46 mmol/1 which meant that the median value at baseline would be considered high 
(> 1.6 mmol/L) which is associated with lower risk of CHD, where as the value after 
four weeks of the intervention would no longer be categorised as high. Regarding the 
individual changes in HDL-C, for four of twelve subjects, their HDL-C values 
decreased from above 1.6 mmol/L to less than this value, which would be considered 
biologically significant for these individuals. It has also been reported that for every 
decrease of about 0.026 mmol/L in HDL-C concentration, the risk of CHD increases 
by 3.2% in women and 2.3% in men (Ford and Liu, 2001). A reduction on HDL-C 
concentration of this magnitude was obseiwed in three of the twelve subjects in this 
study.
Several previous studies have indicated that increased sugar intake may increase 
TAG level during low fat and high carbohydrate diets. Hudgins et a l (1996) Showed 
that change in the ratio of simple sugar to complex carbohydrate from 60:40 to 40:60 
in low fat and high carbohydrate diet prevented stimulation of de novo lipogenesis. 
and an increase in energy from simple sugars was adversely associated with changes 
in HDL cholesterol concentrations among 55 overweight postmenopausal women 
(Bunyard et a l 2002). Although glucose is the monomer of the starch structure, it 
may physiologically act differently in human metabolism when included in an ad 
libitum intake of low-fat and high starch diet (Marckmann et aL 2000). This may be 
related to the GI of the food. Moreover much of the sugar in the diet may be fi'om
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fructose in the fmits and sucrose and high fructose com syrup which has also been 
related to increased TAG (Gross et a l 2004). The current recommendation is that 
complex carbohydrates should provide more than 30% of daily energy intake and 
energy from simple sugar intake should reduce as much as possible. However this 
may be difficult for the general public to achieve if they do not understand the sugar 
contents of foods.
The GL of the diets of the women in this study increased and this may have 
adversely affected their plasma lipids. Results of an observational study of 280 
apparently healthy postmenopausal women revealed that dietary GL and average GI 
were inversely related to plasma HDL concentrations and positively related to fasting 
plasma TAG levels, independent of BMI, weight change, total energy intake, and 
other known CHD risk factors (Liu et al. 2001).
Reduction in HDL cholesterol level is associated with increased risk of CHD. For 
every decrease of about 0.026 mmol/L in HDL-C concentration, the risk of CHD 
increases by 3.2% in women and 2.3% in men (Ford and Liu, 2001). After following 
the dietary intervention in this study, plasma HDL cholesterol concentrations 
decreased 4.5% and 9.8% after one and four weeks of dietary inteiwention, 
respectively. The consumption of a low fat diet results in more rapid clearance of 
HDL and decreased transport of HDL apo-proteins. However, it has been shown that 
diet-induced lowering HDL cholesterol level is not equal to reduced atherogenicity 
in some people consuming a high-fat diet (Brinton et a l 1990).
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Ullm-an et al. (1991) showed that the gradual introduction of a high-carbohydrate 
diet prevented the hypertriacylglycerolaemic effect that occurred when a high- 
carbohydrate diet was introduced abruptly.
There is substantial evidence that in free-living situations low-fat high-carbohydrate 
diets lead to weight loss (Kasim-karakas et a l 1993; Leenen et a l 1993) that in turn 
may correct insulin resistance and plasma TAG metabolism (Purnell and Brunzell,
1997). In the present study, over the four weeks of dietary intervention, there was 
significant reduction in BMI and although there was a trend for increase in HOMA 
score it was not statistically significant.
It seems clear that the increase in TAG that was observed in this study was most 
likely to be due to an increase in carbohydrate intake, as this effect is well known 
and has been recognised for several decades. However, it is less clear whether it was 
the reduction in subjects’ body weight and/or the dietary changes that caused the 
observed reduction in HDL cholesterol. In a study carried out by Kasim-Karakas et 
al (2000) on 64 healthy postmenopausal women, the effects on HDL cholesterol of 
following an energy-controlled high-carbohydrate, low fat (HC-LF) diet for four 
months and an ad libitum HC-LF diet for eight months was studied. The authors 
reported that HDL cholesterol decreased on the energy controlled HC-LF diet in 
which no weight loss was observed and therefore the changes were thought to be due 
to dietary changes. However, HDL cholesterol remained low on the ad libitum HC- 
LF diet which suggests that weight loss can also contribute to lowering HDL 
cholesterol.
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One-very positive aspect of the dietary intervention in this study was that after 
following the recommended diet there was a significant increase in the intake of fruit 
and vegetables. This had the added benefit of increasing the antioxidant power of 
the subjects’ plasma as measured by FRAP (Table 3.7 and 3.9). This appears to 
have mostly been associated with an increase in fruit intake (Table 3.9).
CRP has been introduced as an independent risk factor for type 2 diabetes and CHD 
(Ridker et al. 1999 and Ridker et al 2000). CRP is an acute phase inflammatory 
protein, and proven as a strong indicator of CHD risk (Ridker et al. 2001). The 
possible effects of the dietary changes on CRP level were examined, but there was 
no statistically significant change. In other studies, CRP was positively correlated 
with dietary GI (Liu et al. 2001). Liu et al. (2001) showed positive association 
between CRP concentration and dietary GI in large population. Healthy diet and 
exercise together were shown recently to reduce CRP concentration by 45% (Wegge 
et al. 2004). This study had a relatively small number of subjects compared to these 
studies that have detected changes in CRP and it is likely that it was not sufficiently 
powered to detect any change.
In conclusion, following the UK dietary guidelines by increasing dietary 
carbohydrate with emphasis on starch intake in postmenopausal women resulted in 
weight reduction and an increase in antioxidant power of plasma which should 
benefit health. However, the changes in lipid profile were more likely to favour an 
increased risk of CHD. There seem to be worse effects when women increased their 
simple sugar intake at the expense of starch. GI or GL were not used in the dietary 
advice in this study and this may have affected the interpretation of the guidelines.
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The-effects of these parameters are explored more in the following chapters 
particularly in the intervention study described in chapter 5.
As women who follow dietary guidelines in a free-living situation, rather than under 
very controlled conditions, are likely to make dietary changes in the manner of the 
women in this study, more research is needed to devise better and more appropriate 
guidelines for reducing CHD risk.
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Chapter 4
Relationships between dietary 
glycaemic index and metabolic 
parameters in offspring of patients with 
type 2 diabetes and control subjects
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4.1 Introduction
Type 2 diabetes, formerly known as non-insulin dependent diabetes or adult onset 
diabetes, is the most common form of diabetes and is estimated to affect more than 
150 million adults worldwide (FAO/WHO, 2003). The disease is becoming more 
prevalent and the incidence is expected to double over the next 25 years (King et a l
1998). This is a worrying trend, as not only is it affecting a large proportion of the 
world’s population, but it has also started to appear earlier in life and is now being 
identified in younger age groups including adolescents and children (Aboderin, 
2001).
In recent years there has been a lot of interest in a condition called the metabolic 
syndrome, which was the term put forward by Reaven (1988) to describe a cluster of 
disorders linked with obesity and hyperinsulinaemia, and associated with increased 
risk of type 2 diabetes and CVD. Although a number of different sets of diagnostic 
criteria have been proposed for the metabolic syndrome (Expert Panel on Detection, 
Evaluation, and Treatment of High Blood Cholesterol in Adults, 2001; European 
Group for the Study of Insulin Resistance, 2002), insulin resistance, hyperglycaemia, 
dyslipidaemia, central obesity and hypertension are generally agreed to be the five 
key features.
Insulin resistance is believed to occur up to ten or twenty years before type 2 
diabetes develops (Wareham et a l 1990; Martin et a l 1992). Insulin resistance is the 
resistance of the tissues of the body to the effects of glucose. The body then has to 
produce more insulin to get the same action in response to normal blood glucose 
levels after a meal. This is thought to lead to gradually increasing glucose
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concentrations, which result in even higher insulin secretion and eventually to the 
beta cells in the pancreas that produce insulin not working (Pan et al. 1997).
There are a number of complications associated with type 2 diabetes including 
increased risk of infections, coronary heart disease (CHD) and stroke (King et al 
1998; (FAO WHO, 2003)). In fact, individuals who develop type 2 diabetes are 
reported to have a three- to four fold higher risk of mortality and morbidity from 
CHD compared with healthy individuals (Niskanen e/a/. 1998).
Genetic and environmental factors are believed to influence the development of type 
2 diabetes, and the increasing rates of the condition show the importance of 
environmental and lifestyle factors. The increasing rates of overweight and obesity, 
reductions in physical activity levels and changes in diet are thought to play 
particularly important roles in the increase in rates of type 2 diabetes. In many 
populations, it has been reported that being overweight or obese is associated with 
increased risk of type 2 diabetes, and this has especially been shown to be the case 
when too much of the excess adipose tissue is stored around the abdomen 
(FAO/WHO, 2003).
It is also known that having a genetic susceptibility to type 2 diabetes increases the 
risk of developing the condition. For example, certain ethnic groups such as the Pima 
Indians of Arizona in the USA show the highest known prevalence of type 2 diabetes 
of any population (Haffner, 1998; Lindsay et a l 2002). Furthermore, having a family 
history of type 2 diabetes increases one’s risk of developing the condition, in fact, it 
has been reported that first degree relatives of patients with type 2 diabetes have a
:..
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three-to four fold higher risk of developing type 2 diabetes compared with those 
without this family background (Kobberling and Tillil, 1982).
While lifestyle factors, which contribute to the development o f overweight, are 
certain to increase the risk of type 2 diabetes, whether dietary factors have an effect 
independent of this is not known.
However, a number of large-scale epidemiological studies have provided evidence
for a link between habitual diet and the development of type 2 diabetes. A diet high
in saturated fatty acids has been associated with higher fasting plasma glucose and
insulin concentrations (Feskens et al. 1990; Parker et al. 1993), impaired glucose
tolerance (Feskens et a l 1995), and higher proportions of saturated fatty acids in
semm lipids and muscle phospholipids have been associated with greater risk of
developing type 2 diabetes (Vessby et a l 1994). In contrast, there is evidence that a
higher proportion of long-chain polyimsaturated fatty acids in skeletal muscle
phospholipids is associated with increased insulin sensitivity (Salmeron et al 2001),
.and higher dietary intake of unsaturated fatty acids has been associated with lower 
risk of developing type 2 diabetes (Meyer et a l 2001; Salmeron et a l 2001).
There is also evidence that dietary carbohydrates may influence the risk of 
developing type 2 diabetes, and a number of studies have reported that a lower 
dietary fibre intake is associated with an increased risk of developing type 2 diabetes 
(Salmeron et a l 1997a; Salmeron et a l 1997b; Meyer et a l 2000) while quite a few 
studies have reported no association between total carbohydrate intake and diabetes 
risk (Lundgren et a l 1989). Several studies have used the concept of GI in studying
'■j:
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found between GI and GL and diabetes risk in the 6 year follow up of the Iowa 
Women's Health Study cohort (Meyer et al 2000).
A number of cross-sectional studies have also reported relationships between dietary 
GI and GL and metabolic risk factors for type 2 diabetes and CHD. In a cross- 
sectional study of 1,420 healthy adults in the UK, GI of the habitual diet was the 
only dietary variable found to be significantly related to serum HDL cholesterol 
concentrations (Frost et a l 1999). In the US, high dietary GL was associated with 
low plasma HDL concentrations and elevated fasting triaclyglycerol concentrations 
in 280 postmenopausal women taking parting the Nurses’ Health Study (Liu et a l  
2001). In another cross-sectional analysis of a random sample of 244 healthy middle- 
aged women from the Women’s Health Study (Liu et a l 2002), dietary GI was found 
to be significantly and positively associated with C-reactive protein concentration, 
which is reported to be a sensitive marker of systematic inflammation, independent 
of usual risk factors.
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relationships between dietary carbohydrate and the risk of type 2 diabetes. In the 
Nurses’ Health Study, the multivariate-adjusted relative risk of type 2 diabetes 
during 6 years of follow-up was 1.37 (95% Cl: 1.09, 1.71) for an increase in GI of 15 
units and was 1.47 (95% Cl: 1.16, 1.86) for extreme quintiles of dietary GL. Women 
with both a high dietary GL and a low cereal fibre intake were at an even higher risk 
of type 2 diabetes (relative risk: 2.43; 95% Cl: 1.12, 5.27) (Salmeron et a l 1997a). In 
the Health Professional’s Follow-up Study, the multivariate-adjusted relative risk 
was 1.37 (95% Cl; 1.02, 1.83) in a 6-year follow-up for extreme quintiles of dietary 
GL and 2.17 (95% Cl: 1.04, 4.54) for the combination of a high GL and a low intake
.of cereal fibre (Salmeron et a l 1997b). By contrast, no meaningful associations were
There have been a number of large-scale intervention studies reporting that changes 
in lifestyle including weight loss, increases in physical activity and dietary changes 
can reduce the risk of type 2 diabetes. In the Finnish Diabetes Prevention Study 
(Tuomilehto et al. 2001;Uusitupa et al. 2000), the incidence of type 2 diabetes was 
reduced by 58% following combined dietary and physical activity advice in 522 
middle aged, overweight subjects with impaired glucose tolerance after a 3.2 year 
follow-up. Similarly, in the US Diabetes Prevention Study (Knowler et al. 2002), on 
3,234 non-diabetic, high-risk individuals, a lifestyle intervention including advice to 
lose weight, to follow a ‘healthy, low calorie, low fat diet’ and to increase physical 
activity reduced the incidence of type 2 diabetes by 58% (95% Cl; 48, 66%), and to a 
significantly greater extent compared with a control or intervention with a drug. In 
these studies, it is difficult to separate an effect of diet from other lifestyle advice, 
however, in the Da Qing Impared Glucose Tolerance Test and Diabetes Study (Pan 
et al. 1997), the influence of a dietary intervention was investigated separately. In 
this large-scale intervention study, involving 577 high-risk individuals, diet only, 
exercise only, and diet and exercise inteiwentions, were found to significantly reduce 
the incidence of type 2 diabetes by 31%, 46% and 42%, respectively, over a 6-year 
follow-up period.
Thus, is seems to be the case that there is evidence from epidemiological, large-scale 
intervention and cross-sectional studies that diet may influence the development of 
type 2 diabetes. As I said at the start of this chapter, insulin resistance is a central 
metabolic problem in type 2 diabetes, and a number of possible mechanisms have 
been put forward that could explain how diet could influence insulin sensitivity.
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Diets^ lower in fat might help people lose weight and reduce obesity which could 
improve glucose control in the body and insulin sensitivity (Hu et a l 2001). 
Alternatively, the effects of dietary fats and fatty acids could be explained by the 
their influence on the fatty acid composition of cell membranes in the body. It has 
been shown that increasing the proportion of polyunsaturated fatty acids and 
reducing the proportion of saturated fatty acids in phospholipids in skeletal muscle 
could improve insulin sensitivity (Borkman et al 1993) by several mechanisms 
including altering insulin receptor binding or affinity and influencing ion 
permeability and cell signalling (Vessby, 2000). Furthermore, diets that are higher in 
unrefined carbohydrates and dietary fibre produce slower glycaemic and 
insulinaemic responses compared with more processed refined cereal grains and 
could protect against the development of type 2 diabetes in this way (Hu et a l 2001).
As I already mentioned, offspring of individuals with type 2 diabetes have a higher 
risk of developing this condition compared with people who have no family 
members with the disease (Kobberling et al 1985), and this is thought to be due to 
genetic factors and also lifestyle factors. People in the same family have many 
similar lifestyle habits such as eating similar foods and cooking foods in the same 
way, frying versus grilling of foods. Indeed, studies that have looked into this have 
reported that the children’s food intake and eating patterns are influenced by their 
parents’ (Wardle, 1995; Feunekes et a l 1997). It has also been shown by a study, 
that the what people eat when they are adults is very close to what they ate when 
they were children and adolescents (Welten et a l 1997). Thus it could be believed 
that ‘poor dietary habits’ in families could influence or add to the higher risk of 
diabetes in their offspring. This idea is supported by a study carried out by Adamson
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'et a l (2001) who assessed the dietary intake of 149 non-diabetic relatives and the 
same number of age- and sex-matched control subjects with no family history of 
diabetes. These authors reported that relatives consumed diets that were more likely 
to promote rather than prevent the development of type 2 diabetes as their diets were 
higher in total fat, saturated fat and cholesterol and lower in carbohydrate and non­
starch polysaccharide compared with control subjects. However, the researchers who
4.2 Objectives
The objectives of the study were:
# To assess habitual dietary intake, GI, GL and the metabolic risk factors for
CHD and type 2 diabetes,
» To examine the relationships between habitual dietary intake, GI, GL and
metabolic risk factors in offspring of patients with type 2 diabetes and in 
control subjects.
carried out this study did not examine the dietary GI or GL of type 2 diabetic 
relatives.
Whether the GI or the GL of the habitual diet of high risk individuals such as type 2
diabetic offspring could increase the risk of developing the condition is not known, 
as I could find no other study that reported on this. Furthermore, to my knowledge, 
there is no published studies examining the relationships between habitual GI and 
GL, and anthropometric and metabolic risk factors that are known to be important 
for diabetes risk in this vulnerable group.
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4.3 Materials and methods
The data used in this study was collected as part of a larger study (Higgins et a l 
2004). It was my idea to look at GI in this study. I carried out the GI and GL 
calculations of the subjects’ habitual diets and the comparisons and statistical 
analysis described in this chapter.
4,3.1. Subjects
Thirty-four healthy volunteers participated in this study; 17 (13 females and 4 males) 
were adult offspring of patients with type 2 diabetes (offspring group) and 17 were 
control subjects (control group). Subjects were individually matched for age (± 2 
years) and gender. Subjects were not matched for fatness or adiposity as a number of 
previous studies (Humphiiss et a l 1997; Ezenwaka et a l 2001; van Dam et a l 2001) 
have reported that offspring of patients with type 2 diabetes have greater levels of 
adiposity compared with individuals with no family history of diabetes. To take part 
in the study, subjects in the offspring group were required to have at least one parent 
diagnosed with type 2 diabetes before the age of 65 years and control subjects were 
required to have no first or second-degree relatives with type 2 diabetes. In addition, 
subjects were required to be; aged between 20 and 50 years, to have a fasting glucose 
less than 7mmol.f % be healthy, pre-menopausal, not taking medications that affect 
lipid or carbohydrate metabolism (apart from oral contraceptives), not pregnant, not 
be on any special diet or taking any nutritional supplements. Three offspring subjects 
and five subjects in the control group were smokers. Ten and 11 of the subjects in the 
offspring and control groups, respectively were taking oral contraceptives at the time 
of study. The subjects were all of Northern European extraction. Ethical approval
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was obtained from the Ethics committee at Glasgow Royal Infirmary and subjects 
provided written informed consent.
Subjects were recruited through advertisements in the University of Glasgow 
newsletter and by poster. Letters were also sent to patients with type 2 diabetes 
asking them if their adult daughters or sons would like to participate in the study. 
Subjects were mostly university staff, and postgraduate students and nurses.
4.3,2 Experimental Design
Subjects were required to attend a preliminary screening session at the Department 
of Human Nutrition at Yorkhill hospital in the fasted state. The subject information 
sheet was posted to interested volunteers in advance to allow them time to read it 
carefully and at the preliminary session, subjects were required to sign the consent 
form. At this visit, inclusion criteria were checked, anthropometric measurements 
were made, subjects also completed a health history questionnaire, and provided 
their contact details. Subjects were provided with a 7 day physical activity diary (the 
data on this is not presented here) and detailed instructions on how to complete it. 
Subjects were also provided with a 7-day diet diary, a digital food scales and detailed 
written and oral instruction on recording their habitual diet. Subjects were asked to 
keep a record of their usual diet for 7 days prior to the subsequent visit. For the 
second visit, subjects were collected in a taxi, after an overnight fast, and brought to 
the study room at the Department of Human Nutrition at Yorkhill or at Glasgow 
Royal Infirmary Hospitals, depending on which site was more convenient to the 
subject. Subjects were required to abstain from alcohol and vigorous physical 
activity for 24 hours before this visit. At this visit, subjects were required to take part
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in an oral glucose tolerance test. Subjects also had their completed diet and physical 
activity diaries checked at this visit.
4.3.3 Anthropometric measurements
Height (m) (Holtain Ltd, Crymych, Dyfed), weight (kg) (SEGA scales), waist 
circumference (cm), hip circumference (cm) and mid-upper arm circumference (cm) 
(MUAC) were measured. Body mass index (BMI) was calculated from weight and 
height (weight (kg)/ height (m^)). Body fat was estimated by skinfold thickness. The 
skinfold measurements were made using calipers (Holtain Ltd. Crymych, UK) which 
measure the thickness of a fold of skin with its underlying layer of fat which were 
measured at four different sites; biceps; triceps; subscapular; suprailliac. Three 
measurements were taken at each site and averaged, and the sum of the four values 
was used to calculate the % body fat of each subject using the equations of Durnin & 
Wormersley (1974).
4.3.4 Dietary assessments
Subjects were asked to keep a detailed record of their habitual dietary intake for 7 
days (Bingham, 1987) immediately prior to visiting the laboratory for blood 
sampling. Subjects were provided with portable electronic food scales (Slater 
Household Ltd, Tonbridge, UK), a food dairy, and oral and written instructions on 
how to record their diets, and on correct use of the scales. The completed diet records 
were inspected on their return to ensure that they were complete, and that sufficient 
detail had been recorded. Subjects were asked keep a record of all foods and drinks 
consumed and asked to weigh each food item immediately prior to consumption. The 
diet records were analysed for daily energy and nutrient intakes using a computerised
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version (Diet 5^^, Robert Gordon University, Aberdeen) of the food composition 
tables (Holland a/. 1991).
Subjects’ diet records were not included in the statistical analysis if their reported 
energy intakes were less than their estimated basal metabolic rate (BMR) multiplied 
by 1.1 (under-reporters) or greater than 2.0 (over-reporters). BMR was estimated 
using the Scofield equations (Schofield et a l 1985). These cut-offs were used as it is 
highly unlikely that habitual energy intake would be < 1.1 x BMR or > 2.0 x BMR 
(Goldberg et a l 1991). On this basis, one subject was excluded for under-reporting. 
This will explain which there are 17 subjects in the offspring group but only 16 
subjects in the control group in the dietary results tables.
4.3,5 Calculation of glycaemic index (GI) and glycémie load (GL)
Subjects kept detailed weighed records of their habitual dietary intakes for seven 
days, which in addition to being analysed for daily energy and nutrient intakes, were 
also used for the estimation of GI and GL. Firstly, the GL of each carbohydrate- 
containing food recorded in the diet diary was estimated by multiplying the 
carbohydrate content of the seiwing of food (obtained from Diet 5) by the GI of that 
food item (obtained from the International Table of Glycaemic Index and Glycaemic 
Load; Foster-Powell et a l 2002) divided by 100 (Brand-Miller et a l  2003). The GL 
values, calculated in this way, for each carbohydrate-containing food consumed was 
summed to give the GL for seven days, and this value was then divided by seven to 
give the daily GL. The daily GI value was then calculated by dividing the daily GL 
by the total daily carbohydrate intake (obtained from Diet 5), and by multiplying by 
100 (Foster-Powell et a l 2002),
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4.3.6 Oral glucose tolerance test (OGTT)
Subjects aiTived at the laboratory after an overnight fast (12 h) and were asked to 
refrain from alcohol and vigorous physical activity for 24 h before this visit. On 
arrival, each subject had a cannula placed in the ante-cubital fossa vein in the non­
dominant arm. Blood samples were taken before and 15, 30, 60, 90, and 120 minutes 
after subjects consumed a 75 g oral glucose load (75g glucose dissolved in 250 ml 
water). Sterile saline (9g/l NaCl, 5 ml) was used to prevent blood from clotting in the 
cannula during the test period. The samples were immediately centrifuged for 10 min 
at 3,000 rpm at 4*^ C and plasma separated and stored at -80”C.
4.3.7 Laboratory analysis
Blood samples were collected into ethylenediaminetetra acetic (EDTA), sodium 
fluoride and lithium heparin vacutainers after a 12-hour overnight fast and 
immediately placed on wet ice. Plasma was separated by low speed centrifugation 
(MSE Leicester, U.K) at 3000rpm for 10 minutes at 4°C. Plasma was divided into 
aliquots and stored at -70°C until analysis.
All metabolic parameters were measured either at the Department of Pathological 
Biochemistry or the Department of Biochemistry at the Glasgow Royal Infirmary 
and full details of each of the methods are given in the methodology chapter 
(Chapter 2). I will briefly describe the method here. Plasma samples collected into 
EDTA were used for the determination of triaclyglycerol and total and high-density 
lipoprotein (HDL) cholesterol by standard enzymatic colorimetric procedures (Roche 
Diagnostic Corporation, Lewes, UK). Low-density lipoprotein (LDL) cholesterol
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concentrations were calculated using the Frledelwald equation (Friedelwald et al. 
1972). Non-esterified fatty acid (NEFA) concentrations were determined in EDTA 
plasma using a standard enzymatic method (Roche Diagnostic Corporation, Lewes, 
UK) Plasma samples collected into sodium fluoride were analysed for glucose 
concentrations using a standard enzymatic method (Roche Diagnostic Corporation, 
Lewes, UK). Insulin concentrations were determined in lithium heparin plasma by 
the Department of Biochemistry. Analysis of C-reactive protein (CRP) was carried 
out in EDTA plasma samples using an in house ELISA (Highton and Hessian, 1984). 
Adiponectin concentrations were also measured in EDTA plasma samples using a 
commercially available ELISA (B-Bridge International, Inc. Japan).
The homeostatic model assessment (HOMAir) teclmique (fasting insulin x fasting 
glucose/22.5) was used as a measure of insulin resistance (Matthews et al. 1985). 
Additionally, insulin sensitivity was estimated using fasting and oral glucose 
tolerance test glucose, insulin and NEFA concentrations using the Belfiore et al. 
(2001) method which has been validated against the euglycemic clamp technique.
4.3.8 Statistical analysis
Data were expressed as mean ± standard deviation (SD). Data was checked for 
normality by visual inspection of the histograms in SPSS. Anthropometric data was 
found to be normally distributed but the dietary and metabolic parameter data were 
found not to be normally distributed. Where data was normally distributed, the 
student’s independent t-test was used to compare mean values between the groups 
and to test for significant differences. Where data was not normally distributed, 
differences between the groups were assessed using the non-parametric, Mann
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Whitney U test. In order to explore relationships between the vaiiables, the non- 
parametric Spearman’s correlation coefficient test was used. Chi Square and Fisher 
Exact tests (when required) were used for examining associations between 
categorical variables. Statistical analysis was performed using SPSS (version 11.0) 
and P values were accepted as being statistically significant when they were less than 
0.05.
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4.4 Results
4.4.1 Anthropometric Characteristics
Subjects were matched for gender and age (± 2 years), and therefore, no significant 
difference in the age of the groups was found or expected. There were no significant 
differences in any of the anthi'opometric measurements between the offspring and 
control groups (Table 4.1)
Table 4.1. Anthropometric Characteristics
Offspring Control P *
n==17 «= 17
Mean SD Mean SD
Age (years) 32.7 7.1 35.1 6.0 0.302
Weight (kg) 70.6 9.6 66.8 10.0 0.809
Height (m) 1.7 0.1 1.7 0.1 0.270
Body mass index (kg.m '^ ) 25.8 3.3 24.1 3.1 0.137
Body fat (%) 29.8 5.9 27.6 5.9 0.278
Waist circumference (cm) 81.8 9.0 77.7 9.8 0.217
Waist to hip ratio 0.8 0.1, 0.8 0.1 0.404
Mid upper arm circumference 30.6 2.4 29,0 3.1 0.122
(cm)
* Independent Student t-test
The majority (64.7%) of offspring and 35.3% of control subjects were either 
overweight or obese (BMI > 25 kg.m'^) (P=0.086) (WHO 1998). A significantly 
higher proportion of subjects in the offspring group had a BMI > 27.5 kg.m’^  (35.3 
%) compared with the control group (5.9 %) {P = 0.043, for one-sided Fisher exact 
test) (Table 4.2). This cut-off of 27 kg.m'^ was suggested to be used by Sargeant et 
a l (2000). In addition, the prevalence of high waist circumferences (>80 cm for 
women and >94 cm for men) (Department of Health 2004) was 17.6% in both
I
I
I
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groups. No difference in the prevalence of high waist to hip ratio (0.85 or greater for 
women and 0.95 or greater in men) (Department of Health, 2004) was obseiwed 
between the two groups (the prevalence was three of 17 subjects in both groups).
Table 4.2 Proportion of the offspring and control groups with BMI less than and 
greater than 25 and 27.5 kg.m'^.
BMI (kg.m'^) Offspring («=17) Control («=17) P
n(% ) n (%)
<25 6(35.3) 11 (64.7) 0.086
(Ovemeight or obese) 11 (64.7) 6 (35.3)
<27.5 11 (64.7) 16(94.1) 0.043
>27.5 6(35.3) 1 (5.9)
When the anthropometric characterisitics for the subjects were analysed separately, 
female offspring had a significantly higher waist to hip ratio than control subjects (P 
= 0.036) (Table 4.3). Waist circumference and body mass index were also higher in 
female offspring compared with female control subjects, however, the differences 
did not quite reach statistical significance (P=0.063 and P=0.083, respectively). 
There were no other significant differences in any of the other anthropomtric 
variables between female or male offspring and control subjects (Table 4.3).
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Table 4.4r Daily energy and macronutrient intakes in the offspring and control
subjects by weighed diet record
Offspring
«=17
Control
«=16
P *
Mean SD Mean SD
Energy (kcal) 2,124 401 2,112 453 0.857
Energy (kJ) 8,887 1,678 8,837 1,895 0.857
Nutrient (g)
Total fat 73.2 21.7 72.9 11.9 1.00
Saturated fat 27.3 10.4 25.2 4.7 0.627
Monounsaturated fat 22.6 7.2 24.2 4.5 0.439
Polyunsaturated fat 12.6 4.3 13.3 4.3 0.639
Carbohydrate 272.9 60.6 260.1 64.5 0.564
Sugar 105.3 32.4 102.9 36.0 0.517
Starch 148.4 40.7 125.3 22.5 0.044
Non-milk extrinsic sugar 
Non-starch
72.4 30.6 66.4 26.8 0.540
polysaccharide 15.1 3.5 14.6 6.2 0.705
Protein 85.7 16.0 79.1 21.1 0.078
Alcohol 14.1 9.0 22.2 18.1 0.407
* Mann Whitney U test
4.4.2 D ietary Intake
There were no significant differences in daily energy or in absolute amounts of 
macronutrients between offspring and control subjects with the exception of starch 
intakes, which were significantly higher in offspring compared with control subjects 
(P-0.044) (Table 4.4). GI and GL values were not significantly different between the 
groups (Table 4.5).
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Table 4.5 - Dietary glycaemic index and glycaemic load in the offspring and
control subjects by weighed diet record
Offspring (n=17) Control (n=16) P*
Mean SD Mean SD
Glycaemic load 147.0 34.0 140.7 40.5 0.460
Glycaemic index 54.0 2.8 54.0 4.9 0.971
%
*  Mann Whitney U test
Table 4.6. Percentage of energy intake from macronutrients in the offspring and 
control subjects by weighed diet record
*  Mann Whitney U test
Offspring 
(n=17) 
Mean SD
Control (n=16) 
Mean SD
P*
% energy from:
Total fat 30.3 5.6 31.0 4.3 0.601
Saturated fat 11.2 3.0 10.7 1.9 0.614
M onounsaturated fat 9.5 2.3 10.2 1.5 0.482
Polyunsaturated fat 5.1 1.5 5.6 1.7 0.470
Carbohydrate 48.0 6.5 46.8 5.9 0.418
Sugar 19.1 5.4 18.5 4.1 0.540
Starch 28.1 6.2 24.2 4.2 0.023
Non-milk extrinsic sugar 12.8 4.3 12.0 4.2 0.692
Protein 16.6 3.3 , 15.2 2.3 0.227
Alcohol 4.5 2.8 6.3 4.6 0.339
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Apart from-the percentage o f energy from starch, which was significantly higher {P ~
0.023) in the offspring group, there were no significant differences in the percentage
of energy from carbohydrate, fat, protein or alcohol between the groups (Table 4.6).
Table 4.7. The proportion of the offspring and control subjects meeting the UK 
dietary targets (Scottish Office, 1993)
Nutrient intake Dietary
target
Offspring
«=17
Control
«=16
p*
% Energy from
Carbohydrate >47 58.8 43.7 0.387
Non-milk extrinsic sugar <11 35.3 43.8 0.619
Starch >37 0 0 "
Sugar; starch ratio <0.66 35.3 23.5 0.452
Non-starch polysaccharides
(g) >18 23.5 12.5 0.656
% Energy from
Total fat <33 76.5 56.3 0.218
Saturated fat < 10 35.3 37.5 0.895
Monounsaturated fat <12 88.2 87.5 1.000
Polyunsaturated fat <6 88.2 68.8 0.225
Alcohol <5 58.8 50.0 0.611
Chi square test
The proportion of subjects meeting the UK dietary targets (Scottish Office, 1993) was 
not significantly different between the two groups. However, a low proportion of 
subjects from both groups achieved the dietary targets, and this was especially so for 
percentage energy from non-milk extrinsic sugars, starch, NSP and saturated fat, 
showing that both groups consumed diets that were too high in non-milk extrinsic 
sugars and saturated fat and too low in starch and NSP (Table 4.7).
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Table 4.8. Metabolic parameters in offspring and control subjects
Biochemical factors Offspring «=17 Control «=17 P*
Mean SD Mean SD
Total cholesterol (mmol.f') 4.31 0.83 4.54 0.67 0.367
Triacylglycerol (mmol.f’) 1.38 1.21 1.01 0.35 0.245
VLDL cholesterol (mmol.f’) 0.45 0.50 0.25 0.12 0.116
LDL cholesterol (mmol.f’) 2.59 0.72 2.69 0.85 0.710
HDL cholesterol (mmol.f’) 1.27 0.20 1.61 0.45 0.011
LDL] (mmol.f’) 1.32 1.53 1.09 1.07 0.804
Fasting glucose (mmol.f’) 5.16 0.59 5.20 0.45 0.844
2 hour glucose (mmol.f’) 6.75 2.20 5.69 1.41 0.121
Fasting insulin (pLf.mf’) 8.12 5.86 5.02 1.58 0.049
C-reactive protein (mg.f’) 2.23 2.66 1.37 1.73 0.551
Adiponectin (mg.f’) 6.98 3.65 8.16 4.61 0.278
FastingNEFA (mmol.f’) 0.48 0.20 0.51 0.19 0.697
HOM A ir 1.97 1.56 1.16 0.37 0.052
Insulin Sensitivity Index (Glu) 0.84 0.62 0.92 0.54 0.241
Insulin Sensitivity Index (FFA) 1.20 0.77 I . II 0.73 0.478
* Mann Whitney U test 
4.4.3 Metabolic Param eters
The results show that HDL cholesterol concentrations were significantly lower {P = 
0.011) and fasting insulin concentrations were significantly higher {P = 0.049) in the 
offspring compared with control subjects. HOMAir score was higher in offspring 
compared with control subjects but the difference did not quite reach to statistical 
significance {P = 0.052). There were no significant differences in any other metabolic 
parameters measured (Table 4.8).
,I
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As there were no significant differences in habitual dietary intake, GI or GL between 
offspring and control subjects, the data for both groups was combined to look at the 
relationships between the dietary parameters and anthropometric characteristics and 
metabolic risk factors. Figure 3.1 shows the relationship between dietary GI and waist 
circumference in the study subjects. Dietary GI was positively and significantly 
correlated with waist circumference, an indicator of central obesity. GI was also 
significantly correlated with waist: hip ratio (r = 0.43, P = 0.013) but not correlated 
with BMI or percentage body fat. GL was not significantly correlated with any of the 
anthropometric characteristics. Furthermore, neither dietary GI or GL were 
significantly correlated with any of the metabolic risk factors measured.
Table 4.9 Relationships between anthropometric characteristics and some metabolic 
risk factors (n = 34)
Waist circumference BMI
(cm) (kg.m’*)
r P r P
Total cholesterol (mmol.f’) 0,38 0.025 0.33 0.054
Triacylglycerol (mmol.f’) 0.63 0.001 0.49 0.003
VLDL cholesterol (mmol.f’) 0.38 0.020 0.42 0.014
LDL cholesterol (mmol.f’) 0.51 0.002 0.36 0.034
HDL cholesterol (mmol.f’) -0.69 0.001 -0.49 0.003
LDL] (mmol.f’) 0.54 0,018 O.OI 0.977
TC.'HDL cholesterol ratio 0.72 0.001 0.58 0,001
C-reactive protein (mg.f’) 0.21 0.241 0.41 0.018
Adiponectin (mg.f’) -0.36 0.044 0.08 0.643
Fasting NEFA (mmol.f’) 0.12 0.510 0.01 0.597
HOMA ,R 0.52 0.002 0.50 0.003
Insulin sensitivity index (Glu) -0.39 0.043 -0.34 0.074
Insulin sensitivity index (NEFA) -0.42 0.026 -0.53 0.004
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Figure 4.10. Relationship between dietary glycaemic index (%) and waist 
circumference (cm) (Spearman’s Correlation Coefficient)
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4.4.4 Relationships between anthropometric characteristics and metabolic 
parameters
Waist circumference ws positively correlated with fasting lipids, total cholesterol, 
triacylglycerol, VLDL and LDL cholesterol, total cholesterol to HDL cholesterol 
ratio, LDL], and HOMAir score and negatively coiTelated with HDL cholesterol, 
HDL2 and the insulin sensitivity indices (Table 4.9). BMI was positively correlated 
with TAG, VLDL and LDL cholesterol, total to HDL cholesterol ratio, CRP and 
PIOMAjr score and was inversely correlated with the HDL cholesterol, and the insulin 
sensitivity index assess against NEFA (Table 4.9)
HOMAir score was significantly and positively correlated with BMI, waist 
circumference and waist to hip ratio (Table 4.10), while the insulin sensitivity indices 
were inversely conelated with waist circumference, and the insulin sensitivity index 
assessed against NEFA was inversely correlated against BMI. FIOMAir was 
positively correlated with fasting triacylglycerol, LDL cholesterol, total to HDL 
cholesterol ratio and C-reactive protein and inversely correlated with HDL cholesterol 
concentrations. The insulin sensitivity index assessed against glucose was inversely 
coiTelated with VLDL cholesterol, C-reactive protein and positively correlated with 
adiponectin concentrations. The insulin sensitivity index assessed against NEFA was 
inversely correlated with fasting triaclyglycerol, VLDL cholesterol and C-reactive 
protein (Table 4.10).
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Table 4.10^ Relationships between HOMAir and the insulin sensitivity indices (ISI
GLU, ISI NEFA) with anthropometric characteristics and metabolic
risk factors
HOMAir ISI (GLU) ISI (NEFA)
r P r P R P
BMI (kg.m‘^ ) 0.46 0.007 -0.34 0.074 -0.53 0.004
Waist (cm) 0.52 0.002 -0.39 0.043 -0.42 0.026
Waist to hip ratio 0.49 0.003 -0.36 0.057 -0.24 0.212
Total cholesterol (mmol.f’) 0.30 0.085 -0.15 0.448 -0.27 0.162
Triacylglycerol (mmol.f’) 0.48 0.004 -0.36 0.061 -0.55 0.003
VLDL cholesterol (mmol.f’) 0.22 0.220 -0.37 0.050 -0.43 0.002
LDL cholesterol (mmol.f’) 0.36 0.038 -0.11 0.569 -0.20 0.298
HDL cholesterol (mmol.f’) -0.35 0.041 0.27 0.158 0.25 0.194
TCiHlDL cholesterol ratio 0.41 0.016 -0.23 0.238 -0.31 0.103
Fasting NEFA (mmol.f’) -0.14 0.458 0.07 0.716 -0.25 0.200
C-reactive protein (mg.f’) 0.41 0.019 -0.58 0.002 -0.74 0.001
Adiponectin (mg.f’) -0.26 0.147 0.53 0.004 0.37 0.060
In offspring, CRP was positively correlated associated with BMI, waist 
circumference, HOMAir score and fasting triaclyglycerol concentrations and 
inversely correlated with the insulin sensitivity indices. In the control group, CRP was 
only correlated with the insulin sensitivity indices (Table 4.11).
i
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Table 4.1 L  Relationships between C-reactive protein with anthropometric
characteristics and metabolic parameters in offspring and control 
groups separately
Offspring {n=\l) Control
R P r P
BMI (kg.m'") 0.65 0.005 0.13 0.648
Waist circumference (cm) 0.49 0.046 -0.32 0.239
HOMAir 0.59 0.013 0.02 0.950
Insulin sensitivity index (Glu) -0.60 0.015 -0.57 0.066
Insulin sensitivity index (NEFA) -0.77 0.001 -0.65 0.032
Total cholesterol (mmol.f’) 0.39 0.126 -0.07 0.795
Triacylglycerol (mmol.f’) 0.57 0,017 -0.08 0.775
HDL cholesterol (mmol.f’) -0.31 0.227 0.36 0.183
TC:HDL cholesterol ratio 0.36 0.154 -0.34 0.211
Adiponectin (m g .f’) -0.26 0.309 O.ll 0.694
Fasting NEFA (mmol.f’) 0.40 0.130 -0.01 0.974
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4.5 Discussion
The objectives of the study were, first, to assess habitual dietary intake, glycaemic 
index (GI), glycaemic load (GL) and metabolic risk factors for CHD and type 2 
diabetes, in offspring of patients with type 2 diabetes and in control subjects. 
Secondly, to examine the relationships between dietary GI and GL with 
anthropometric characteristics and metabolic risk factors in these subjects.
The main findings of the cuiTent study were that there were no differences in habitual 
dietary intake, GI or GL between offspring and control subjects. Offspring were found 
to have greater levels of adiposity with a greater proportion of the offspring subjects 
having a BMI > 27.5 kg.m^. Female offspring were found to have a significantly 
higher waist to hip ratio (P = 0.036), and a higher waist circumference {P ~ 0.063) 
and BMI {P = 0.083) compared with female control subjects. Offspring were found to 
be significantly more insulin resistant compared with control subjects with 
significantly higher fasting insulin {P = 0.049) and higher FIOMAir (P = 0.052), and 
significantly lower HDL cholesterol concentrations (P = 0.011). While dietary GI and 
GL were not found to be directly associated with any of the metabolic parameters 
measured in the study, GI was positively correlated with waist circumference (P = 
0.039) and waist to hip ratio (P = 0.043), and these measures of adiposity (i.e. waist 
circumference and BMI) were significantly correlated with many of the metabolic 
parameters measured in the study. Thus, while the glycaemic quality of the diet did 
not appear to directly influence metabolic risk factors, the results do support the idea 
that they influence metabolic risk factors through their affect on adiposity, and in 
particular central adiposity.
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There was no difference in absolute daily energy or macronutrient intakes (Table 4.4) 
or in the proportion of energy from the main energy providing nutrients (Table 4.6) 
between offspring and control groups. This finding of no significant difference in 
dietary intake is in agreement with the results of a study carried out by Johanson et al. 
(2003) but in disagreement with the results of an earlier study by Adamson et al. 
(2001). In the present study, and in the study by Johanson et al. (2003), habitual 
dietary intake was assessed by 7-day weighed intake. In contrast, Adamson et al. 
(2001) used a food fi*equency questioimaire to assess habitual dietary intake, and the 
authors admitted excluding more than half of their subjects (60%) due to suspected 
unreliable reporting, suggesting that there may have been a problem with the 
questionnaire that they used. Adamson et al.'s (2001) findings of Tess healthy’ 
habitual diet in relatives of patients with type 2 diabetes compared with control 
subjects led the authors to suggest that “shared dietary habits amongst families could 
contribute to increased familial diabetes risk”. We found that dietary intake was 
similar between offspring and control subjects and the dietary assessment method that 
we used was a more reliable method. Thus, if our results are correct it might be the 
case that factors other than family influences on diet may be more important. This 
might not be that surprising since there are many factors that influence diet, including 
current trends and fashions in diet and cuisine, intensive advertising by the food 
industry and large supermarket chains, and also ‘healthy eating’ campaigns by health 
promotion groups (Food Standards Agency, 2004).
Dietary GI or GL were not found to be significantly different between offspring and 
control subjects, in the present study (Table 4.5.). However, the GI and GL values 
reported in the crurent study (GI 54 in both offspring and control subjects, GL 147 in
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offspring and 141 in control subjects, respectively) are similar to values reported in 
healthy adult volunteers in the UK (Haji Faraji et al. 2003). To my knowledge, no 
other study has reported on the dietary GI or GL of type 2 diabetic offspring, thus, 
very little is known regarding these dietary parameters, which have been shown to be 
associated with diabetes risk (Salmeron et al. 1997a and b).
The proportion of subjects in both the offspring and control groups who were meeting 
the UK dietary reference values (Department of Health, 1991), were compared and 
were found not to be significantly different (Table 4.7). However, a relatively small 
proportion of subjects in both groups were found to be achieving the dietary targets, 
and this was especially so for the percentage energy from starch, non-milk extrinsic 
sugars (NMES), NSP and saturated fat, showing that both groups consumed diets that 
were too high in NMES and saturated fat and too low in starch and NSP, thus both 
groups should try to improve their diet. Furtheimore, these dietary characteristics are 
associated with higher levels of insulin resistance, poorer glycaemic control and 
adverse effects on blood lipids (Hung et al. 2003).
It has been reported by a number of studies (Perseghin et ah 1997; Humphriss et al. 
1997; Ezenwaka et al. 2001), that offspring of patients with type 2 diabetes have a 
metabolic profile compared with the general population. In agreement with these 
findings, the offspring in the present study appeared to have significantly more insulin 
resistance with significantly higher fasting insulin {P = 0.049), higher HOMAir scores 
{P -  0.052) and significantly lower HDL cholesterol concentrations {P = 0.011). We 
also found that a greater proportion of offspring subjects had a BMI above the cut-off 
(BMI > 27.5) recommended by (Sargeant et al. 2001) and that female offspring had
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higher BMI {P ~ 0.083) and a greater degree of abdominal obesity (waist to hip ratio 
P = 0.036; waist circumference P = 0.063) compared with female control subjects, 
this is also in agreement with other studies (Humphriss et aL 1997; Ezenwaka et a l  
2001; Vaag et a l  2001). The offspring in this study were found to have many of the 
characteristics of the ‘metabolic syndrome’ (i.e. higher BMI and waist circumference, 
higher fasting insulin and HOMAir and lower HDL cholesterol concentrations) 
(Gibney et al. 2005) compared with individuals with no family history of type 2 
diabetes. This is not a new finding and has been reported before (Humphriss et al. 
1997; Ezenwaka et al. 2001; Vaag et al. 2001).
As habituai dietary intake, GI and GL were found to be similar between offspring and 
control groups, I decided to combine the data for both groups, to examine the 
relationships between the dietary parameters and the anthropometric and metabolic 
characteristics measured in the study. Dietary GI was found to be positively correlated 
with waist circumference (r = 0.36; P = 0.039; Figure 4.1) and waist to hip ratio {r = 
0.43; P = 0.013), in that as the as the GI of the diet increased, abdominal adiposity 
also increased. I was surprised that GL was not found to be significantly associated to 
any of the anthropometric characteristics.
Waist circumference, which is a measure o f  abdominal obesity, was found to be 
positively correlated with fasting lipids, total cholesterol, triacylglycerol, V L D L  and 
LDL cholesterol, total cholesterol to H D L cholesterol ratio, L D L 3 , and HOMAjr score 
and negatively coiTelated with H D L cholesterol, and the insulin sensitivity indices. 
BMI was positively correlated with triaclyglycerol, V L D L  cholesterol, LD L  
cholesterol, total to FIDL cholesterol ratio, C-reactive protein and HOMAir and was
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inversely correlated with HDL cholesterol concentrations and the insulin sensitivity 
index assessed against NEFA. Thus, a higher waist circumference and BMI were 
associated with a more adverse metabolic profile (Table 4.9). There are many 
different studies that have reported that increasing adiposity is associated with an 
increase in metabolic risk factors that increase risk of CHD and type 2 diabetes 
(Grundy, 2004).
Dietary GI and GL were not significantly correlated with any of the metabolic 
parameters measured in the study. However, GI was positively correlated with waist 
circumference, and waist circumference was significantly associated with most of the 
metabolic parameters. These correlations support the idea that the dietary GI could 
influence metabolic risk for diabetes through its effects on abdominal adiposity. O f 
course, correlations do not prove cause and effect. A randomised control trial would 
need to be set up to look at the effect of high and low GI diets on metabolic risk 
factors to confirm this idea.
In the present study, plasma GRP levels were not significantly different between 
offspring and control subjects (2.23 vs 1.37 mg.f \  NS; Table 4.8). My results do not 
agree with the results of a study by Pannacciulli et al. (2002) who carried out a study 
of 162 non-smoking women, and found that women with a family history of type 2 
diabetes (n = 95) had significantly higher GRP plasma levels than age- and BMI- 
matched control subject (n = 67; 5.5 vs. 3.5 mg.1'% P = 0.012). However, our results 
of similar GRP plasma levels in offspring and control subjects are in agreement with a 
more recent report by Kriketos et al. (2004) who reported that first-degree relatives of 
patients with type 2 diabetes had normal and comparable levels of GRP. However,
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like my study, the numbers in this study (19 first degree relatives and 22 control 
subjects) were relatively small, and the study may not have had adequate statistical 
power to detect a statistically significant difference between the two groups.
The relationships between plasma CRP levels and anthropometric and metabolic 
parameters were explored in this study (Table 4.11), and interestingly, it was found
that in offspring, CRP was positively correlated with BMI, waist circumference, 
HOMAir and fasting triaclyglycerol concentrations and inversely correlated with the 
insulin sensitivity indices, while in control subjects, CRP was only significantly 
correlated (inversely) with insulin sensitivity, suggesting the CRP is more sensitive to 
increasing adiposity in people with a family history of type 2 diabetes. Pannacciulli et 
aL (2002) also reported that CRP levels were positively correlated with BMI, waist 
circumference and HOM Air, in a pooled analysis of females with and without a 
family history of type 2 diabetes. Similarity, Yudkin et al. (1999) reported in a cross- 
sectional study of 107 non-diabetic subjects, that CRP levels were related to insulin 
resistance, blood pressure, HDL and fasting triaclyglycerol concentrations. Therefore, 
my results are in agreement with previous studies (Yudkin et al. 1999; Pannacciulli et 
al. 2001; 2002) which reported a positive association (possibly mediated by cytokines 
produced by adipose tissue) of BMI, waist and insulin resistance with plasma CRP 
concentrations.
In conclusion, in this study, habitual diet, GI or GL were not found to be different 
between offspring and control subjects. Both offspring and control subjects did not 
comply well with the current dietary guidelines and could have improved their diets. 
It is important for individuals, and especially for offspring of patients with type 2
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diabetes to “have a healthy diet as a number of recent large inteiwention studies (Pan et 
al. 1997; Uusitupa et aL 2000; Tuomilehto et al. 2001; Knowler et al. 2002) have 
shown that improving diet can substantially reduce risk of developing type 2 diabetes 
in people who have a high risk. Although my results showed that GI was associated 
with measures of abdominal adiposity, I did not find any significant correlations 
between GI and any of the metabolic risk factors. It is possible that GI could influence 
metabolic risk factors through an effect on abdominal adiposity, however, my study 
did not prove this. The reasons for this could have been that the study was cross- 
sectional rather than an intervention study, and also the study may not have had 
enough subjects to detect significant relationships. This does not mean that GI does 
not influence metabolic risk, as there are many epidemiological studies that have 
shown that GI may be important for risk of type 2 diabetes (Salmeron et al. 1997a; 
Salmeron et a l 1997b; Frost et al. 1999; Liu et a l 2000; Liu et al. 2001).
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Chapter 5
The effect of high and low glycaemic 
index diets on metabolic risk factors for
CHD
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5.1 Introduction
Coronary heart disease (CHD) is a leading cause of mortality and morbidity 
worldwide (FAO/WHO, 2003), and is the most common cause of death in the United 
Kingdom, being responsible for 22% and 17% of deaths in males and females, ‘‘Ï
respectively (British Heart Foundation, 2004). Type 2 diabetes is also a major public 
health concern and the number of people with the disease is expected to rise from 
135 million in 1995 to 300 million by 2025 (King et al. 1998). Insulin resistance is 
of central importance in the pathogenesis of type 2 diabetes and is also implicated in 
the development of risk factors for CHD such as abnormal blood lipid patterns.
Furthermore, suffering from type 2 diabetes is now recognised to be a risk factor for 
the development of CHD (Diabetes UK, 2004).
Current trends in health promotion emphasize the importance of reducing dietary fat 
intake (Department of Health, 1991; FAO/WHO, 2003). However, as dietary fat is 
reduced, the dietary carbohydrate content of the diet usually increases and the 
desired reduction in plasma cholesterol concentration is frequently accompanied by 
an elevation of plasma triacylglycerol (TAG) and reduced HDL-cholesterol 
concentrations (Mensink & Katan, 1992; Parks & Hellerstein, 2000) that are 
associated with an increased risk of CHD and type 2-diabetes. Furthermore, results 
from the previous experimental studies presented in this thesis have shown that 
increasing carbohydrate intakes (Chapter 3) in postmenopausal women and higher 
carbohydrate intakes in healthy relatives of individuals with type 2 diabetes and 
control subjects (Chapter 4) are associated with significantly higher TAG 
concentrations and lower HDL cholesterol concentrations.
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However, it is also evident from the literature (Parks & Hellerstein, 2000; Parks, 
2002; Hellerstein, 2002) that not all carbohydrates have the same effects on health, 
and while some have been shown to have adverse effects on health, especially with 
regard to lipid levels, it may be that it is the type of carbohydrate that dietary fat is 
replaced with that is the problem.
Traditionally carbohydrates in foods have been classified as ‘simple’ or ‘complex’ 
depending on how many sugars are in the chain. However, more recently is has been 
suggested (Jenkins et al. 1981) that it may be more useful to describe the effects of 
carbohydrates on health on the basis of their physiological effects, for example, their 
ability to raise blood glucose levels, which depend on their constituent sugars 
(glucose, fructose, and galactose), the physical foim of the carbohydrate (particle 
size and degree of hydration), the nature of the starch (amylose and amylopectin) and 
other components of the food (dietary fibre, fat). This classification is referred to as 
the glycaemic index (GI) of a food, which is a method of ranking carbohydrate- 
containing foods by their blood glucose raising ability (Jenkins et al. 1981). A high 
GI food with an equivalent carbohydrate content as a low GI food induces a larger 
area under the glucose curve over the postprandial period. Thus, reducing the rate of 
carbohydrate absoiption by lowering the GI of the diet may have several health 
benefits, such as reduced insulin demand, improved blood glucose control and 
reduced blood lipid concentrations (Augustin et al. 2002).
There is increasing evidence that the GI of carbohydrates is important in the 
prevention of and control of chronic disease (Brand-Millar, 2002; Frost, 2000; Liu et 
al. 2000). There are reports from a number of the large cohort studies that have
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investigated relationships between the dietary GI and glycaemic load (GL; GI x 
carbohydrate content) and risk of chronic disease. Results from the Nurses’ Health 
study, investigating 75 521 women over a 10-year follow up period, showed that 
individuals in the highest GL quintile had a significantly increased risk of CHD (OR: 
1.98, 95% Cl: 1.41, 2.77) (Liu et a l 2000). Data from this study following 75 543 
women over a 6 year period showed that individuals in the highest GL quintile had a 
significantly increased risk of developing type 2-diabetes (OR: 1.47, 95% Cl: 1.16, 
1.86) (Salmeron et a l 1991a), No significant association was found between dietary 
GL and type 2-diabetes in the Health Professionals Follow-up study, in which 51, 
529 men were followed for 6 years (Salmeron et a l 19976). However, individuals 
who were in the highest quartile for dietary GI had a significantly increased risk 
(OR: 1.37, 95% Cl: 1.02,1.83) of developing the condition (Salmeron et al 19976).
In a cross sectional analysis of the Nurses’ Health Study, a strong positive 
association between GL and fasting plasma TAG levels was observed in 
postmenopausal women, with a 0.0284 mmol/L increase in TAG per 25-unit increase 
of GL, along with an inverse relationship with HDL-cholesterol, 0.03 mmol/L 
reduction per 25-unit increase in GL (Liu et a l 2001). In a cross-sectional analysis 
of the Third National Health and Nutrition Examination Smwey and the Survey of 
British Adults data, significant inverse relationships between GL and HDL- 
cholesterol were obseiwed (Ford & Liu, 2000; Frost et a l 1999). However, in a 
prospective study of elderly men in the Netherlands these associations were not 
found (van Dam et a l 2000).
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A recent review of randomised controlled trials involving individuals with at least 
one risk factor for CHD by Kelly et al. (2004) reported that that low GI diets appear 
to reduce total cholesterol. In patients with diabetes, intervention studies involving 
the consumption of low GI diets have generally been found to improve plasma 
glueose and lipid profiles (Brand-Millar et al. 2003). However, whether consuming a 
diet of low GI is beneficial with regards to the improvement of risk factors for CHD 
and type 2 diabetes in the healthy non-diabetic population remains controversial. 
There are very few studies on the effects of low compared with high GI diets in 
healthy individuals, however, some of these studies have reported beneficial effects 
of a low versus a high GI diet. In the study of Bouche et al. (2002) consumption of a 
low GI diet for 5 weeks lowered postprandial glucose, insulin and TAG profiles 
compared with the high GI diet. Sloth et al. (2004) reported reduced LDL cholesterol 
concentrations after a 10-week ad libitum low GI diet in overweight healthy subjects. 
In a study involving six healthy male subjects, Jenkins et al. (1987) reported 
significant reductions in fructosamine (indicator of blood glucose control), 12-h 
blood glucose profile, 24-h C-peptide concentrations (measure of insulin secretion), 
and total serum cholesterol concentrations following a low compared with a high GI 
diets.
Therefore, it appears that there is some evidence from the large cohort studies, cross- 
sectional studies and from a limited number of intervention studies that consumption 
of a low GI diet could improve metabolic parameters such as blood glucose, insulin 
and lipid concentrations and reduce the risk of CHD and type 2 diabetes.
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CRP-and IL-6 are acute inflammatory cytokines, and associated with increased risk 
of CHD (Ridker et al. 2002; Pradhan et al. 2002) and type 2 diabetes (Hu et al. 
2004), and whose concentrations in the body appear to be related to glycaemic 
control. While CRP concentrations are known to be associated with obesity (Visser 
et al. 1999), they have also been independently associated with the HOMAir index 
(Wallace et al. 2004). In a recently published study conducted in a sample of 1000 
middle-aged subjects, CRP levels were positively and independently associated with 
fasting glucose levels, indicating that hyperglycaemia may also play an important 
role in the regulation of CRP levels. It has also been reported that CRP
concentrations were more strongly associated with post-challenge glycaemia
compared with fasting glucose levels (Festa et al. 2002). Similarly, IL-6
concentrations have been shown to be associated with insulin sensitivity,
independently of BMI (Fernandez-Real et al. 2001). Furtheimore, Esposito et al. 
(2002) showed that elevating glucose levels to 15 mmol/L for 5 hours while blocking 
endogenous insulin release significantly increased inflammatory cytokines (IL-6, IL- 
18, TNF-a) in both noimal and impaired glucose tolerant (IGT) subjects.
Thus, there appears to be a relationship between CRP, IL-6 and hyperglycaemia and 
insulin resistance, and it is conceivable that a diet that leads to better glycaemic 
control i.e. diets with a lower GI could reduce or be associated with lower levels of 
CRP and IL-6. I could only find one published report which examined this 
hypothesis. Liu et al. (2002) carried out an analysis on a sub sample of the Women’s 
Health Study Cohort and reported a strong statistically positive association between 
GL and CRP levels, and the odds ratio for the highest GL quintile compared to the
.
,5
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lowest was 9.43 (95% Cl 1.92, 46.23), suggesting that diets with higher GL are 
associated with higher CRP levels.
Therefore, there appears to be some evidence from the literature that consumption of 
a low GI diet could reduce the risk of CHD and type 2 diabetes. Thus, it may be that 
the benefits of reducing fat intake (i.e. cholesterol lowering) could be maintained, 
and the adverse effects associated with increasing carbohydrate intakes could be 
avoided if dietary fat was replaced with carbohydrates of low GL As we have 
discussed, there are very few intervention studies that have been carried out in 
healthy individuals and more studies (of both short and long-term) are needed to 
answer this question. I decided to carry out a short-term study employing healthy 
subjects whereby dietary carbohydrate intake was increased, and the diets consumed 
were either of high or low GL
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5.2 Objective
The objective of the study was to examine the influence of high carbohydrate, 
isocaloric, high and low GI and GL diets for three days on metabolic parameters in 
the fasted state including plasma lipids, glucose, insulin, NEFA and inflammatory 
markers in healthy male subjects.
It is much more effective from an economic and a personal cost perspective to 
prevent chronic diseases such as CHD and type 2 diabetes rather than to treat people 
who have already developed these conditions. For this reason, it is important to study 
the effects of different types of diets that may have a role in protecting against the 
development of these diseases in individuals who are healthy as well as those who 
already have the conditions or have a high risk. Furtheimore, two very recent meta­
analyses by Opperman et al. (2004) and Kelly et a l (2004) have suggested that more 
studies on the effects of GI on metabolic risk factors among healthy young people 
free of chronic diseases are needed.
5.3 Methodology
In this study, I was involved in the plarming of the study and the development of the 
intervention diets, I carried out the dietary (Diet 5) analysis of the subjects’ 
compliance to the interventions, and I also carried out the calculations of GI and GL 
and subsequent analysis of the data.
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5.3.1-Study design
A randomised, crossover design was used in which subjects followed high 
carbohydrate, high and low GI diets for three days, separated by a washout period of 
at least two weeks (Figure 5.1). The design of the study was based on that described 
by Koutsari et al. (2000), in which a short-term (i.e. 3-day) high carbohydrate (68% 
of energy from carbohydrate) diet that was shown to have significant effects on a 
number of metabolic parameters. Written consent was given by each of the subjects 
who participated in the study and ethical approval awarded by the University of 
Glasgow Ethical Committee.
5.3.2 Study outline
Subjects attended five separate visits to the Human Performance Laboratoiy, located 
in the Kelvin Building, University of Glasgow. During the first visit, subjects were |
signed the consent form at this visit. Subjects were randomised to start either a high 
or a low GI diet. At the second visit a fasting blood sample was taken and food for 
the first dietary inteiwention was provided, along with individualised version of the 
menu plans shown in figures 5.2 and 5.3, and careful instructions on how to follow 
the diet. Anthropometric measuiements were also taken during this visit and only 
body weight was measured at each subsequent visit. The third visit took place, after 
a 12 hour fast, on the morning after the final day of the first dietary intervention, 
during which another fasting blood sample was taken. After the washout period the 
subjects attended their fourth visit to the laboratory where a third fasting blood 
sample was taken (washout sample) and food, menu plans and instructions for the
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given written and oral instructions explaining how to complete a 3-day weighed
Irecord of their habitual diet. Digital scales and a diary were provided. Subjects also
I
second dietary intervention was provided. The final visit took place the morning 
following the final day of the secondary intervention when a final fasting blood 
sample was taken. Subjects were instructed not to drink alcohol, change their 
activity levels or participate in vigorous exercise over the study period, as these are 
factors known to affect blood lipids.
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5.3.3-Subjects
The subjects who participated in this study were fellow students and friends of the 
BSc and MSc students who were involved in the study. Fourteen apparently healthy 
male subjects participated in the study. Subjects were required to fulfil the following 
inclusion and exclusion criteria;
Inclusion criteria:
• Healthy,
• Normal body weight (i.e. body mass index of between 18.5-25 kg/m'^)
• Recreationally active (exercising not more than three times per week)
• Not on weight reducing diet/ weight stable for 1 month prior to testing
Exclusion criteria:
• Taking prescribed medications known to influence lipid metabolism, 
nutritional supplements and following a special diet (e.g. vegetarian)
• Smoking
5.3.4 Anthropometric measurements
Anthropometric measurements were carried out in the fasted state at the end of the 
habitual diet-recording period using standard procedures and body weight was 
measured in the fasted state at each visit. Height (m) (Stadiometer, Holtan Ltd. 
Crymych) and weight (kg) (SECA scales) were measured and body mass index 
(BMI) was calculated using the following formula: BMI = weight (kg)/(height (m^)). 
Waist, hip and mid upper arm circumferences were measured using standard 
procedures. Body fat was estimated by skinfold thickness. Three measurements at 
each of four different sites (biceps, triceps, subscapular and supiliac) in the standing 
position were taken using callipers (Holtain Ltd. Crymych, UK) and then averaged.
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The -sum of the four skinfold thickness measurements were used for body fat 
calculation using the equations of Dumin & Wormersley (1974).
5.3.5 Development and design of the high and low glycaemic index diets
Prior to starting the study, a number of students who participated in the study carried 
out a 7-day weighed intake of their habitual diet to determine their approximate daily 
energy intake. The energy intake of the subjects averaged 2,500 kcal per day and the 
energy content of the standard intervention diets shown figures 5.2 and 5.3 were 
based on this value. The main high and low GI foods for the intervention diets were 
then selected using the International table of Glycaemic Index and Glycaemic Load 
values (Foster-Powell et al. 2002). The low GI foods chosen were porridge, 
wholemeal rye bread, lentil soup, spaghetti (cooked for only 5 minutes) and apple 
juice. The high GI foods chosen were wholemeal bread, cornflakes, instant mashed 
potato and lucozade. Initial drafts of the diets were constructed with these high and 
low GI foods and other foods were added to the diet to make them palatable and to 
ensure that they would provide adequate energy intake. A substantial amount of time 
was required to ensure that the high and low GI diets contained similar energy, 
proportions of energy from carbohydrate, fat and protein, and that the amount of 
non-starch polysaccharide was as similar as possible. Supermarket research was then 
carried out to make sure that these foods were readily available and could be 
purchased within the budget for the study. It was also important the foods contained 
in the diet did not require too much preparation or cooking.
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5.3.6 High and low glycaemic index diets
The intervention diets were designed to be iso-energetic, high in carbohydrate 
(approximately 70% of energy from car bohydrate), low in fat (approximately 17% 
energy from fat) and contain equal amounts of dietary fibre, and to differ only in GI 
and GL. The nutritional composition o f the diets is shown in table 1. Menus of the 
standard intervention diets are provided in Figure 5.2 and 5.3, and the major high and 
low glycémie foods highlighted in bold. As already mentioned, subjects completed a 
3-day diet record o f their habitual diet. These diaries were analysed using Diet 5. A 
new individually planned diet was created based on the standard diets, but modified 
so that it would be iso-energetic with the habitual diet of the subjects. We also could 
have predicted the subjects’ energy requirements using the Schofield et aL (1985) 
equations to estimate BMR and by adjusting for a moderate level o f physical 
activity. Using o f this method would have avoided the problems associated with 
under-reporting. However, we were also able to use the 3-day diet records to 
examine the quality of the diet and the GI and GL.
5.3.7 Dietary analysis, calculation of glycaemic index and glycaemic load
Dietary analysis of the habitual and intervention diets was carried out using a 
computerised version (Diet 5^^, Robert Gordon University, Aberdeen) of the food 
composition tables (Holland et al. 1991). GI values were taken from the International 
table of GI and GL values (Foster-Powell et al. 2002). GL of individual foods were 
calculated by multiplying the amount of carbohydrate, in grams, in each food 
(obtained from Diet 5™, Robert Gordon University, Aberdeen) with their respective 
GI value and dividing by 100. The GL for each diet was obtained by finding the sum 
of each individual GL value. The GI o f each diet was calculated by dividing the GL
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of the diet by the total amount of carbohydrate in the diet (obtained from Diet 5^^) 
then multiplying by 100.
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Tabfe 5.1 Nutritional Com position o f the high and low glycaem ic index diets
High GI diet Low GI diet
Energy (Kcal) 2524 2531
Percentage energy from
CHO 69.9 70.7
Fat 17.1 17.5
Protein 13.0 U.8
NSP (g) 2&2 24.5
GI 77 35
GL 358 155
Figure 5.2. High Glycaemic Index Diet
Breakfast
Wholemeal bread (2 slices) with jam (40g) and low fat spread (14g) 
Mug tea (260g) with semi-skimmed milk (40g)
Corn Flakes (55g) with semi skimmed milk (lOOg)
Morning Snack 
Apple (150g)
Lunch
Ham sandwich (made with 4 slices wholemeal bread (140g) with low fat spread (28g) and
lean ham (48g)
Glass of lucozade (330g)
Afternoon snack 
Glass of lucozade (330g)
Evening meal 
Glass of lucozade (330g)
Low fat chicken casserole (200g)
Instant potato cooked (240g) with lOg of low fat spread 
Peas boiled (65g)
Evening snack
Wholemeal bread (2 slices) with jam (40g) and low fat spread (14g) 
Mug tea (260g) with semi-skimmed milk (40g)__________
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Figure 5.3. Low Glycaemic Index Diet
Breakfast
Glass apple juice (330g), Mug tea (260g) with semi-skimmed milk (40g) 
Bowl porridge (made with semi-skimmed milk) (300g) 
Wholemeal rye bread (2 slices) + low-fat spread (14g)
Morning Snack 
Banana (green/under-ripe) (120g), Apple (150g)
Lunch
Ham sandwich (made with rye bread (50g) with low fat spread (14g) and lean ham (48g) 
Can lentil soup (400g), apple juice (330g)
Apple (150g)
Afternoon snack 
Banana (green/under-ripe) (120g), Apple (150g)
Evening meal
Spaghetti (boiled for only 5 minutes) (400g cooked weight) 
Pasta sauce (355g), apple juice (330g)
Low fat fruit yogurt (200g)
Evening snack
Wholemeal rye bread (50g) with low fat spread (14g) + 2 slices processed cheese (40g)
Glass water
5.3.8 Compliance
The diets were designed to ensure maximum compliance by using foods that were 
easy to prepare and involved little cooking. All foodstuffs were provided to the 
subjects and in many cases delivered to their homes. Subjects were provided with 
individually tailored versions of the menus plans shown in figures 5.2 and 5.3 along 
with clear written and oral instructions, and subjects were able to make at any time 
by telephone if they had any queries. Subjects were encouraged to follow the 
individually tailored menu plans as closely as possible and to note changes, if any, 
which were returned to the investigators during the laboratory visit following the 
dietary intervention and analysed using Diet 5™ (Robert Gordon University,
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Aberdeen) to assess reported compliance to the prescribed diets. GI and GL of the 
actual diets were calculated as already described. I carried out the analysis of 
compliance to the diets myself.
5.3.9 Blood sampling
Blood sampling was carried out by my supervisor using a cannula inserted into a 
forearm vein. A cannula was used as subjects took part in an exercise trial involving 
additional blood sampling after the fasted blood sample was obtained. Fasted blood 
samples were taken into EDTA (2 x 7ml) and lithium heparin (1 x 6ml) vacutainers 
and were centrifuged (Mistral BOOOi, Sanyo Gallenkamp pic, Leicester UK) at 3,000 
rpm for 10 min at 4 °C. After separation, plasma was alliquoted into pre-labelled 
ependorf tubes that were then stored at -70 for analysis later on. EDTA plasma 
was used for the analysis of plasma lipids, glucose, NEFA, CRP and IL-6, while 
lithium heparin plasma was used for the analysis of insulin.
5.3.10 Laboratory analysis
The majority of the laboratory analysis for this study was carried out at the 
Department of Pathological Biochemistry (lipids, glucose, NEFA, CRP) or the 
Department of Biochemistry (insulin) at the Glasgow Royal Infirmary. For this 
reason only a brief indication of the methods are provided here and full details of 
each of the methods are given in Chapter 2. Interleukin-6 measurements were carried 
out at the Department of Human Nutrition and the method is described below. 
Plasma samples collected into EDTA were used for determinations of TAG, total 
cholesterol, HDL cholesterol, non-esterified fatty acid (NEFA) and glucose by 
standard enzymatic colorimetric procedures (Roche Diagnostic Corporation, Lewes,
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UK)r Low-density lipoprotein (LDL) cholesterol concentrations were calculated 
using the Friedelwald equation (Friedelwald et al. 1972). Insulin concentrations were 
determined from lithium heparin plasma using an automated analyser technique 
(Abbot IMX) and dry slice technology. Analysis of C-reactive protein was carried 
out in EDTA plasma samples using an in house ELISA (Highton & Hessian, 1984). 
Finally, from the fasting insulin and fasting glucose values, the HOMA index was 
calculated (fasting insulin x fasting glucose/22.5) and used as a measure of insulin 
resistance (Matthews et al. 1985).
Interleukin-6 (IL-6) determination was performed using a quantitative sandwich 
enzyme linked immunosorbent assay (ELISA) kit (R&D Systems, Europe Ltd). The 
Quantikine High Sensitivity kit was chosen since all our subjects were healthy 
individuals and no extreme values were expected. The analysis was performed at the
I
Department of Human Nutrition laboratory in Yorkhil hospital by an MSc student 
(Dimitrios Kessaris), one of my supervisors (Dr Siobhan Higgins) and with the help w
of an experienced technician (Alexander Fletcher). The full method is described in 
the methodology chapter (Chapter 2). :V
5.3.11 Statistical analysis )i'
I carried out a power calculation before starting the study to find out how many if
subjects would be needed to see a statistically significant difference in fasting TAG 
levels. The information for the power calculation was collected in my first study and 
I used baseline and week one of the intervention TAG concentrations to calculate the 
mean difference and the standard deviation of the difference (mean difference = -  
0.046; standard deviation of the difference = 0.0529; Power = 80%). The results of
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thisj)ower calculation showed that at least 8 subjects would be needed in the present 
study.
As mentioned above, a total of fourteen subjects completed the trial, however not all 
of these subjects were included in the statistical analysis and the reasons for that are 
given here. The results for one of the subjects were excluded from analysis as this 
subject was found to have dyslipidemia according to the cut off values (TAG > 2.26 
mmol/L, total cholesterol > 6.22 mmol/L and LDL-cholesterol >4 .14) defined by the 
National Cholesterol Education Program (NCEP) (2001). Thus, the number of 
subjects that I have for the dietary, lipid, glucose, insulin and NEFA results for is 
thiiteen. There were two other subjects for which results for CRP and thiee subjects 
for which IL-6 results were not analysed and therefore the subject number is 11 for 
CRP and 10 for IL-6.
Data were expressed as mean ± standard deviation (SD) for normally distributed 
variables and median and range for non-parametric variables. Data was checked for 
normality by inspecting the histograms in SPSS. All variables apart from CRP and 
IL-6 data were normally distributed. Where data were normally distributed, paired t- 
test was used to compare mean values before and after dietary intervention for 
significant differences. Where data was not normally distributed, the comparison was 
made using Wilcoxon Signed Ranlcs test. Statistical analysis was performed using 
SPSS (version 11.0) and P values less than 0.05 were considered to be statistically 
significant.
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5.4 Results
5.4.1 Subject characteristics
The mean body mass index (BMI) for the group was within the healthy range (20-25 
kg.m'^), however, three of the thirteen subjects were classified as overweight with a 
BMI over 25 kg.m'^. However, these subjects were not excluded from the study as 
their waist circumference (<102 cm ; Janssen et al 2004) and percentage body fat 
(<25%) were within the acceptable ranges for good health (American Council on 
Exercise, 2004) (Table 5.2). Body weight remained constant over each study period.
Table 5.2. Subject characteristics at baseline (n=13)
Characteristics Mean SD Min Max
Age (years) 24.2 4.5 19.0 33.0
BMI (kg.m'^) 23.9 2.0 20.2 26.9
Waist circumference (cm) 79.8 5.0 71.4 87.5
Waist to hip ratio 0.84 0.05 0.78 0.94
Body fat (%) 15.0 2.7 10.7 19.2
Mid upper arm 31.0 3.4 23.0 35.0
circumference (cm)
5.4.2 Daily energy and m acronutrient intakes (absolute amounts)
The low and high glycaemic index (GI) intervention diets consumed were 
significantly higher in carbohydrates, sugar, non-milk extrinsic sugar, starch, non­
starch polysaccharides and protein compared with the subjects’ habitual diet. The 
intervention diets consumed were significantly lower total fat, polyunsaturated fat 
and alcohol compared to the subjects’ habitual diet. The low GI diet was 
significantly lower in saturated and monounsaturated fat compared to the subjects 
habitual diet. As expected, the GI of the low GI diet was significantly lower that the
Ihabitual diet and the GI of the high GI intervention diet was significantly higher
I
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compared to the subjects habitual diet. The glycémie load (GL) of the high GI diet 
was significantly higher that the subjects habitual diet (Table 5.3).
'I"
While the high and low GI intervention diets were designed to be similar 
nutritionally with exception of GI and GL, the low GI diet consumed was found to 
be significantly higher in the intake of sugars (f-0 .001) and polyunsaturated fat 
(T=0.006) compared to the high GI diet (Table 5.3).
5.4.3 Percentage of energy from the main energy producing macronutrients in 
habitual, low and high GI diets
The percentage of energy derived from total fat and each of the different types of fat 
and protein in both intervention diets consumed by the subjects was significantly
lower compared with subjects’ habitual diet. The proportion of energy from 
carbohydrates, sugars, non-milk extrinsic sugar, and starch was significantly higher 
in both low and high GI diets compared with habitual diet.
There were no differences in percentage of energy from carbohydrates, non-milk 
extrinsic sugar, starch, and non-starch polysaccharides between the intervention 
diets. However, the mean percentage of energy from sugar was significantly greater 
in the low compared with high GI diet (P=0.001). There was no significant 
difference in percentage of energy from total fat, saturated and monounsaturated fat 
between low and high GI diets while the percentage of energy from polyunsaturated 
fat was significantly lower in the high GI diet compared with the low GI diet 
( f =0.011). No significant difference was found in other energy-producing 
macronutrients between the two intervention diets (Table 5.4).
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5.4.4- Fasting plasma lipid concentrations
There were reductions in total cholesterol, HDL cholesterol level and LDL 
cholesterol following low GI diet (T=0.029, T=0.009 and P=0.058, respectively) 
compared with baseline values. After the high GI diet, HDL cholesterol 
concentration was also significantly lower than baseline. However, the ratio of total 
cholesterol to HDL cholesterol was significantly higher (P=0.009) after the high GI f
diet compared with baseline. TAG levels were significantly increased after both the 
high and low GI diets compared to baseline. TAG concentrations were significantly L
higher after the low GI diet compared with after the high GI diet ( f =0.004). There 
were no significant differences in any of the other plasma lipids after the intervention 
diets (Table 5.5).
.
5.4.5 Fasting NEFA, glucose, insulin, HOMAir
There were no significant changes in fasting NEFA, glucose, insulin concentrations 
or HOMAir score after the low or high GI diets compared with baseline values. 
Furthermore, there were no significant differences in any of these parameters 
between the low and high GI diet interventions (Table 5.6).
5.4.6 Fasting C-reactive protein (CRP) and interleukin-6 (IL-6) concentrations 
As the data for IL-6 and CRP were not normally distributed, the median and range 
for the data is presented (Table 5.7). The medians for CRP were higher after both the 
low and high GI diets compared with baseline values, however the changes were not 
statistically significantly. However, CRP concentrations after the low GI diet were 
almost significantly higher (P=0.075) compared with baseline concentrations. When
■■■■■the individual CRP concentrations were examined, CRP concentrations were found
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to be higher after either high (6/11) or low (7/11) GI diets in 9 of the 11 subjects 
(Figure 5.4).
The medians for IL-6 concentrations were also higher after both the low and high GI 
diets compared with baseline values, however the differences were not statistically 
significant. When the IL-6 concentrations were examined for each individual (Figure 
5.5), it was found that IL-6 concentrations were higher after either low (5/10) and 
high (6/10) in 7 o f the 10 subjects for which IL-6 results were available.
207
II01IXJ
IX)
5I' af
Î
**a.
0) oi
3 I
■-
s
f
I
X)I
Q00
I
Q
00
IN IN-ON ooo gON iO O V O o
oNT INNO CNm OIN go O o o o
OOON 00p g NCNo rri CN cri
i i sO
OOVOo
OOCN
o o o o o
mVO op NOp 3 mONo o o o o
IN'p oON NOp oom CNCN
rri (N rri
r--p r~\q NOp CNIN CNo o o o o
COoo NO o ONVO N-Oo CN cri
oooCN
IIi t
62,%% %^  gI 1ii*w) =i l lXX a ■+r{C3 .2« <u X<L> B w
3 % O
%%S33 o
a s E
1 1o <uJS gA ag oO22'v, •c SX« aa 1B C3
! O 1
«S Ba. ft,4t* -KCQ
T3
N" m N- N-CNIN l/NON in pO O o O
OO ON O nNO o o NO OO•X p T f po o o O
i l st i
9h-j gI
mO o en<Nmo pO o c r i o
o <Nun ooN- ON p
O N
tN On unp p o IN
O O cri O
OO f—, CM N -N ; p
O u n  N .—1
N N* l> ONun p p
O O ,—1 o
O n (N NO CNP O N p
O un NO .—1
I
e I« b  8s %% X X X
1 1  .s .H11 
I I
i lW qj 
11 ilCi 3
:  gII« ai!4c 4t
P<
N- o
en N-
O O
en ©o'tN p
P T-2o urip TÇ
o O
N NP
O O
u n ONN uno oo
O o
INN " CN
CNCN
o'p u n
O o
NO N-N" N
O O
CNu np p
O '—1
O NOo ■Nt
o O
u n 00CNpo o
Tj
o ba
1 Io
a NOIo
> o
y og1
o  B
MI
-g
1.^  0D«3% gg|II^  g S '«| .  P“I1w B
IÆI •S!!
•H t
mA
I
&
ONOCN
Figure 5.4. Individual C-reactive protein concentrations at baseline, after low and 
high GI diets
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Figure 5.5. Individual interleukin-6 concentrations at baseline, after low and high 
GI diets.
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5.5 Discussion
The aim of this study was to investigate the short-term effects of two high- 
carbohydrate, low-fat high and low glycaemic index (GI) diets on a number of 
fasting metabolic parameters using a randomised crossover design in healthy male 
subjects.
Reported compliance to the intervention diets showed that as planned, the low and 
high GI diets were of equal energy content with the habitual diets, and the 
intervention diets were significantly higher in carbohydrate (increased from 46.9% to 
%70% of energy) and lower in fat (reduced from 33.7% to «17% of energy) 
compared with the habitual diets. Furthermore, the GI values of the low (36.2 ±1.1) 
and high (70.0 ± 2.7) GI diets consumed were significantly different from that of the 
habitual diet (55.9 ± 4.4) and were significantly different from each other. The 
glycaemic load (GL) of the high GI diets (332.3 ± 83.8) consumed were also 
significantly higher compared with those of the subjects’ habitual (159.1 ± 30.8) and 
low GI diets (162.1 ± 18.6). Thus, subject compliance to the prescribed diets in this 
study appears to have been very good.
The main findings of the present study were that both high-carbohydrate, low-fat 
intervention diets significantly increased fasting plasma TAG and significantly 
reduced HDL cholesterol concentrations, and the low GI diet also reduced total and 
LDL cholesterol (almost significant; P = 0.058) concentrations. Furthermore, the 
increase in fasting plasma TAG was greater after the low GI diet compared with the 
high GI diet. There were no significant changes in fasting plasma NEFA, glucose or 
insulin concentrations, or in the HOMAir score following either of the intervention
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diets.- Although no statistically significant changes in either IL-6 or CRP were 
observed following either the high or low GI diets, there does appear to be a trend for 
both of these high carbohydrate diets to have increased these inflammatory markers.
The increase in fasting plasma TAG and the reduction in HDL cholesterol 
concentrations observed after both of these high-carbohydrate, low-fat intervention 
diets are consistent with many previous reports (Mensinlc & Katan, 1992; Parks et a i
1999). This finding is also in agreement with a study of similar design in which 
switching to a high carbohydrate diet (68% of total energy intake) for tliree days 
resulted in an increase in fasting TAG and a reduction in HDL cholesterol 
concentration (Koutsari et aï. 2000).
The mechanism for the increase in TAG after consumption of a high carbohydrate 
diets is debated but is most likely due to an increase in hepatic secretion and 
synthesis of VLDL-TAG (Blades & Garg, 1995; Mittendorfer & Sidossis, 2001). 
The two mostly likely sources of the fatty acids used for TAG synthesis are believed 
to be firstly, fatty acids derived from the plasma non-esterified fatty acid pool, which 
in the fasted state, mainly come from adipose tissue; and, secondly, fatty acids 
synthesised from glucose in the liver or de novo lipogenesis (Parks et al. 2002). It 
has also been suggested that a reduction in TAG clearance may occur following a 
high-carbohydrate diet, and there are two mechanisms by which TAG clearance 
could be effected (Parks et a l 1999). The first is via lipoprotein lipase, an enzyme 
that hydrolyses core TAG off circulating chylomicrons and VLDL. One hypothesis 
is that increases in insulin after high carbohydrate diet decreases lipoprotein lipase 
activity in muscle, leading to decreased TAG clearance. The second mechanism by
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which TAG clearance from plasma is believed to occur is via a receptor mediated 
process (which could be down-regulated by a high-carbohydrate diet) in which TAG- 
rich lipoproteins are taken up by the liver (Parks et al, 2002). Which of these 
mechanisms is most important when high carbohydrate diets cause an elevation in 
TAG is not currently known.
Elevated TAG concentrations are associated with lowered HDL cholesterol 
concentrations as was found following both intervention diets in the present study. 
Increased TAG concentrations due to an increased carbohydrate intake have been 
shown to lead to adverse changes in HDL and LDL cholesterol via excessive transfer 
of TAG catalysed by the action of cholesterol ester transfer protein (CETP). The 
accumulation of excessive amounts of TAG on HDL and LDL leads to the removal 
of TAG from these lipoproteins via hepatic lipase resulting in the formation of small, 
dense lipoprotein particles (Gibney et al. 2003). In the case of HDL, smaller, more 
dense particles are more quickly broken down by the liver leading to reductions in 
circulating levels as we observed in the present study. A second explanation for the 
lower HDL cholesterol concentrations observed might be the reduced need for 
cholesterol to be removed out of circulation due to the lower dietary saturated fat 
intake of the high-carbohydrate, low-fat intervention diets (Velez-Carrasco et al.
1999). On the other had, small, dense LDL remains in circulation for longer as it is 
not well recognised by the LDL receptor. Due to its small size and the fact that it 
remains in circulation for longer periods than normal, it is better able to penetrate the 
endothelium and contribute to the development of atherosclerosis (Gibney et al. 
2003).
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The results this study appear to suggest that a high carbohydrate diet of low GI has 
more hannful effects on fasting plasma TAG, short-term, than a high carbohydrate 
diet of high GI, as TAG concentrations were significantly higher after the low GI 
diet compared with the high GI diet (P = 0.004). This adverse effect on fasting TAG 
after the low GI diet was unexpected. Numerous intervention studies have examined 
the effects of dietary GI on TAG in individuals with diabetes under macronutrient- 
controlled condition, and the majority reported that plasma TAG was reduced by a 
low GI diet (Ludwig, 2002). However, a recent Cochrane review (Kelly et aL 2004) 
reported no evidence of an effect of a low GI diet on plasma TAG in individuals with 
at least one risk factor for or established CHD. I could find no other study on healthy 
subjects of similarly short duration comparing low and high GI diets on plasma 
TAG, and studies in which the intervention period was of longer duration (ie. two 
weeks or more) have reported either no significant differences (Jenkins et al. 1987; 
although TAG was reduced in five of the six subjects studied) or changes (Sloth et 
al. 2004), or significantly reduced postprandial TAG (Bouche et al. 2002).
The low GI diet was higher in sugar compared with the high GI diet, and this may be 
the reason for the adverse effect on TAG, as sugars have been reported to have a 
more adverse effect on TAG than other types of carbohydrate (Parks and Hellerstein, 
2000). The amount of sugar calculated (using Diet 5) to be in the low GI diet was 
significantly higher (260.4g ± 44.0g; P = 0.001) compared with the high GI diet 
(177.4g ± 39.2g) (Table 5.3). There was approximately an 83g calculated difference 
in the amount of sugar between the diets. This seems to be related to the amount of 
intrinsic food sugars rather than the non-milk extrinsic sugars (NMES) supplied by 
foods such as apple juice, lucozade, pasta sauce or yoghurt. In fact there was no
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difference calculated in the NMES contents of the intervention diets (140.6 ± 24.4 
vs. 141.0 ± 15.6; NS) (Table 5.3). The low GI diet in this study contained two 
bananas (weighing 240g; 20.9g sugar per lOOg banana = 50.2g sugar) and two apples 
(weighing 300g; 11.8g sugar per lOOg apple = 35.4g) more than in the high GI diet, 
which seems to have supplied this additional sugar. The food tables show that the 
carbohydrate contained in bananas is almost all sugars (Holland et aL 1991), and in 
particular sucrose, galactose and fructose (Forster et aL 2002). Unfortunately I did 
not carry out a chemical analysis of the inteiwention diets. However, Englyst & 
Cummings (1992) studied the digestion and absorption of the carbohydrate in 
bananas by feeding ileostomy subjects bananas of different degrees of ripeness. The 
authors reported a ten-fold difference in non digestible starch in very ripe and not so 
ripe bananas with 37% of the dry weight in the least ripe being non digestible starch 
to only 3% of the dry weight in the bananas that were most ripe. Thus, with 
progressive ripeness there is a decrease in starch and an increase in the sugar content 
of bananas (Ercan et aL 1993). As the bananas used in the study were green 
(therefore under-ripe) they probably contained much more non-digestible starch than 
sugar. Thus the difference in the sugar contents of the diets may have been over­
estimated, and the low GI diet may only have contained about 35g of sugar (from the 
apples) more than the high GI diet. Thus, it may have been this additional sugar 
supplied by the two extra apples that caused the more adverse effect on TAG of the 
low GI diet.
In the present study, there was a reduction in total cholesterol {P ~ 0.029) and LDL 
cholesterol (almost significant, P = 0.058) after the low GI diet but not after the high 
GI diet. This finding is in agreement with most previous studies which have show
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that a low GI diet reduces either total or LDL cholesterol or both parameters. Ludwig 
(2002) reviewed twelve studies involving diabetic and hyperlipidémie patients, and 
reported that in all but one of theses studies, a low GI diet was associated with lower 
LDL cholesterol concentrations. In the recent review by Kelly et al. (2004), a meta­
analysis of pooled data from thirteen studies showed a mean reduction in total 
cholesterol of 0 .17mmol/L, P = 0.03 (95% confidence interval -0.32 to -0.02) but no 
evidence of an effect of low GI diets on LDL cholesterol. In the studies that have
"1been carried out on healthy individuals, Jenkins et al. (1987) reported a reduction in f
total cholesterol of 15 ± 3% (P < 0.01) after the low GI diet. Sloth et al. (2004) 
reported a 10% decrease (P < 0.05) in LDL cholesterol and a tendency for a larger
reduction in total cholesterol (P = 0.06) with consumption of the low GI as compared ?
1
with the high GI diet. Bouche et al. (2002) reported a tendency for a reduction in 
total cholesterol (P = 0.065) as well as apo B (P = 0.076) after the low GI 
intervention of their study. A reduction of fat intake, especially saturated fat intake, 
as occurred with both intei’vention diets in this study, is known to reduce cholesterol
is
levels. A reduction in saturated fat is believed reduce cholesterol in the circulation by
up-regulating the LDL receptors in the liver to increase the uptake of cholesterol out
of circulation and thus reducing total plasma levels and that carried by the
,lipoprotein fractions (Conor & Conor, 1997; Gibney et al. 2003). However, this 
could explain why both intei-vention diets would have reduced cholesterol not why 
the low GI diet only had these effects.
Our results appear to show a trend towards increased levels of inflammatory markers 
after both high carbohydrate intervention diets with no clear difference between the 
high and low GI interventions. CRP concentrations were non-significantly increased
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after-both the low (P=0.075) and high GI diets compared with baseline values, and 
individual CRP concentrations higher in 9 of the II subjects after the dietary 
interventions. Similarly, median IL-6 concentrations were non-significantly 
increased after both diets compared with baseline values, and IL-6 concentrations 
were higher in 7 of the 10 subjects.
However, there were a number of factors associated with the design of this study 
which may not have made it the most suitable for investigating the effects of these 
diets on inflammatory markers. This study was initially designed primarily to 
examine the effect of the diets on plasma lipids and the power calculation was 
carried out using data for TAG concentrations. However, a power calculation was 
can'ied out retrospectively using the IL-6 data, and this showed that 25 subjects 
would have been necessary to identify significant changes in IL-6. Thus, it is very 
likely that the present study did not have the statistical power to see a difference in 
inflammatory markers between these two diets. Also, the length of dietary 
interventions was based on the time needed to see a change in plasma lipids, and as 
there is no other similar study in the literature, it is not known the length of dietary 
intervention that would be optimal, if any, to observe a change in inflammatory 
markers with high and low GI diets.
There were no changes in fasting NEFA, glucose or insulin concentrations, or in 
HOMAir observed in the present study. Fasting concentrations of these metabolites 
are well regulated, and this may be the reason that we were not able to observe any 
changes. In addition, the fact that healthy individuals were employed as subjects 
made it more difficult to see changes in these metabolites (Parks & Hellerstein,
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2000) However, it could be speculated that the changes in fasting lipid 
concentrations and the trend towards increases in the inflammatory markers observed 
were due to changes in the day time profiles of these metabolites during the three- 
day dietary intervention. For example, increasing the carbohydrate contents of the 
diets to approximately 70% energy may have resulted in higher day-time profiles of 
glucose and insulin, especially on the high GI diet. Unfortunately, we were not able 
to measure the day-time profiles of these metabolites at part of the present study, 
however, postprandial changes that occur during high and low GI diets are clearly 
shown in a number of other studies (Jenkins et al. 1987; Kiens & Richer, 1996). 
Jenkins et al. (1987) reported that while fasting glucose concentrations were not 
different after twelve days on a high GI diet compared with a low GI diet, 12-hour 
blood glucose profiles were found to be significantly higher. Similarly, in the study 
of Kiens & Richer (1996), while morning fasting insulin concentrations were not 
different after high and low GI diets, serum insulin concentrations were found to be 
significantly lower after the lunch-time meal after three days on a low GI diet 
compared with the high GI diet.
There were a number of limitations associated with this study. Ideally, I would have 
like to have measured lipids not only in the fasted state but also collected 
postprandial blood samples. It is generally agreed ((Zilversmit, 1979; Chen et al. 
1995; Jeppessen et al. 1995; Frayn et al. 1997; Frayn, 1998a; 1998c; Koutsari et al. 
2000; Lemieux et al. 2000; Yu and Cooper 2001; Daly 2003; Wole ver and Mehling, 
2003a; Wolever et al. 2004; Parks et al. 2002) that disease risk is better predicted by 
a postprandial test, especially in the case of TAG, as most individual are in the 
postprandial state for 16-18 h/d and only in the fasted state for about 6 h in the
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middle of the night. Unfortunately, collection of postprandial blood samples was not 
possible in this study.
The calculation of GI and the GL of the diets was performed using published 
glycaemic index tables (Foster-Powell et a l 2002) rather than actually measuring the 
GI of the foods or meals or diets themselves. In addition, while the tables provided 
data for all the foods used in the two intervention trials some of the foods of the 
habitual diets of the subjects were missing from the tables. As mentioned above, in 
that case GI values of similar foods were used. These factors may have led to 
incoiTect estimations of the GI and the GL of the diets and for this reason the 
difference between the two intervention diets and the habitual diet may not have 
been as great as estimated.
Another limitation o f our study is that we used a three day weighed diet record to 
assess subjects’ habitual energy intake. Ideally we would have used the doubly 
labelled water method to assess habitual energy expenditure, which is recognised as 
the more objective measm'e of habitual energy intake. However, this technique is 
expensive and was beyond the scope of this study. However, we could have asked 
subjects to record their habitual diets for at least seven days which would have been 
more reliable than thi'ee days..
In conclusion, the results of this study showed a beneficial effect of a low versus a 
high GI diet on total and LDL cholesterol concentration. However, as regards effects 
on TAG and HDL cholesterol, no benefits of a low GI were found, but this was 
probably due to the high carbohydrate content of the diets. Surprisingly, the low GI
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diet appeared to have a more adverse effect on TAG which may be explained by the 
fact that the low GI diet was higher in sugar. Overall, the results suggest that in a 
high carbohydrate diet, the total carbohydrate and sugar content of the diet may have 
a more important influence on lipids and other metabolic parameters than the 
glycaemic index of the diet. That is not to say that glycaemic index of the diet is not 
important, and there are several epidemiological studies which support a beneficial 
effect low GI diets (Salmeron et al. 1997a; Salmeron et a l 1997b; Frost et a l 1999; 
Liu et al. 2000; Ford & Liu, 2000; Liu et a l 2001). Furthermore, diets of low GI 
tend to be associated with other healthy dietary attributes, for example, they tend to 
contain more whole grain, more non-starch polysaccharide, antioxidants and other 
micronutrients, and tend to be lower in fat. This was an experimental, mechanistic 
type study and future studies should look at the effects of glycaemic index diets in 
diets with a more realistic carbohydrate content (50% energy) which would have 
more relevance to real life situations and to public health.
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Chapter 6
General discussion and conclusion
221
6.1 Introduction
Coronary heart disease (CHD) is leading cause of death and ill health worldwide 
(FAO/WHO, 2004), and is the most common cause of mortality in the United 
Kingdom (British Heart Foundation, 2004), and it is a particularly serious problem in 
Scotland (The Scottish Office, 2000). Type 2 diabetes is also a major public health 
concern with the rates o f this condition increasing rapidly worldwide (King et aL 
1998), and worryingly the disease has also started to appear in children (Aboderin,
2001). Also, individuals who develop type 2 diabetes have a high risk o f developing 
CHD (Niskanen et al. 1998)
Insulin resistance, which is the term given to the situation in which the actions o f 
insulin are blunted in the presence o f normal or increased insulin secretion (Gibney 
et aL 2005), is a central feature in the development of type 2 diabetes and is now 
recognised to play a role in many o f the risk factors for CHD such as abnormal lipid 
levels or dyslipidemia. It is also now recognised that insulin resistance may be the 
common link between obesity, impaired glucose tolerance or type 2 diabetes, 
dyslipidemia (high LDL cholesterol, low HDL cholesterol, high TAG 
concentrations), hypertension and impaired fibrinolysis which together have been 
called metabolic syndrome or syndrome X (Reaven et aL 1996).
Diet has an important role to play in the prevention o f CHD, type 2 diabetes, the 
metabolic syndrome and insulin resistance (Hankey & Leslie, 2001; Fung et aL 
2001; Joshipura et aL 2001; Hu et aL 2001b; Poulter, 2003). The most important 
aspect o f diet seems to be to consume a diet that will provide enough energy to 
maintain a healthy body weight and avoid overweight. O f course, regular physical
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activity is a very important part o f maintaining a healthy body weight. However, as 
well as the overall energy intake, the composition o f the diet has also been shown to 
be important, and cunent dietary guidelines recommend a reduction in total and 
saturated fat intake and increasing carbohydrate intake, especially complex 
carbohydrates (Department o f Health, 1991; Department of Health, 1994; 
FAO/WHO, 2003)
However, as dietary fat is reduced and is replaced with carbohydrate, the desired 
reduction in LDL cholesterol is often accompanied by abnormal lipid concentrations 
such as an increase in TAG concentrations and a reduction in HDL cholesterol 
concentration (Jeppesen et al. 1997; Mensink & Katan, 1992), which has been shown 
to be associated with increased risk o f CHD (Austin et al. 1999).
However, not all carbohydrates have the same effects on health (Parks & Hellerstein, 
2000) and it may be that carbohydrates that are broken down into their constituent 
sugars very quickly and have consequent effects on raising blood glucose and insulin 
levels are the problem. Glycaemic index (GI) is a physiological measm’e o f the 
ability o f carbohydrate foods to raise blood glucose levels (Jenkins et al. 1981). A 
food with a high GI produces a much larger area under the blood glucose curve after 
consumption compared with a low GI food of equivalent carbohydrate content. The 
glycaemic load (GL) is a measm’e o f both the GI and the amount o f carbohydrate 
contained in a food. Examples o f foods with low GI include pulses, wholegrain foods 
such as rye bread, and porridge; and examples of high GI foods include white bread, 
mashed potato and cornflakes. When foods with similar amount of carbohydiate are 
compared, there is a gap o f (up to 10 fold diflFerences) in their glycaemic effects 
(Foster-Powell et al. 2002; Brand-Miller & Holt, 2004).
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There j s  currently much interest in the concept of GI and in the ability of low GI 
diets to reduce risk o f chronic disease. There is evidence available from a number o f 
large epidemiological studies that have shown that the dietary GI and GL may be 
important in the prevention o f CHD (Liu et al. 2000) and type 2 diabetes (Salmeron 
et al. 1997a; Salmeron et al. 1997b) and in the contiol o f risk factors for these 
diseases (Frost et al. 1999; Ford & Liu, 2000; Liu et al. 2001; Brand-Milier et al. 
2003). However, not all studies have shown that GI is important in risk o f chronic 
disease (van Dam et al. 2000).
Furthermore, it seems that there is no general agreement about the importance o f GI 
on human health, nutrition and disease prevention (Ludwig & Eckel 2002). In fact 
while a number o f major organisations (European Association for the Study o f 
Diabetes, EASD, 2000; Canadian Diabetes Association, 2000; FAO/WHO, 2003; 
Diabetes UK, 2003) encourage the use o f the GI concept, there are also a number of 
large organisation who do not accept or encourage the use o f GI in dietary 
management (American Heart Association, 2000; American Diabetes Association 
2001).
The objectives of the studies in this thesis were:
1. To investigate the effect o f advice to increase carbohydrate intake as pai t o f 
dietary advice to follow the UK dietary guidelines on some metabolic risk 
factors for CHD in healthy free-living postmenopausal women (Chapter 3).
2. To assess habitual dietary intake, GI, GL, anthropometric measurements and 
metabolic risk factors for CHD and type 2 diabetes (Chapter 4).
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3 . - To examine the relationships between GI, GL and anthropometric 
characteristic and metabolic risk factors in offspring o f patients with type 2 
diabetes and in control subjects (Chapter 4).
4. To examine the influence o f high carbohydrate, isocaloric, high and low GI 
diets for three days on metabolic parameters in the fasted state in healthy 
male subjects (Chapter 5).
6.2 Summary of findings
6.2.1. Study to investigate the effect of advice to increase carbohydrate intake as 
part of dietary advice to follow the UK dietary guidelines on metabolic risk 
factors for CHD in healthy free-living postmenopausal women
After the menopause, women lose the protective effects that the reproductive 
hormones have on lipid metabolism, and their risk o f CHD is increased (Rich- 
Edwards et al. 1995; Jeppesen et al. 1997). There are no specific dietaiy guidelines 
for the prevention o f CHD for postmenopausal women, and the role o f diet and in 
particular, caibohydrate intake has not been well studied in this vulnerable group. In 
this study, effect of increasing car bohydrate intake, with emphasis on starch, as part 
o f dietary advice to follow the current dietary guidelines on some metabolic risk 
factors for CHD was examined in a group of postmenopausal women.
The main finding of this study showed that there was a significant reduction in body 
mass index (BMI) after the four-week intervention. Subjects appear to have followed 
the dietary advice given as they reported significantly reducing their total daily
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energy, fat and non-milk extrinsic sugar (NMES) intake, and significantly increasing 
their total carbohydrate, starch and non-starch polysacchai ide (NSP) intake. Subjects 
also significantly increased their dietary GI and GL during the intervention. There 
was an adverse effect on fasting plasma lipids including an increase in fasting TAG, 
and a decrease in HDL cholesterol concentrations. A number o f correlations were 
carried out, and they showed a protective effect of complex carbohydrates and starch 
and an adverse effect o f simple sugars on fasting plasma lipid concentrations. 
Subjects reported increasing their consumption o f fruit and vegetables, and there was 
a significant increase in the ‘antioxidant power’ of plasma as measured by FRAP. 
This appears to have mostly been associated with an increase in fiuit intake.
The dietary intervention was associated with a significant reduction in BMI, and this 
was likely to be due to the fact that the subjects reduced their energy intake as a 
result o f following advice to reduce fat intake. However, even though subjects were 
asked not to change their lifestyle or physical activity levels (other than diet) during 
the study, activity levels were not measured or recorded, therefore it is not definite 
that the observed reduction in BMI was not due to an increase in physical activity. 
The advice to increase carbohydrate intake was also associated with significant 
increases in dietary GI and GL, which from the literature would be associated with 
increased risk o f CHD (Liu et al. 2000) and type 2 diabetes (Salmeron et al. 1997a 
and b) and a worsening o f metabolic risk factors (Frost et ah 1999; Ford & Liu; 
2000; Liu et ah 2001) for these diseases. The advice given in this intervention study 
was associated with adverse eflfects on TAG and HDL cholesterol, however, the 
advice to increase fruit and vegetable intake appears to have had a positive effects on 
the ‘antioxidant power’ o f plasma. In conclusion, although the dietary advice given
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to these women appeared to have some important positive effects on health, namely 
on weight loss and on the ‘antioxidant power’ of plasma, adverse effect on plasma 
lipids were also observed. Thus, the findings of the present study show that more 
research is needed to develop more appropriate dietary advice for reducing not only 
some but all aspects of risk o f CHD in postmenopausal women.
In this study, it was seen from the correlations that were cairied out that simple 
sugar's appeared to have a more adverse effect on plasma lipids than starch. Due to 
this finding, it was decided that it would be very interesting to look at relationships 
between GI, which is a physiological measure of the blood glucose raising ability of 
carbohydrate containing foods which might reveal the real effects o f carbohydrates 
on plasma lipids and other metabolic risk factors in data that had already been 
collected on offspring o f patients o f type 2 diabetes and control subjects.
6.2.2. Relationships between dietary glycaemic index and metabolic parameters in 
offspring of patients with type 2 diabetes and control subjects.
Type 2 diabetes is a major public health concern as it increases risk of CHD and 
other complications and its rates are increasing worldwide. Offspring o f patients with 
type 2 diabetes have an increased risk o f developing the condition, and this is 
thought to be due to both genetic and lifestyle factors such as diet and physical 
activity. Improving diets has been shown in a number of large intervention studies 
(Pan et al. 1997; Uusitupa et al. 2000; Tuomilehto et al. 2001; Knowler et al. 2002) 
to substantially reduce the risk o f developing type 2 diabetes in high risk groups. 
Furthermore, a number o f cohort studies (Salmeron et al. 1997a; Salmeron et al.
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1997b) have shown that diets with low GI and GL may be protective against the 
development of type 2 diabetes.
The main findings o f this case control study on offspring o f patients of type 2 
diabetes (offspring) and control subjects showed that there were no differences in 
habitual dietary intake, GI or GL between the groups. Only a small proportion of the 
offspring and control subjects followed the dietary guidelines. A number o f recent 
large intervention studies (Pan et al. 1997; Uusitupa et al. 2000; Tuomilehto et al. 
2001; Knowler et al. 2002) have shown that improving diet can substantially reduce 
risk o f developing type 2 diabetes in people who have a high risk. However, the 
offspring subjects in this study did not seem to be aware o f their higher risk o f 
developing diabetes, as they were not found to be following a healthier diet than the 
control subjects. Offspring were found to have greater levels o f adiposity with a 
greater proportion o f the offspring subjects having a BMI > 27.5 kg.m^. Female 
offspring were found to have a significantly higher waist to hip ratio (P ~ 0.036), and 
a higher waist circumference {P = 0.063) and BMI (P = 0.083) compared with 
female control subjects. Offspring were found to have a poorer metabolic profile and 
appeared to be significantly more insulin resistant compared with control subjects 
with significantly higher fasting insulin (P = 0.049) and higher HOMAjr (P = 0.052), 
and significantly lower HDL cholesterol concentrations (P = 0.011).
A number of correlations were carried outto study relationships between the 
glycaemic quality o f the diet and anthropometric characteristics and metabolic risk 
factors. Dietary GI and GL were not found to be directly associated with any o f the 
metabolic parameters measured in the study, but GI was positively correlated with 
waist circumference (P = 0.039) and waist to hip ratio (P = 0.043), and these
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measures o f adiposity (i.e. waist circumference and BMI) were significantly 
correlated with many of the metabolic parameters measured in the study. Thus, while 
the glycaemic quality of the diet did not appear to directly influence metabolic risk 
factors, the results do support the idea that they influence metabolic risk factors 
through their affect on adiposity, and in particular central adiposity. O f cour se this 
study was not able to show this for certain. In support of these findings there are 
many large epidemiological studies (Salmeron et a l 1997a; Salmeron et a l 1997b; 
Frost et ah 1999; Liu et ah 2000; Liu et ah 2001) that have shown that GI may be 
important for risk o f type 2 diabetes.
Thus, this cross-sectional study provided some idea that the glycaemic quality o f the 
diet could have an effect on metabolic risk factors, which is supported by 
epidemiological studies. There were very few intei-vention studies that had been 
carried out in healthy individuals, o f either short or longer-term. It was decided that 
it would be interesting to see if the benefits o f reducing fat intake (i.e. cholesterol 
lowering) could be maintained, and the adverse effects associated with increasing 
carbohydrate intakes (increasing TAG and reducing HDL cholesterol) that were 
observed in the first study on postmenopausal women, could be avoided if dietary fat 
was replaced with carbohydrates of low GL For this reason, it was decided to cany 
out a high and low GI intervention study on healthy individuals using a high- 
carbohydrate, short-term study model (Koutsari et ah 2000), which had been shown 
to be a good model for studying effects on plasma lipids.
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6.2.3. _ The influence of high carbohydrate, isocaloric, high and low GI diets for 3 
days on metabolic parameters in the fasted state in healthy male subjects.
This was a randomised, cross-over study in which subjects recorded theh habitual 
diet and had a baseline blood sample taken and then followed high carbohydrate, 
high and low GI diets for three days with a washout period between. The results of 
the study showed that the low GI diet had some beneficial effects in that it reduced 
total and LDL cholesterol. Both high and low GI diets had adverse effects on TAG 
and HDL cholesterol concentrations but this was probably due to the fact that the 
diets were very liigh in carbohydrate (70% energy intake) as high carbohydrate diets 
have been shown to have this effect in many other studies. TAG concentrations were 
found to be higher after the low GI diet, which was surprising, as studies in the 
literature have generally reported that low GI diets either have no effect or reduce 
TAG concentrations. In this study, this could possibly be explained by the fact that 
the low GI diet was higher in sugars compared with the high GI diet, and it has been 
reported that sugars have an adverse effect on plasma lipids (Parks & Hellerstein,
2000). These results are interesting and suggest that the overall carbohydrate and 
sugai- content o f the diet have a more important influence on plasma lipids and other 
metabolic parameters than the glycaemic quality o f the diet. O f course, it should be 
remembered that the intervention diet used in this study was high in carbohydrate 
and for this reason, these results may not be applicable to the general population who 
would probably not have this much cai'bohydrate in their diet. Many studies have 
shown beneficial effect o f low GI diets (Salmeron et al. 1997a; Salmeron et al. 
1997b; Frost et al. 1999; Liu et al. 2000; Ford & Liu, 2000; Liu et al. 2001). Also, 
diets o f low GI tend have other healthy chaiacteristics, for example, they tend to 
contain more non-staich polysaccharide, antioxidants and other micronutrients, and
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tend to be lower in fat. All o f these dietary aspects have been shown to have 
protective health effects. Finally, it should be remembered that his was an 
experimental, mechanistic type study and future studies should look at the effects of 
glycaemic index diets in diets with a more realistic carbohydrate content (50% 
energy) which would have more relevance to real life situations and to public health.
Before concluding this thesis, a few methodological points will be considered. First, 
it would have been better to assess lipids in the postprandial as well as the fasted 
state. It is generally agreed (Zilversmit, 1979; Parks et al. 2002) that disease risk is 
better predicted by a postprandial test, especially in the case of TAG, as most 
individual are in the postprandial state for 16-18 h/d and only in the fasted state for 
about 6 h in the middle o f the night. Unfortunately, collection o f postprandial blood 
samples was not possible in this study.
An important issue when studying the GI and GL is that the calculation o f GI and the 
GL of the diets was performed using published glycaemic index tables (Foster- 
Powell et al. 2002) rather than actually measuring the GI of the foods or meals or 
diets themselves. Thi'oughout the world there are just 15 laboratories that have been 
approved to measure that actual GI of the foods (Foster-Powell et al. 2002). This is 
a very difficult issue when considering the many variations in foods, food 
composition and food preparation all o f which may affect digestibility and glycaemic 
response. It would be impossible to measiue GI directly for each food in a study, but 
if GI and GL are to be used for scientific research then much more comprehensive 
tables are needed to cover the huge range o f foods and country specific data may be 
needed.
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Each o f  the studies in this thesis involved dietary assessment methods and there are 
well known errors associated with these methods including reporting error, 
difficultly in assessing real habitual diet, errors associated with using the food tables. 
It must be admitted that the use o f the cut-offi for exclusion o f under and over­
reporters are limited and imperfect as they only exclude individuals who have 
reported biologically implausible energy intakes and do not identity individuals who 
mis-report to a lesser degree. The methods for dealing with these are described in the 
relevant chapters.
6.3 Conclusion
In both the intervention studies described in my thesis, adverse effects o f increasing 
carbohydrate intakes on plasma lipids were found. In the first study, healthy free- 
living postmenopausal women were simply advised to increase thefr carbohydrate 
intake to the level recommended by the current dietary guidelines (50-55% energy) 
(Chapter 3). The second was an experimental, more mechanistic type, high 
carbohydrate (70% energy) intervention study in which healthy male subjects were 
provided with all the foods and give detailed instructions on diet (Chapter 5). The 
adverse effects on plasma lipids include an increase in TAG and a reduction in HDL 
cholesterol concentration, and are associated with in increased risk of CHD (Austin 
et al. 1999). In my thfrd study (Chapter 5), even when subjects were advised to 
increase carbohydrate intake and the carbohydrate food were low GI, adverse effects 
on these lipid pai’ameters were still observed. Thus, it seems that increasing 
carbohydrate intake even if the carbohydrate is low GI still has adverse effects on 
plasma lipids. O f coui se, the particular characteristics o f the low GI diet used in oui" 
study, which was high in carbohydrate and sugar may explain this.
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While-there are many epidemiological studies that have reported protective effects o f 
low GI diets on risk o f CHD and type 2 diabetes and these have been referred to 
numerous times in this thesis, in fact very few intervention studies have been carried 
out looking at the effect of GI on metabolic risk factors in healthy individuals. Two 
meta-analyses on the effects on health effects of GI have recently been published, 
one on mainly diabetic individuals (Opperman et al. 2004) showing that low GI diets 
significantly reduced indicators o f glycaemic control, total and LDL cholesterol but 
no significant effects on HDL cholesterol or TAG were reported. The other on 
individuals with at least one risk factor for CHD (Kelly et al, 2004) reported weak 
evidence o f an effect o f low GI diets on total cholesterol but no evidence o f an effect 
on LDL or HDL cholesterol, TAG, fasting glucose or insulin levels.
GI is a measure o f the blood glucose raising ability o f carbohydrate foods and in 
general low GI diets are made up of carbohydr ate foods that release glucose slowly 
into the blood stream. It is by this mechanism that it is hypothesised that low GI diets 
would have a beneficial effect on glycaemic control, blood, lipids and other 
metabolic parameters. However, one problem with GI is that foods that are liigh in 
fructose such as ripe sweet fruit and foods sweetened with high fructose com syrup 
have low GI values. This is because fructose does not have the same effect on raising 
blood glucose and stimulating insulin secretion and causes a smaller blood 
postprandial insulin secretion compared with glucose containing foods (Elliott et al.
2002). However, the problem is that fructose still does have adverse effects on TAG 
levels (Jeppessen et al. 1995). Thus, this issue may be a major problem with the use 
of GI and for this reason, it may be better to go back to the idea o f advising people to 
eat more slowly digestible carbohydrates, for example beans pulses and whole 
grains, rather than low GI diets which could still contain a lot o f fr uctose-containing
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foods_which may mask the positive effects of the low GI diet on lipids and especially 
TAG.
If we are to give beneficial dietary advice to the general public then we need to give 
advice based on good science and using good communication. Most people do not 
understand which foods are high in sugar but have a low GI and, as seen in study 
one, the response to advice to increase carbohydrate intake often resulted in 
increased sugars. We need to do more research to find develop better and more 
specific dietary guidelines and to educate the public so they can use them 
appropriately.
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